2023Q3FALSE--12-31000106887500010688752023-01-012023-09-3000010688752023-10-30xbrli:shares00010688752023-09-30iso4217:USD00010688752022-12-31iso4217:USDxbrli:shares00010688752023-07-012023-09-3000010688752022-07-012022-09-3000010688752022-01-012022-09-300001068875us-gaap:CommonStockMember2022-12-310001068875us-gaap:AdditionalPaidInCapitalMember2022-12-310001068875us-gaap:RetainedEarningsMember2022-12-310001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001068875us-gaap:TreasuryStockCommonMember2022-12-310001068875us-gaap:CommonStockMember2023-01-012023-03-310001068875us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-3100010688752023-01-012023-03-310001068875us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001068875us-gaap:RetainedEarningsMember2023-01-012023-03-310001068875us-gaap:CommonStockMember2023-03-310001068875us-gaap:AdditionalPaidInCapitalMember2023-03-310001068875us-gaap:RetainedEarningsMember2023-03-310001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001068875us-gaap:TreasuryStockCommonMember2023-03-3100010688752023-03-310001068875us-gaap:CommonStockMember2023-04-012023-06-300001068875us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000010688752023-04-012023-06-300001068875us-gaap:TreasuryStockCommonMember2023-04-012023-06-300001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001068875us-gaap:RetainedEarningsMember2023-04-012023-06-300001068875us-gaap:CommonStockMember2023-06-300001068875us-gaap:AdditionalPaidInCapitalMember2023-06-300001068875us-gaap:RetainedEarningsMember2023-06-300001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001068875us-gaap:TreasuryStockCommonMember2023-06-3000010688752023-06-300001068875us-gaap:CommonStockMember2023-07-012023-09-300001068875us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001068875us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001068875us-gaap:RetainedEarningsMember2023-07-012023-09-300001068875us-gaap:CommonStockMember2023-09-300001068875us-gaap:AdditionalPaidInCapitalMember2023-09-300001068875us-gaap:RetainedEarningsMember2023-09-300001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001068875us-gaap:TreasuryStockCommonMember2023-09-300001068875us-gaap:CommonStockMember2021-12-310001068875us-gaap:AdditionalPaidInCapitalMember2021-12-310001068875us-gaap:RetainedEarningsMember2021-12-310001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001068875us-gaap:TreasuryStockCommonMember2021-12-3100010688752021-12-310001068875us-gaap:CommonStockMember2022-01-012022-03-310001068875us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-3100010688752022-01-012022-03-310001068875us-gaap:TreasuryStockCommonMember2022-01-012022-03-310001068875us-gaap:RetainedEarningsMember2022-01-012022-03-310001068875us-gaap:CommonStockMember2022-03-310001068875us-gaap:AdditionalPaidInCapitalMember2022-03-310001068875us-gaap:RetainedEarningsMember2022-03-310001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001068875us-gaap:TreasuryStockCommonMember2022-03-3100010688752022-03-310001068875us-gaap:CommonStockMember2022-04-012022-06-300001068875us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000010688752022-04-012022-06-300001068875us-gaap:TreasuryStockCommonMember2022-04-012022-06-300001068875us-gaap:RetainedEarningsMember2022-04-012022-06-300001068875us-gaap:CommonStockMember2022-06-300001068875us-gaap:AdditionalPaidInCapitalMember2022-06-300001068875us-gaap:RetainedEarningsMember2022-06-300001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001068875us-gaap:TreasuryStockCommonMember2022-06-3000010688752022-06-300001068875us-gaap:CommonStockMember2022-07-012022-09-300001068875us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001068875us-gaap:RetainedEarningsMember2022-07-012022-09-300001068875us-gaap:CommonStockMember2022-09-300001068875us-gaap:AdditionalPaidInCapitalMember2022-09-300001068875us-gaap:RetainedEarningsMember2022-09-300001068875us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001068875us-gaap:TreasuryStockCommonMember2022-09-3000010688752022-09-300001068875avta:CeteraHoldingsMemberavta:AvantaxIncMembersrt:ScenarioForecastMember2023-11-012023-11-300001068875avta:CeteraHoldingsMemberavta:AvantaxIncMembersrt:ScenarioForecastMember2023-11-300001068875us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberavta:FormerTaxSoftwareBusinessMember2022-10-312022-10-31avta:segment0001068875us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberavta:FormerTaxSoftwareBusinessMember2023-01-012023-09-300001068875us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberavta:FormerTaxSoftwareBusinessMember2023-07-012023-09-300001068875us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberavta:FormerTaxSoftwareBusinessMember2022-07-012022-09-300001068875us-gaap:DiscontinuedOperationsDisposedOfBySaleMemberavta:FormerTaxSoftwareBusinessMember2022-01-012022-09-300001068875us-gaap:TransferredAtPointInTimeMemberavta:CommissionRevenueMember2023-07-012023-09-300001068875us-gaap:TransferredAtPointInTimeMemberavta:CommissionRevenueMember2022-07-012022-09-300001068875us-gaap:TransferredAtPointInTimeMemberavta:CommissionRevenueMember2023-01-012023-09-300001068875us-gaap:TransferredAtPointInTimeMemberavta:CommissionRevenueMember2022-01-012022-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredAtPointInTimeMember2023-07-012023-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredAtPointInTimeMember2023-01-012023-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300001068875us-gaap:TransferredAtPointInTimeMember2023-07-012023-09-300001068875us-gaap:TransferredAtPointInTimeMember2022-07-012022-09-300001068875us-gaap:TransferredAtPointInTimeMember2023-01-012023-09-300001068875us-gaap:TransferredAtPointInTimeMember2022-01-012022-09-300001068875avta:AdvisoryRevenueMemberus-gaap:TransferredOverTimeMember2023-07-012023-09-300001068875avta:AdvisoryRevenueMemberus-gaap:TransferredOverTimeMember2022-07-012022-09-300001068875avta:AdvisoryRevenueMemberus-gaap:TransferredOverTimeMember2023-01-012023-09-300001068875avta:AdvisoryRevenueMemberus-gaap:TransferredOverTimeMember2022-01-012022-09-300001068875us-gaap:TransferredOverTimeMemberavta:CommissionRevenueMember2023-07-012023-09-300001068875us-gaap:TransferredOverTimeMemberavta:CommissionRevenueMember2022-07-012022-09-300001068875us-gaap:TransferredOverTimeMemberavta:CommissionRevenueMember2023-01-012023-09-300001068875us-gaap:TransferredOverTimeMemberavta:CommissionRevenueMember2022-01-012022-09-300001068875avta:AssetBasedRevenueMemberus-gaap:TransferredOverTimeMember2023-07-012023-09-300001068875avta:AssetBasedRevenueMemberus-gaap:TransferredOverTimeMember2022-07-012022-09-300001068875avta:AssetBasedRevenueMemberus-gaap:TransferredOverTimeMember2023-01-012023-09-300001068875avta:AssetBasedRevenueMemberus-gaap:TransferredOverTimeMember2022-01-012022-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredOverTimeMember2023-07-012023-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredOverTimeMember2022-07-012022-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredOverTimeMember2023-01-012023-09-300001068875avta:TransactionAndFeeRevenueMemberus-gaap:TransferredOverTimeMember2022-01-012022-09-300001068875us-gaap:TransferredOverTimeMember2023-07-012023-09-300001068875us-gaap:TransferredOverTimeMember2022-07-012022-09-300001068875us-gaap:TransferredOverTimeMember2023-01-012023-09-300001068875us-gaap:TransferredOverTimeMember2022-01-012022-09-300001068875avta:AdvisoryRevenueMember2023-07-012023-09-300001068875avta:AdvisoryRevenueMember2022-07-012022-09-300001068875avta:AdvisoryRevenueMember2023-01-012023-09-300001068875avta:AdvisoryRevenueMember2022-01-012022-09-300001068875avta:CommissionRevenueMember2023-07-012023-09-300001068875avta:CommissionRevenueMember2022-07-012022-09-300001068875avta:CommissionRevenueMember2023-01-012023-09-300001068875avta:CommissionRevenueMember2022-01-012022-09-300001068875avta:AssetBasedRevenueMember2023-07-012023-09-300001068875avta:AssetBasedRevenueMember2022-07-012022-09-300001068875avta:AssetBasedRevenueMember2023-01-012023-09-300001068875avta:AssetBasedRevenueMember2022-01-012022-09-300001068875avta:TransactionAndFeeRevenueMember2023-07-012023-09-300001068875avta:TransactionAndFeeRevenueMember2022-07-012022-09-300001068875avta:TransactionAndFeeRevenueMember2023-01-012023-09-300001068875avta:TransactionAndFeeRevenueMember2022-01-012022-09-300001068875us-gaap:CustomerRelationshipsMember2023-01-012023-09-300001068875srt:MaximumMember2023-09-300001068875avta:AmendedAndRestatedCreditFacilityMember2023-09-300001068875avta:AmendedAndRestatedCreditFacilityMember2022-12-310001068875avta:AmendedAndRestatedCreditFacilityMemberavta:TermLoanMember2023-01-240001068875avta:AmendedAndRestatedCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-01-240001068875avta:AmendedAndRestatedCreditFacilityMemberavta:TermLoanMember2023-02-242023-02-240001068875avta:AmendedAndRestatedCreditFacilityMemberavta:TermLoanMember2023-04-012023-06-300001068875avta:AmendedAndRestatedCreditFacilityMember2023-01-240001068875avta:TermLoanMember2023-09-300001068875us-gaap:RevolvingCreditFacilityMember2023-09-300001068875avta:AmendedAndRestatedCreditFacilityMemberavta:TermLoanMember2023-09-30xbrli:pure0001068875srt:MinimumMemberavta:AmendedAndRestatedCreditFacilityMemberavta:TermLoanMember2023-01-012023-09-300001068875srt:MaximumMemberavta:AmendedAndRestatedCreditFacilityMemberavta:TermLoanMember2023-01-012023-09-300001068875avta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875avta:SecuredOvernightFinancingRateSOFRMembersrt:MinimumMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875avta:SecuredOvernightFinancingRateSOFRMembersrt:MaximumMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875avta:SecuredOvernightFinancingRateSOFRMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875us-gaap:FederalFundsEffectiveSwapRateMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875us-gaap:BaseRateMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875srt:MinimumMemberus-gaap:BaseRateMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875srt:MaximumMemberus-gaap:BaseRateMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875srt:MinimumMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875srt:MaximumMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875avta:DebtCovenantPeriodOneMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875avta:AmendedAndRestatedCreditFacilityMemberavta:DebtCovenantPeriodTwoMember2023-01-242023-01-240001068875avta:DebtCovenantPeriodThreeMemberavta:AmendedAndRestatedCreditFacilityMember2023-01-242023-01-240001068875avta:CorporateHeadquarters5YearSubleaseMember2023-01-012023-09-300001068875avta:CorporateHeadquarters10YearSubleaseMember2023-01-012023-09-300001068875us-gaap:IndemnificationGuaranteeMember2023-09-300001068875us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-09-300001068875us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueInputsLevel3Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-12-310001068875us-gaap:DesignatedAsHedgingInstrumentMemberavta:InterestRateCollarsMember2023-09-300001068875us-gaap:DesignatedAsHedgingInstrumentMemberavta:InterestRateCollarsMember2022-12-310001068875us-gaap:DesignatedAsHedgingInstrumentMember2023-09-300001068875us-gaap:DesignatedAsHedgingInstrumentMember2022-12-310001068875us-gaap:InterestRateCapMemberus-gaap:NondesignatedMember2023-09-300001068875us-gaap:InterestRateCapMemberus-gaap:NondesignatedMember2022-12-310001068875us-gaap:NondesignatedMember2023-09-300001068875us-gaap:NondesignatedMember2022-12-310001068875avta:AccruedExpensesAndOtherCurrentLiabilitiesMember2023-09-300001068875avta:InterestRateCollarsMemberus-gaap:CashFlowHedgingMember2023-04-012023-06-30avta:derivativeContract0001068875avta:InterestRateCollarsMemberus-gaap:CashFlowHedgingMember2023-06-300001068875avta:InterestRateCollarsMemberus-gaap:CashFlowHedgingMember2023-09-300001068875us-gaap:InterestRateCapMemberus-gaap:CashFlowHedgingMember2023-09-300001068875avta:InterestRateCollarsMembersrt:ScenarioForecastMemberus-gaap:CashFlowHedgingMember2023-04-012026-05-310001068875avta:InterestRateCollarsMember2023-07-012023-09-300001068875avta:InterestRateCollarsMember2022-07-012022-09-300001068875avta:RevenueMemberavta:InterestRateCollarsMember2023-07-012023-09-300001068875avta:RevenueMemberavta:InterestRateCollarsMember2022-07-012022-09-300001068875avta:InterestRateCollarsMember2023-01-012023-09-300001068875avta:InterestRateCollarsMember2022-01-012022-09-300001068875avta:RevenueMemberavta:InterestRateCollarsMember2023-01-012023-09-300001068875avta:RevenueMemberavta:InterestRateCollarsMember2022-01-012022-09-300001068875us-gaap:InterestRateCapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember2023-04-012023-06-30avta:derivativeContractSold0001068875us-gaap:InterestRateCapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember2023-06-300001068875us-gaap:InterestRateCapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember2023-09-300001068875us-gaap:InterestRateCapMemberus-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember2023-01-012023-09-300001068875us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateCapMember2023-07-012023-09-300001068875us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateCapMember2022-07-012022-09-300001068875us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateCapMember2023-01-012023-09-300001068875us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateCapMember2022-01-012022-09-300001068875avta:InterestRateCollarsMember2022-12-310001068875avta:DeferredTaxesMember2022-12-310001068875avta:InterestRateCollarsMember2023-03-310001068875avta:DeferredTaxesMember2023-03-310001068875avta:InterestRateCollarsMember2023-04-012023-06-300001068875avta:DeferredTaxesMember2023-04-012023-06-300001068875avta:InterestRateCollarsMember2023-06-300001068875avta:DeferredTaxesMember2023-06-300001068875avta:InterestRateCollarsMember2023-07-012023-09-300001068875avta:DeferredTaxesMember2023-07-012023-09-300001068875avta:InterestRateCollarsMember2023-09-300001068875avta:DeferredTaxesMember2023-09-3000010688752023-01-272023-01-270001068875srt:MinimumMember2023-01-270001068875srt:MaximumMember2023-01-270001068875avta:StockRepurchaseAuthorizationProgramMember2022-12-190001068875avta:StockRepurchaseAuthorizationProgramMember2023-07-012023-09-300001068875avta:StockRepurchaseAuthorizationProgramMember2023-01-012023-09-300001068875avta:StockRepurchaseAuthorizationProgramMember2023-09-300001068875avta:StockRepurchaseAuthorizationProgramMember2022-07-012022-09-300001068875avta:StockRepurchaseAuthorizationProgramMember2022-01-012022-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

  
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2023
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                          to                     
Commission File Number: 000-25131
avantaxlogo.jpg
Avantax, Inc.
(Exact name of registrant as specified in its charter)
Delaware91-1718107
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
3200 Olympus Blvd, Suite 100, Dallas, Texas 75019
(Address of principal executive offices) (Zip Code)
(972870-6400
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.0001 per shareAVTANASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. ý Yes o No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  ý Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
ý
Accelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ý No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
As of October 30, 2023, 36,811,784 shares of the registrant’s Common Stock were outstanding.



TABLE OF CONTENTS
Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
This report includes some of the trademarks, trade names, and service marks of Avantax, Inc. (referred to throughout this report as “Avantax,” the “Company,” “we,” “us,” or “our”), including Avantax Wealth Management, Avantax Planning Partners, Avantax Retirement Plan Services, HD Vest, 1st Global, and HKFS. Each one of these trademarks, trade names, or service marks is either (i) our registered trademark, (ii) a trademark for which we have a pending application, (iii) a trade name or service mark for which we claim common law rights, or (iv) a registered trademark or application for registration that we have been authorized by a third party to use.
Solely for convenience, the trademarks, service marks, and trade names included in this report are without the ®, ™, or other applicable symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the rights of the applicable licensors to these trademarks, service marks, and trade names. This report may also include additional trademarks, service marks, and trade names of others, which are the property of their respective owners. All trademarks, service marks, and trade names included in this report are, to our knowledge, the property of their respective owners.
References to our or our subsidiaries’ website addresses or the website addresses of third parties in this report do not constitute incorporation by reference of the information contained on such websites and should not be considered part of this report.




CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q (“Form 10-Q”) contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Many of the forward-looking statements are located in Part I, Item 2 of this Form 10-Q under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “anticipates,” “believes,” “plans,” “expects,” “future,” “intends,” “may,” “will,” “would,” “could,” “should,” “estimates,” “predicts,” “potential,” “continues,” “target,” “outlook,” and similar terms and expressions, but the absence of these words does not mean that the statement is not forward-looking. Actual results may differ significantly from management’s expectations due to various risks and uncertainties including, but not limited to:
our ability to effectively compete within our industry;
our ability to generate strong performance for our clients and the impact of the financial markets on our clients’ portfolios;
our expectations concerning the revenues we generate from fees associated with the financial products that we distribute;
our ability to attract and retain financial professionals, employees, and clients, as well as our ability to provide strong client service;
the impact of significant interest rate changes;
our ability to maintain our relationships with third-party partners, providers, suppliers, vendors, distributors, contractors, financial institutions, industry associations, and licensing partners, and our expectations regarding and reliance on the products, tools, platforms, systems, and services provided by these third parties;
political and economic conditions and events that directly or indirectly impact the wealth management industry;
our ability to respond to rapid technological changes, including our ability to successfully release new products and services or improve upon existing products and services;
our future capital requirements and the availability of financing, if necessary;
the impact of new or changing legislation and regulations (or interpretations thereof) on our business, including our ability to successfully address and comply with such legislation and regulations (or interpretations thereof) and increased costs, reductions of revenue, and potential fines, penalties, or disgorgement to which we may be subject as a result thereof;
risks, burdens, and costs, including fines, penalties, or disgorgement, associated with our business being subjected to regulatory inquiries, investigations, or initiatives, including those of the Financial Industry Regulatory Authority, Inc. and the Securities and Exchange Commission (the “SEC”);
any compromise of confidentiality, availability, or integrity of information, including cyberattacks;
risks associated with legal proceedings, including litigation and regulatory proceedings;
our ability to close, finance, and realize all of the anticipated benefits of acquisitions, as well as our ability to integrate the operations of recently acquired businesses, and the potential impact of such acquisitions on our existing indebtedness and leverage;
our ability to retain employees and acquired client assets following acquisitions;
our ability to manage leadership and employee transitions, including costs and time burdens on management and our board of directors related thereto;
our ability to develop, establish, and maintain strong brands;
our ability to comply with laws and regulations regarding privacy and protection of user data;
our assessments and estimates that determine our effective tax rate;
our ability to protect our intellectual property and the impact of any claim that we infringed on the intellectual property rights of others;
Avantax, Inc. | Q3 2023 Form 10-Q 3


risks related to goodwill and acquired intangible asset impairment;
our failure to realize the expected benefits of the sale of our former tax software business (the “TaxAct Sale”);
disruptions to our business and operations resulting from our compliance with the terms of the transition services agreement entered into in connection with the TaxAct Sale;
disruptions or adverse effects on our business prospects, financial condition, and results of operations caused by the proposed acquisition of the Company by Cetera;
our inability to timely and successfully close the proposed acquisition of the Company by Cetera;
provisions within our Agreement and Plan of Merger with Cetera that could discourage competing acquisition proposals from third parties or adversely affect future acquisition proposals in the event the proposed acquisition of the Company by Cetera is terminated; and
our ability to mitigate and manage risks caused by yield curve, duration and interest rate fluctuations, and other macroeconomic factors upon our business and financing arrangements through derivative transactions pursuant to our recently implemented hedging policy.
Forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and other factors that may cause our results, levels of activity, performance, achievements, and prospects to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties, and other factors include, among others, the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, as well as in our other filings with the SEC. All forward-looking statements speak only as of the date of this Form 10-Q. We do not undertake any obligation and do not intend to update or revise any forward-looking statement to reflect new information, events, or circumstances after the date of this Form 10-Q or to reflect the occurrence of unanticipated events, except as required by law.




Avantax, Inc. | Q3 2023 Form 10-Q 4


PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
AVANTAX, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
September 30,
2023
December 31,
2022
(Unaudited)
ASSETS
Current assets:
Cash and cash equivalents$106,435 $263,928 
Accounts receivable, net 24,680 24,117 
Commissions and advisory fees receivable22,177 20,679 
Prepaid expenses and other current assets32,944 15,027 
Total current assets186,236 323,751 
Long-term assets:
Property, equipment, and software, net49,932 53,041 
Right-of-use assets, net18,126 19,361 
Goodwill, net266,279 266,279 
Acquired intangible assets, net256,867 266,002 
Other long-term assets48,239 35,081 
Total long-term assets639,443 639,764 
Total assets$825,679 $963,515 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$3,771 $7,531 
Commissions and advisory fees payable15,033 13,829 
Accrued expenses and other current liabilities49,798 111,212 
Current deferred revenue4,241 4,583 
Current lease liabilities5,107 5,139 
Current portion of long-term debt11,813  
Total current liabilities89,763 142,294 
Long-term liabilities:
Long-term debt, net248,388  
Long-term lease liabilities27,797 30,332 
Deferred tax liabilities, net15,584 20,819 
Long-term deferred revenue3,701 4,396 
Other long-term liabilities36,759 22,476 
Total long-term liabilities332,229 78,023 
Total liabilities421,992 220,317 
Commitments and contingencies (Note 9)
Stockholders’ equity:
Common stock, par value $0.0001 per share—900,000 shares authorized; 43,530 shares issued and 36,807 shares outstanding as of September 30, 2023; 51,260 shares issued and 48,079 shares outstanding as of December 31, 2022
4 5 
Additional paid-in capital1,391,702 1,636,134 
Accumulated deficit(825,783)(829,542)
Accumulated other comprehensive loss(13,043) 
Treasury stock, at cost—6,723 shares as of September 30, 2023 and 3,181 shares as of December 31, 2022
(149,193)(63,399)
Total stockholders’ equity403,687 743,198 
Total liabilities and stockholders’ equity$825,679 $963,515 

See accompanying notes.
Avantax, Inc. | Q3 2023 Form 10-Q 5


AVANTAX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited) (In thousands, except per share amounts)

 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Revenue$192,343 $165,032 $557,251 $494,104 
Operating expenses:
Cost of revenue117,684 105,809 336,783 341,443 
Engineering and technology2,352 2,617 7,264 6,733 
Sales and marketing26,298 23,770 79,902 70,826 
General and administrative33,011 23,792 91,747 69,388 
Acquisition and integration(100)416 (17)(4,710)
Depreciation4,142 3,343 11,318 8,428 
Amortization of acquired intangible assets6,404 6,342 18,973 19,435 
Total operating expenses189,791 166,089 545,970 511,543 
Operating income (loss) from continuing operations2,552 (1,057)11,281 (17,439)
Interest expense and other, net(5,115)(158)(8,919)(423)
Income (loss) from continuing operations before income taxes(2,563)(1,215)2,362 (17,862)
Income tax benefit (expense)1,068 1,536 (524)22,582 
Income (loss) from continuing operations(1,495)321 1,838 4,720 
Discontinued operations (Note 3)
Income (loss) from discontinued operations before gain on disposal and income taxes (22,352) 74,165 
Pre-tax gain on disposal  2,539  
Income (loss) from discontinued operations before income taxes (22,352)2,539 74,165 
Income tax benefit (expense) 190 (618)(26,681)
Income (loss) from discontinued operations (22,162)1,921 47,484 
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Basic net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.05 $0.10 
Discontinued operations (0.47)0.04 0.99 
Basic net income (loss) per share$(0.04)$(0.46)$0.09 $1.09 
Diluted net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.04 $0.10 
Discontinued operations (0.46)0.05 0.96 
Diluted net income (loss) per share$(0.04)$(0.45)$0.09 $1.06 
Weighted average shares outstanding:
Basic36,921 47,847 39,971 47,981 
Diluted36,921 49,016 40,940 49,153 
Comprehensive income (loss):
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Other comprehensive loss, net of tax(982) (13,043) 
Comprehensive income (loss)$(2,477)$(21,841)$(9,284)$52,204 


See accompanying notes.
Avantax, Inc. | Q3 2023 Form 10-Q 6


AVANTAX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited) (In thousands)
Accumulated other comprehensive loss
Common stockAdditional paid-in capitalAccumulated deficitTreasury stock
SharesAmountSharesAmountTotal
Balance as of December 31, 202251,260 $5 $1,636,134 $(829,542)$ 3,181 $(63,399)$743,198 
Common stock issued pursuant to stock incentive and employee stock purchase plans307 — 1,135 — — — — 1,135 
Stock repurchases— — — — — 9,291 (279,562)(279,562)
Retirement of common stock(8,333)(1)(254,538)— — (8,333)254,539  
Stock-based compensation— — 4,714 — — — — 4,714 
Tax payments from shares withheld for equity awards— — (3,114)— — — — (3,114)
Net income— — — 1,673 — — — 1,673 
Balance as of March 31, 202343,234 4 1,384,331 (827,869) 4,139 (88,422)468,044 
Common stock issued pursuant to stock incentive and employee stock purchase plans229 — 1,506 — — — — 1,506 
Stock repurchases— — — — — 2,206 (51,624)(51,624)
Stock-based compensation— — 2,910 — — — — 2,910 
Tax payments from shares withheld for equity awards— — (1,156)— — — — (1,156)
Other comprehensive loss, net of tax— — — — (12,061)— — (12,061)
Net income— — — 3,581 — — — 3,581 
Balance as of June 30, 202343,463 4 1,387,591 (824,288)(12,061)6,345 (140,046)411,200 
Common stock issued pursuant to stock incentive and employee stock purchase plans67 — 1,146 — — — — 1,146 
Stock repurchases— — — — — 378 (9,147)(9,147)
Stock-based compensation— — 3,041 — — — — 3,041 
Tax payments from shares withheld for equity awards— — (76)— — — — (76)
Other comprehensive loss, net of tax— — — — (982)— — (982)
Net loss— — — (1,495)— — — (1,495)
Balance as of September 30, 202343,530 $4 $1,391,702 $(825,783)$(13,043)6,723 $(149,193)$403,687 
















See accompanying notes.
Avantax, Inc. | Q3 2023 Form 10-Q 7


Accumulated other comprehensive loss
Common stockAdditional paid-in capitalAccumulated deficitTreasury stock
SharesAmountSharesAmountTotal
Balance as of December 31, 202150,137 $5 $1,619,805 $(1,249,789)$ 1,306 $(28,399)$341,622 
Common stock issued pursuant to stock incentive and employee stock purchase plans247 — 96 — — — — 96 
Stock repurchases— — — — — 1,645 (30,537)(30,537)
Stock-based compensation— — 4,641 — — — — 4,641 
Tax payments from shares withheld for equity awards— — (1,569)— — — — (1,569)
Net income— — — 34,620 — — — 34,620 
Balance as of March 31, 202250,384 5 1,622,973 (1,215,169) 2,951 (58,936)348,873 
Common stock issued pursuant to stock incentive and employee stock purchase plans537 — 2,402 — — — — 2,402 
Stock repurchases— — — — — 230 (4,463)(4,463)
Stock-based compensation— — 3,683 — — — — 3,683 
Tax payments from shares withheld for equity awards— — (467)— — — — (467)
Net income— — — 39,425 — — — 39,425 
Balance as of June 30, 202250,921 5 1,628,591 (1,175,744) 3,181 (63,399)389,453 
Common stock issued pursuant to stock incentive and employee stock purchase plans34 — 307 — — — — 307 
Stock-based compensation— — 3,725 — — — — 3,725 
Tax payments from shares withheld for equity awards— — (54)— — — — (54)
Net loss— — — (21,841)— — — (21,841)
Balance as of September 30, 202250,955 $5 $1,632,569 $(1,197,585)$ 3,181 $(63,399)$371,590 































See accompanying notes.
Avantax, Inc. | Q3 2023 Form 10-Q 8


AVANTAX, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited) (In thousands)
 Nine Months Ended September 30,
 20232022
Operating activities:
Net income$3,759 $52,204 
Less: Income from discontinued operations, net of income taxes1,921 47,484 
Income from continuing operations1,838 4,720 
Adjustments to reconcile income from continuing operations to net cash from operating activities:
Depreciation and amortization of acquired intangible assets30,291 27,863 
Stock-based compensation17,678 14,782 
Change in the fair value of acquisition-related contingent consideration (5,320)
Reduction of right-of-use lease assets1,235 1,103 
Deferred income taxes(1,043)(599)
Amortization of debt discount and issuance costs871  
Accretion of lease liabilities1,405 1,522 
Other non-cash items4,610 4,218 
Changes in operating assets and liabilities, net of acquisitions and disposals:
Accounts receivable, net(551)(2,505)
Commissions and advisory fees receivable(1,498)4,587 
Prepaid expenses and other current assets(16,533)(3,755)
Other long-term assets(17,276)(14,829)
Accounts payable(3,760)(5,047)
Commissions and advisory fees payable1,204 (4,137)
Lease liabilities(3,972)(3,788)
Deferred revenue(1,037)(1,447)
Accrued expenses and other current and long-term liabilities(77,023)(7,459)
Net cash provided (used) by operating activities from continuing operations(63,561)9,909 
Investing activities:
Purchases of property, equipment, and software(8,257)(12,601)
Asset acquisitions(8,017)(3,743)
Net cash used by investing activities from continuing operations(16,274)(16,344)
Financing activities:
Proceeds from credit facilities, net of debt discount and issuance costs261,543  
Payments on credit facilities(3,375)(35,906)
Acquisition-related fixed and contingent consideration payments(287)(14,548)
Stock repurchases(337,192)(35,000)
Proceeds from issuance of stock through employee stock purchase plan1,584 2,324 
Proceeds from stock option exercises2,203 481 
Tax payments from shares withheld for equity awards(4,346)(2,090)
Net cash used by financing activities from continuing operations(79,870)(84,739)
Net cash used by continuing operations(159,705)(91,174)
Net cash provided by operating activities from discontinued operations 69,508 
Net cash provided (used) by investing activities from discontinued operations2,212 (4,552)
Net cash provided by financing activities from discontinued operations  
Net cash provided by discontinued operations2,212 64,956 
Net decrease in cash and cash equivalents(157,493)(26,218)
Cash and cash equivalents, beginning of period263,928 100,629 
Cash and cash equivalents, end of period$106,435 $74,411 
Supplemental cash flow information:
Cash paid for income taxes$99,966 $2,408 
Cash paid for interest$11,422 $23,005 

See accompanying notes.
Avantax, Inc. | Q3 2023 Form 10-Q 9


AVANTAX, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1: Description of the Business
Avantax, Inc. (the Company,” “Avantax, we, our, or us) is a leading provider of integrated tax-intelligent wealth management services and software, assisting consumers, small business owners, tax professionals, financial professionals, and certified public accounting (“CPA”) firms. Our integrated tax-intelligent wealth management services consist of the operations of Avantax Wealth Management and Avantax Planning Partners.
Avantax Wealth Management provides tax-intelligent wealth management solutions for financial professionals, tax professionals, CPA firms, and their clients. Avantax Wealth Management offers its services through its registered broker-dealer, which is a leading U.S. tax-focused independent broker-dealer, registered investment advisor (“RIA”), and insurance agency subsidiaries. Avantax Wealth Management works with a nationwide network of financial professionals that operate as independent contractors. Avantax Wealth Management provides these financial professionals with an integrated platform of technical, practice, compliance, operations, sales, and product support tools that enable them to offer tax-intelligent planning, investing, and wealth management services to their clients.
Avantax Planning Partners is an in-house/employee-based RIA, insurance agency, and wealth management business that partners with CPA firms in order to provide their consumer and small business clients with holistic financial planning and advisory services, as well as retirement plan solutions through Avantax Retirement Plan Services.
Merger Agreement
On September 9, 2023, Avantax entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Aretec Group, Inc., a Delaware corporation that does business as Cetera Holdings (“Parent”), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Sub”) whereby Parent will acquire all of the issued and outstanding equity of Avantax in an all-cash transaction valuing Avantax at approximately $1.2 billion, inclusive of Avantax’s net debt. On the terms and subject to the conditions of the Merger Agreement, holders of shares of Avantax common stock (other than Excluded Shares and Dissenting Shares (each, as defined in the Merger Agreement)) will receive $26.00 per share in cash, without interest and less any required tax withholdings. Upon the closing of the transactions contemplated by the Merger Agreement, Avantax will operate as a privately-held company. The closing remains subject to customary closing conditions, including approval by Avantax’s stockholders. Avantax expects the closing to occur by the end of November 2023.
Divestiture of Tax Software Business
On October 31, 2022, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with TaxAct Holdings, Inc. (f/k/a Avantax Holdings, Inc.), a Delaware corporation and a direct subsidiary of Avantax, Franklin Cedar Bidco, LLC, a Delaware limited liability company (the “Buyer”), and, solely for purposes of certain provisions thereof, DS Admiral Bidco, LLC, a Delaware limited liability company, pursuant to which we sold our former tax software business to Buyer for an aggregate purchase price of $720.0 million in cash, subject to customary purchase price adjustments set forth in the Purchase Agreement (the TaxAct Sale). This transaction subsequently closed on December 19, 2022.
In accordance with ASC 205 (“ASC 205”), Presentation of Financial Statements, we determined that the sale of our tax software business represented a strategic shift that will have a major effect on our operations and financial results. As a result of the TaxAct Sale, the historical results of our former tax software business, and any adjustments to amounts previously reported in discontinued operations in a prior period (if applicable) have been reclassified as a discontinued operation and are excluded from continuing operations for all periods presented within the condensed consolidated financial statements.
Segments
Our Chief Executive Officer is our chief operating decision maker and assesses performance and allocates resources on a consolidated basis. Given the similarities in economic characteristics between our operations and the common nature of the products, services, we currently operate in one reportable segment.
Avantax, Inc. | Q3 2023 Form 10-Q 10


Note 2: Summary of Significant Accounting Policies
Interim Financial Information
The accompanying unaudited condensed consolidated financial statements have been prepared by us under the rules and regulations of the SEC for interim financial reporting. These condensed consolidated financial statements are unaudited and, in management’s opinion, include all adjustments, consisting of normal recurring adjustments and accruals, necessary for a fair presentation of the condensed consolidated financial position, results of operations, and cash flows for the periods presented. Certain information and footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States (GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2022. Interim results are not necessarily indicative of results for a full year.
A summary of our significant accounting policies is included in Note 2 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022. Other than below, there have been no significant changes in our significant accounting policies since December 31, 2022.
Derivative Financial Instruments
We primarily enter into derivative financial instruments as part of our strategy to manage our exposure to changes in interest rates. Derivative instruments represent contracts between parties that result in one party delivering cash to the other party based on a notional amount and an underlying term (such as an interest rate or index) as specified in the contract. The amount of cash delivered from one party to the other is determined based on the interaction of the notional amount of the contract with the underlying term. We do not enter into derivative instruments for any purpose other than hedging interest rate risk, and none of our derivative instruments are used for trading purposes.
We recognize derivatives as assets or liabilities on our consolidated balance sheets at their fair value in accordance with ASC 815, Derivatives and Hedging. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, and further, on the type of hedging relationship. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Currently, we have only designated derivative instruments as cash flow hedges. We may also enter into derivative contracts that are intended to economically hedge interest rate risk, even though hedge accounting does not apply, or we elect not to apply hedge accounting.
To qualify for hedge accounting, concurrent with the execution of a derivative contract, we formally document our risk management objective and strategy for undertaking the hedging transaction, how the hedging instrument is expected to hedge the designated risk related to the hedged item, and the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.
For derivatives designated as cash flow hedging instruments, changes in fair value are initially recorded net of tax in accumulated other comprehensive income (loss) and subsequently reclassified into earnings when the hedged transaction affects earnings. Additionally, changes in the fair value of amounts excluded from the assessment of effectiveness are recorded net of tax in accumulated other comprehensive income (loss) and recognized in earnings using a straight-line amortization method over the term of instrument. Changes in fair value for derivative contracts that do not qualify for hedge accounting (or for those that we elect to not apply hedge accounting), are immediately recognized within earnings. Realized and unrealized gains and losses for derivatives are presented in the statements of comprehensive income (loss) based on the nature and use of the instrument.
We prospectively discontinue hedge accounting if it is determined that the derivative is no longer effective in offsetting the designated risk of the hedged item, the derivative is terminated prior to maturity, or the occurrence of the forecasted transaction (for a cash flow hedge) is no longer probable. When hedge accounting for a cash flow hedge is discontinued, any subsequent changes in fair value of the derivative are recognized immediately in earnings. The cumulative unrealized gain or loss related to the discontinued hedge continues to be reported in accumulated other comprehensive income (loss) and is subsequently reclassified into earnings in the same manner
Avantax, Inc. | Q3 2023 Form 10-Q 11


discussed above, unless it is probable that the forecasted transaction will not occur by the end of the originally specified time period, in which case the cumulative unrealized gain or loss is reclassified into earnings immediately.
Note 3: Discontinued Operations
On October 31, 2022, we entered into the Purchase Agreement with the Buyer to sell our former tax software business for an aggregate purchase price of $720.0 million in cash, subject to customary purchase price adjustments set forth in the Purchase Agreement. The TaxAct Sale subsequently closed on December 19, 2022. This divestiture was considered part of our strategic shift to become a pure-play wealth management company and was determined to meet discontinued operations accounting criteria under ASC 205.
During the nine months ended September 30, 2023, we finalized our previously estimated closing date working capital balance, resulting in an incremental pre-tax gain of $2.5 million which is included within “Pre-tax gain on disposal” in the condensed consolidated statements of comprehensive income (loss).
The following table presents summarized information regarding certain components of income (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Revenues$ $6,664 $ $242,028 
Operating expenses 19,425  142,579 
Interest expense and other, net (9,591) (25,284)
Income (loss) from discontinued operations before gain on disposal and income taxes (22,352) 74,165 
Pre-tax gain on disposal  2,539  
Income (loss) from discontinued operations before income taxes (22,352)2,539 74,165 
Income tax benefit (expense) 190 (618)(26,681)
Income (loss) from discontinued operations$ $(22,162)$1,921 $47,484 
Note 4: Revenue Recognition
Revenue primarily consists of advisory revenue, commission revenue, asset-based revenue, and transaction and fee revenue.
Revenues by major category and the timing of revenue recognition was as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Recognized upon transaction:
Commission$20,448 $17,868 $57,333 $56,373 
Transaction and fee1,054 1,307 3,066 3,813 
Total revenue recognized upon transaction$21,502 $19,175 $60,399 $60,186 
Recognized over time:
Advisory$108,393 $95,070 $309,234 $306,394 
Commission22,903 23,920 69,329 75,905 
Asset-based33,444 21,147 100,524 33,774 
Transaction and fee6,101 5,720 17,765 17,845 
Total revenue recognized over time$170,841 $145,857 $496,852 $433,918 
Total revenue:
Advisory$108,393 $95,070 $309,234 $306,394 
Commission43,351 41,788 126,662 132,278 
Asset-based33,444 21,147 100,524 33,774 
Transaction and fee7,155 7,027 20,831 21,658 
Total revenue$192,343 $165,032 $557,251 $494,104 
Avantax, Inc. | Q3 2023 Form 10-Q 12


Note 5: Asset Acquisitions
During the nine months ended September 30, 2023, we completed acquisitions that met the criteria to be accounted for as asset acquisitions. Total initial purchase consideration, including acquisition costs and fixed deferred payments, was $5.2 million. This purchase consideration was allocated to client relationship intangibles. Client relationship intangibles are amortized on a straight-line basis over an amortization period of 15 years.
We are subject to variable contingent consideration payments related to our asset acquisitions that are not recognized as a liability on our condensed consolidated balance sheets until all contingencies related to the achievement of future financial targets are resolved and the consideration is payable. As of September 30, 2023, the maximum future fixed and contingent payments associated with all prior asset acquisitions were $25.6 million, with specified payment dates from 2023 through 2027.
Note 6: Debt
Our debt consisted of the following as of the periods indicated in the table below (in thousands):
September 30, 2023December 31, 2022
Delayed Draw Term Loan Facility
Principal outstanding$266,625 $ 
Unamortized debt issuance costs(5,208) 
Unamortized debt discount(1,216) 
Net carrying value$260,201 $ 
In May 2017, we entered into a credit agreement (as the same has been amended, the “Credit Agreement”) with a syndicate of lenders, which provided for a term loan facility and a revolving line of credit (including a letter of credit sub-facility) for working capital, capital expenditures, and general business purposes. Subject to the terms of the Credit Agreement, we repaid the remaining principal amount outstanding under the Credit Agreement in connection with the TaxAct Sale in the fourth quarter of 2022.
On January 24, 2023 (the “Closing Date”), we entered into a restatement agreement (the Amended and Restated Credit Agreement”), which amended and restated in its entirety our previous Credit Agreement. The Amended and Restated Credit Agreement provides for a new delayed draw term loan facility up to a maximum principal amount of $270.0 million (the “Delayed Draw Term Loan Facility”) and a revolving credit facility with a commitment amount of $50.0 million (the “Revolving Credit Facility”). We may borrow term loans under the Delayed Draw Term Loan Facility (the “Term Loans”) until January 24, 2024. The stated maturity date of the Delayed Draw Term Loan Facility and the Revolving Credit Facility is January 24, 2028 (the “Maturity Date”). The proceeds of any Term Loans may be used to fund shareholder distributions and for general corporate purposes. The proceeds of any loans under the Revolving Credit Facility may be used to finance working capital needs and for general corporate purposes. On February 24, 2023, we borrowed $170.0 million under the Delayed Draw Term Loan Facility. During the second quarter of 2023, we borrowed the remaining $100.0 million available under the Delayed Draw Term Loan Facility.
We capitalized approximately $8.5 million of debt discount and issuance costs in connection with the Amended and Restated Credit Agreement. A portion of these costs were allocated to the Revolving Credit Facility and are included in other long-term assets on the Company’s condensed consolidated balance sheets.
As of September 30, 2023, we had $266.6 million in principal amount outstanding under the Delayed Draw Term Loan Facility and no amounts outstanding under the Revolving Credit Facility. As of September 30, 2023, $50.0 million was available for future borrowings under the Revolving Credit Facility, subject to customary terms and conditions. Subject to certain conditions set forth in the Amended and Restated Credit Agreement, we may borrow, prepay, and reborrow under the Revolving Credit Facility and terminate or reduce the Lenders’ commitments at any time prior to the Maturity Date.
We are required to make quarterly principal amortization payments on the Delayed Draw Term Loan Facility on the last business day of each fiscal quarter, beginning with the last business day of June 2023. These payments will amortize in equal quarterly installments based on the following aggregate annual amounts (expressed as a percentage of the principal amount of Term Loans borrowed): 2.5% during the first year ended December 31, 2023, 5% during years two and three, 7.5% during year four, and 10% during year five. Any remaining Term Loans outstanding are due on the Maturity Date.
Avantax, Inc. | Q3 2023 Form 10-Q 13


Commencing with the first year ending December 31, 2023, we may be required to make annual prepayments on the Term Loans in an amount equal to a percentage of Excess Cash Flow (as defined in the Amended and Restated Credit Agreement). The percentage of Excess Cash Flow ranges from 0% to 50% depending on our Consolidated First Lien Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement). We may voluntarily prepay the Term Loans in whole or in part without premium or penalty.
Subject to customary reference rate availability provisions, the borrowings under the Amended and Restated Credit Agreement will bear interest at a rate per annum equal to (i) the Term SOFR Rate (as defined in the Amended and Restated Credit Agreement, and which includes a 0.10% credit spread adjustment) plus a margin ranging from 2.25% to 2.75% (which margin would be 2.75% as of the Closing Date), or (ii) a base rate based on the highest of the Wall Street Journal prime rate, the federal funds rate plus 0.50% and the Term SOFR (as defined in the Amended and Restated Credit Agreement, and which includes a 0.10% credit spread adjustment) rate plus 1.00%, in each case plus a margin ranging from 1.25% to 1.75% (which margin would be 1.75% as of the Closing Date). The margin is determined based on the Company’s Consolidated First Lien Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement). We are required to pay a quarterly commitment fee on the daily amount of the undrawn portion of the revolving commitments under the Revolving Credit Facility ranging from 0.35% to 0.45%. Interest is payable at the end of each interest period, typically quarterly.
The obligations of the Company under the Amended and Restated Credit Agreement are secured by a first-priority security interest in substantially all of the existing and future personal property of the Company and certain of its subsidiaries.
Pursuant to the Amended and Restated Credit Agreement, we shall not permit (i) the Consolidated Total Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement) to exceed 4.00 to 1.00 between March 31, 2023 and June 30, 2024, or 3.75 to 1.00 between July 1, 2024 and the Maturity Date, (ii) the Consolidated Fixed Charge Coverage Ratio (as defined in the Amended and Restated Credit Agreement) to be less than 1.25 to 1.00 or (iii) Liquidity (as defined in the Amended and Restated Credit Agreement) on the last day of any fiscal quarter to be less than $50 million. The Company was in compliance with the debt covenants of the Amended and Restated Credit Agreement as of September 30, 2023.
Note 7: Leases
Our leases are primarily related to office space and are classified as operating leases. Operating lease cost, net of sublease income, is recognized in “General and administrative” expense for those net costs related to leases used in our operations and within “Acquisition and integration” expense for those net costs related to an unoccupied lease assumed in a previous acquisition on the condensed consolidated statements of comprehensive income (loss).
During the nine months ended September 30, 2023, we began subleasing portions of our corporate headquarters in Dallas, Texas. These subleases were classified as operating leases at inception, with sublease income recognized on a straight-line basis over the five-year and ten-year respective sublease terms.
Operating lease cost, net of sublease income, and cash paid on operating lease liabilities for the three and nine months ended September 30, 2023 and 2022 were as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Fixed lease cost$972 $965 $2,908 $2,885 
Variable lease cost415 258 1,163 1,023 
Operating lease cost, before sublease income1,387 1,223 4,071 3,908 
Sublease income(684)(235)(1,642)(703)
Total operating lease cost, net of sublease income$703 $988 $2,429 $3,205 
Additional lease information:
Cash paid on operating lease liabilities$1,336 $1,297 $3,955 $3,788 
Lease liabilities obtained from new right-of-use assets$ $262 $ $390 
Avantax, Inc. | Q3 2023 Form 10-Q 14


Right-of-use assets and operating lease liabilities were recorded on the condensed consolidated balance sheets as follows (in thousands):
September 30, 2023December 31, 2022
Right-of-use assets, net$18,126 $19,361 
Current lease liabilities$5,107 $5,139 
Long-term lease liabilities27,797 30,332 
Total operating lease liabilities$32,904 $35,471 
Weighted-average remaining lease term (in years)8.99.4
Weighted-average discount rate5.5 %5.5 %
The maturities of our operating lease liabilities as of September 30, 2023 were as follows (in thousands):
Undiscounted cash flows:
Remainder of 2023$1,329 
20245,174 
20255,086 
20264,256 
20273,858 
Thereafter22,315 
Total undiscounted cash flows42,018 
Imputed interest(9,114)
Present value of cash flows$32,904 
Note 8: Balance Sheet Components
Prepaid expenses and other current assets consisted of the following (in thousands):
September 30, 2023December 31, 2022
Prepaid expenses$9,679 $7,857 
Prepaid income taxes14,062  
Forgivable loans6,910 5,951 
Other current assets2,293 1,219 
Total prepaid expenses and other current assets$32,944 $15,027 
Accrued expenses and other current liabilities consisted of the following (in thousands):
September 30, 2023December 31, 2022
Salaries and related benefit expenses$15,734 $17,481 
Accrued legal costs5,539 1,102 
Accrued vendor and advertising costs1,650 2,726 
Accrued taxes5,444 85,965 
Accrued fixed and variable acquisition consideration3,386 897 
Accrued cash-settled stock-based compensation8,629 2,121 
Interest rate derivatives7,581  
Other1,835 920 
Total accrued expenses and other current liabilities$49,798 $111,212 
Avantax, Inc. | Q3 2023 Form 10-Q 15


Other long-term liabilities consisted of the following (in thousands):
September 30, 2023December 31, 2022
Deferred compensation$13,555 $7,974 
Accrued cash-settled stock-based compensation5,594 7,556 
Accrued tax positions4,248 3,616 
Interest rate derivatives10,291  
Other3,071 3,330 
Other long-term liabilities$36,759 $22,476 
Note 9: Commitments and Contingencies
TaxAct Indemnification Obligations
In connection with the TaxAct Sale, we have certain indemnification obligations to the Buyer, TaxAct Holdings, Inc. and their respective affiliates and representatives with respect to certain losses actually incurred or suffered as a result of any claim, action, suit, or proceeding against such indemnitees arising out of or relating to the use by us or any of our affiliates in the tax software business of website tracking and analytics technologies prior to the closing of the TaxAct Sale. Such indemnification obligations terminate on December 19, 2027 and may not exceed $5.4 million ($1.0 million of which is allocable to the deductible under our insurance policies). We believe that applicable insurance policies will cover all or a substantial portion of any claims made by the Buyer under such indemnification obligations. The current carrying amount of the liability for these indemnification obligations is approximately $0.9 million as of September 30, 2023 and is included within “Other long-term liabilities” on the condensed consolidated balance sheets.
Litigation
From time to time, we are subject to various legal proceedings, regulatory matters or fines, or claims that arise in the ordinary course of business. We accrue a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. Although we believe that resolving such claims, individually or in aggregate, will not have a material adverse impact on our financial statements, these matters are subject to inherent uncertainties.
We are not currently a party to any such matters for which we have recognized a material liability on our condensed consolidated balance sheet as of September 30, 2023.
We have entered into indemnification agreements in the ordinary course of business with our officers and directors. Pursuant to these agreements, we may be obligated to advance payment of legal fees and costs incurred by the defendants pursuant to our obligations under these indemnification agreements and applicable Delaware law.
Note 10: Fair Value Measurements
Certain of our assets and liabilities are carried at fair value and are valued using inputs that are classified in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs, other than Level 1, or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data and reflect our own assumptions.
Avantax, Inc. | Q3 2023 Form 10-Q 16


Assets and Liabilities Measured on a Recurring Basis
The fair value hierarchy of our financial assets and liabilities carried at estimated fair value and measured on a recurring basis were as follows (in thousands):
  Fair value measurements at the reporting date using
 September 30, 2023Quoted prices in
active markets
using identical 
assets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Cash equivalents: money market and other funds
$219 $219 $ $ 
Deferred compensation assets14,012 14,012   
Total assets at fair value$14,231 $14,231 $ $ 
Deferred compensation liabilities$14,012 $14,012 $ $ 
Interest rate derivatives 17,872  17,872  
Total liabilities at fair value$31,884 $14,012 $17,872 $ 
  Fair value measurements at the reporting date using
 December 31, 2022Quoted prices in
active markets
using identical 
assets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Cash equivalents: money market and other funds
$4,369 $4,369 $ $ 
Deferred compensation assets7,974 7,974   
Total assets at fair value$12,343 $12,343 $ $ 
Deferred compensation liabilities$7,974 $7,974 $ $ 
Total liabilities at fair value$7,974 $7,974 $ $ 
Cash equivalents are classified within Level 1 of the fair value hierarchy because we value them utilizing quoted prices in active markets.
We offer non-qualified deferred compensation plans to our executive officers, board of directors, and certain independent financial professionals. Participants in these plans direct the investment of their accounts among the available investment options, which are generally the same as those available under our 401(k) plan. We have elected to fund these obligations through a rabbi trust which mirrors the investment elections made by participants. The assets in the rabbi trust are held for the purpose of satisfying our obligations to participants, however, remain subject to the claims of our creditors in the event we become insolvent. Our obligations and corresponding investments held under these non-qualified deferred compensation plans primarily consist of money market and mutual funds and are classified within Level 1 of the fair value hierarchy because we value them utilizing quoted prices in active markets. These investments, and the corresponding deferred compensation liabilities, are primarily included within “Other long-term assets” and “Other long-term liabilities,” respectively, on the condensed consolidated balance sheets.
We utilize a third-party pricing service to estimate the fair value of our derivative financial instruments. Fair value is estimated using industry standard valuation models that primarily rely on observable market inputs, including daily simple secured overnight financing rates (“SOFR”) overnight index swap rate curves, SOFR swap rate curves, and volatility. Credit valuation adjustments are incorporated in the fair values to reflect nonperformance risk for both the Company and our counterparties. Although we have determined that the majority of the inputs used to value these derivative instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments utilize Level 3 inputs, such as estimates of current credit spreads. We have determined that the impact of the credit valuation adjustments is not significant to the overall valuation of these derivatives. As a result, we have classified our derivative financial instruments in Level 2 of the fair value hierarchy.
Fair Value of Financial Instruments
We consider the carrying values of accounts receivable, commissions receivable, other receivables, prepaid expenses, other current assets, financial professional loans, accounts payable, commissions and advisory fees
Avantax, Inc. | Q3 2023 Form 10-Q 17


payable, accrued expenses, and other current liabilities to approximate fair values primarily due to their short-term natures.
As of September 30, 2023, the principal amount outstanding for our Delayed Draw Term Loan Facility was $266.6 million. The principal amount outstanding approximated its fair value as it is a variable rate instrument, and its applicable margin is consistent with current market conditions.
Note 11: Derivative Financial Instruments
We primarily enter into derivative financial instruments as part of our strategy to manage our exposure to changes in interest rates. Our objective in using interest rate derivatives is to reduce variability in the future cash flows we earn from our cash sweep program by limiting our exposure to changes in our contractually specified rate, which is primarily tied to the federal funds rate. To accomplish this objective, we currently utilize interest rate collar and interest rate cap derivative instruments. Our interest rate collar derivatives involve the payment of variable-rate amounts if interest rates rise above the cap strike rate on the contracts and receipts of fixed-rate amounts if interest rates fall below the floor strike rate on the contracts. Our interest rate cap derivatives involve the payment of variable-rate amounts if interest rates rise above the cap strike rate on the contracts. Our interest rate collar derivatives are designated and qualify as cash flow hedges, as defined in ASC 815. Our interest rate cap derivatives do not qualify for cash flow hedge accounting and are considered economic hedges. As of September 30, 2023, the total notional value of our interest rate derivatives represented approximately 65% of the ending client cash balances in our cash sweep program.
We are exposed to credit risk in the event of nonperformance of counterparties for our derivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and actively monitoring counterparty credit ratings. We also employ master netting arrangements which allow us to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative financial instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.
We recognize derivative financial instruments in the condensed consolidated financial statements at fair value regardless of the purpose or intent for holding the instruments. The following table presents the gross fair value of our derivative financial instruments as of September 30, 2023 and December 31, 2022 (in thousands):
 Derivative AssetsDerivative Liabilities
September 30, 2023December 31, 2022September 30, 2023December 31, 2022
Derivatives designated as hedging instruments under ASC 815:
Interest rate collars (1)
$ $ $17,235 $ 
Total derivatives designated as hedging instruments under ASC 815  17,235  
Derivatives not designated as hedging instruments under ASC 815:
Interest rate caps (1)
  637  
Total derivatives not designated as hedging instruments under ASC 815  637  
Total derivatives$ $ $17,872 $ 
______________________
(1)As of September 30, 2023, approximately $7.6 million of the fair value of these derivative financial instruments was recorded within “Accrued expenses and other current liabilities,” with the remaining balance recorded within “Other long-term liabilities” on the condensed consolidated balance sheets.
Cash Flow Hedges of Interest Rate Risk
During the second quarter of 2023, we entered into two interest rate collar derivative contracts for a total notional value of $1.5 billion. Each contract is indexed to daily simple SOFR and is a combination of a purchased floor instrument with a strike rate of 2.5% and a sold cap instrument with a strike rate of 5.5%, both of which expire
Avantax, Inc. | Q3 2023 Form 10-Q 18


on May 31, 2026. The total cost for these interest rate collars was $15.3 million, which we elected to defer and will settle through monthly straight-line cash payments to the counterparties over the term of the instruments. This hedging strategy enables us to limit the downside risk of significant reductions to interest rates over the term of the instruments in exchange for capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
We designated these derivative instruments as cash flow hedges and determined that they are highly effective at achieving offsetting changes in cash flows attributable to interest rate fluctuations associated with our cash sweep program. The changes in fair value of the effective portion of these derivative instruments are initially recorded net of tax in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity. These accumulated gains or losses are reclassified into “Revenue” (where the hedged transaction is recorded) on the condensed consolidated statements of comprehensive income (loss) when the hedged transaction affects earnings. We have elected to exclude the change in fair value of these derivative instruments attributable to the passage of time from the assessment of hedge effectiveness. Changes in the fair value of amounts excluded from the assessment of effectiveness are recorded net of tax in accumulated other comprehensive income (loss) and recognized as a reduction to “Revenue” on the condensed consolidated statements of comprehensive income (loss) using a straight-line amortization method over the term of the instruments.
The table below presents the amount of gains and losses related to these derivative financial instruments and their location in the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 (in thousands):
 Gain (Loss)
Recognized in OCI
Gain (Loss)
Recognized in Income
Three Months EndedSeptember 30, 2023September 30, 2022Location of Gain (Loss) Recognized in IncomeSeptember 30, 2023September 30, 2022
Interest rate collars, net of tax$(1,957)$ Revenue$(975)$ 
Nine Months Ended
Interest rate collars, net of tax$(14,350)$ Revenue$(1,307)$ 
As of September 30, 2023, we estimate that $4.9 million of the deferred amounts recorded in accumulated other comprehensive income (loss) for our cash flow hedges will be reclassified into earnings within the next twelve months.
Gains and losses on our cash flow hedges are net of income tax benefit of $0.3 million and $4.2 million for the three and nine months ended September 30, 2023, respectively. Cash flows from these derivative instruments are included within operating activities in the condensed consolidated statements of cash flows, as our accounting policy is to present cash flows from hedging instruments in the same category as the item being hedged.
Economic Hedges of Interest Rate Risk
We also utilize interest rate cap derivatives to manage our economic exposure to interest rate movements which do not meet the hedge accounting requirements of ASC 815. During the second quarter of 2023, we sold two interest rate cap derivative contracts for a total notional value of $240.0 million. Each contract is indexed to daily simple SOFR, has a strike rate of 5.5%, and expires on May 31, 2026. These interest rate caps were sold for a total premium of $1.2 million, which were deferred and will be settled by the counterparties through monthly straight-line cash payments over the term of the instruments. This hedging strategy enables us to offset a portion of the total cost of our interest rate collar derivatives by capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
These derivative instruments are not designated for hedge accounting treatment, therefore, realized and unrealized gains or losses on the instruments are immediately recognized within “Interest expense and other, net” on the condensed consolidated statements of comprehensive income (loss). Cash flows from these derivative instruments are included within operating activities in the condensed consolidated statements of cash flows.
Avantax, Inc. | Q3 2023 Form 10-Q 19


The table below presents the amount of gains and losses related to these derivative financial instruments and their location in the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 (in thousands):
 Gain (Loss)
Recognized in Income
Three Months EndedLocation of Gain (Loss)
Recognized in Income
September 30, 2023September 30, 2022
Interest rate capsInterest expense and other, net$336 $ 
Nine Months Ended
Interest rate capsInterest expense and other, net$(506)$ 
Accumulated Other Comprehensive Income (Loss)
The table below presents a roll forward of the amounts included in accumulated other comprehensive income (loss), net of taxes, for the three and nine months ended September 30, 2023 (in thousands):
Interest Rate CollarsDeferred TaxesAccumulated Other Comprehensive Income (Loss)
Balance as of December 31, 2022$ $ $ 
Balance as of March 31, 2023   
Changes in fair value(16,377)3,984 (12,393)
Reclassification to earnings439 (107)332 
Balance as of June 30, 2023(15,938)3,877 (12,061)
Changes in fair value(2,585)628 (1,957)
Reclassification to earnings1,288 (313)975 
Balance as of September 30, 2023$(17,235)$4,192 $(13,043)
There was no derivative activity to report for the three and nine months ended September 30, 2022.
Note 12: Stockholders' Equity
Capital Return Program
On January 27, 2023, we commenced a modified “Dutch Auction” tender offer (the “Tender Offer”) to purchase shares of our common stock for an aggregate purchase price of up to $250.0 million at a price per share not less than $27.00 and not greater than $31.00. The Tender Offer was in addition to, and separate from, the $200.0 million stock repurchase authorization discussed below. Upon the conclusion of the Tender Offer, we repurchased and subsequently retired approximately 8.3 million shares of our common stock at the purchase price of $30.00 per share, for aggregate cash consideration of $250.0 million. We incurred approximately $4.5 million for fees and expenses associated with the Tender Offer, including approximately $2.4 million for estimated excise taxes owed under the Inflation Reduction Act of 2022, which were recorded within stockholders’ equity.
Repurchased common stock that is subsequently retired is deducted from common stock for par value and from additional paid-in capital for the excess over par value. Direct costs incurred to repurchase common stock are included in the total cost of the shares.
Stock Repurchase Authorization
On December 19, 2022, we announced that our board of directors authorized the Company to repurchase up to $200.0 million of our common stock. This repurchase authorization does not obligate us to repurchase any specific number of shares, may be suspended or discontinued at any time, and does not have a specified expiration date.
For the three months ended September 30, 2023, we repurchased approximately 0.4 million shares of our common stock under the stock repurchase authorization for aggregate purchase consideration of approximately $9.1 million. For the nine months ended September 30, 2023, we repurchased approximately 3.5 million shares of
Avantax, Inc. | Q3 2023 Form 10-Q 20


our common stock under the stock repurchase authorization for aggregate purchase consideration of approximately $85.0 million. The remaining authorized amount under the stock repurchase authorization as of September 30, 2023, was approximately $115.0 million.
For the three months ended September 30, 2022, we did not repurchase any shares of our common stock under our previous stock repurchase plan. For the nine months ended September 30, 2022, we repurchased approximately 1.9 million shares of our common stock under our previous stock repurchase plan for aggregate purchase consideration of approximately $35.0 million.
Note 13: Interest Expense and Other, Net
“Interest expense and other, net” on the condensed consolidated statements of comprehensive income (loss) consisted of the following (in thousands):            
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Interest expense$5,556 $52 $11,748 $133 
Amortization of debt issuance costs363  737  
Amortization of debt discount68  134  
Total interest expense5,987 52 12,619 133 
Interest income and other106 106 (918)290 
Transition services agreement income(642) (3,288) 
Derivative losses (gains) - interest rate caps(336) 506  
Interest expense and other, net$5,115 $158 $8,919 $423 
In connection with the TaxAct Sale, we entered into a transition services agreement with the Buyer pursuant to which we will provide the Buyer with certain transition services for an initial period ending on June 19, 2023. Under the terms of the original transition services agreement, this agreement was extended to and completed on September 19, 2023. The income from this agreement is included in the table above and largely offsets the costs incurred to provide these transition services, which are included within our operating expenses.
Note 14: Income Taxes
Our provision for income taxes in interim periods is based on our estimated annual effective tax rate. We record cumulative adjustments in the quarter in which a change in the estimated annual effective rate is determined. The estimated annual effective tax rate does not include the effects of discrete events that may occur during the year. The effect of these events, if any, is recorded in the quarter in which the event occurs.
We recorded income tax benefit of $1.1 million and income tax expense of $0.5 million for the three and nine months ended September 30, 2023, respectively. Our effective income tax rate for the three and nine months ended September 30, 2023 differed from the 21% statutory rate primarily due to non-deductible compensation and the effect of state taxes.
We recorded an income tax benefit of $1.5 million and $22.6 million for the three and nine months ended September 30, 2022, respectively. Our effective tax rate for the three and nine months ended September 30, 2022 differed from the 21% statutory rate primarily due to the release in our valuation allowance and the effect of state income taxes.
Note 15: Net Income Per Share
“Basic net income (loss) per share” is calculated using the weighted average number of common shares outstanding during the applicable period. “Diluted net income (loss) per share” is calculated using the weighted average number of common shares outstanding plus the number of dilutive potential common shares outstanding during the applicable period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of outstanding stock options and the vesting of outstanding RSUs using the treasury stock method. Cash-settled restricted stock units are not settled in common shares and are therefore excluded from dilutive potential common shares. Dilutive potential common shares are excluded from the calculation of diluted net income (loss) per share if their effect is antidilutive, including when we report a loss from continuing operations. Performance-based RSUs are considered contingently issuable shares and are excluded from the diluted weighted
Avantax, Inc. | Q3 2023 Form 10-Q 21


average common shares outstanding computation if the related performance-based criteria are not expected to be achieved as of the end of the reporting period.
The calculation of basic and diluted net income (loss) per share is as follows (in thousands, except per share amounts):
Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Numerator:
Income (loss) from continuing operations$(1,495)$321 $1,838 $4,720 
Income (loss) from discontinued operations (22,162)1,921 47,484 
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Denominator:
Basic weighted average common shares outstanding36,921 47,847 39,971 47,981 
Dilutive potential common shares (1)
 1,169 969 1,172 
Diluted weighted average common shares outstanding36,921 49,016 40,940 49,153 
Basic net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.05 $0.10 
Discontinued operations (0.47)0.04 0.99
Basic net income (loss) per share$(0.04)$(0.46)$0.09 $1.09 
Diluted net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.04 $0.10 
Discontinued operations (0.46)0.05 0.96
Diluted net income (loss) per share$(0.04)$(0.45)$0.09 $1.06 
Shares excluded (1)
2,647 893 387 921 
________________________
(1)Potential common shares were excluded from the calculation of diluted net income per share for these periods because their effect would have been anti-dilutive. For the three months ended September 30, 2023, all potential common shares were excluded from the calculation of diluted net loss per share as their effect would have been anti-dilutive due to the net loss recognized for the period.
Avantax, Inc. | Q3 2023 Form 10-Q 22


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion provides an analysis of our financial condition, cash flows, and results of operations from management’s perspective and should be read in conjunction with our condensed consolidated financial statements and accompanying notes thereto included under Part I, Item 1 and the section titled “Cautionary Statement Regarding Forward-Looking Statements” in this Form 10-Q, as well as with our consolidated financial statements, accompanying notes thereto, and “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Overview
Avantax, Inc. (the “Company,” “Avantax,” “we,” “our,” or “us”), is a leading provider of integrated tax-intelligent wealth management services and platforms, assisting consumers, small business owners, tax professionals, financial professionals, and certified public accounting (“CPA”) firms. Our mission is to enable financial success by changing the way individuals and families plan and achieve their goals through tax-intelligent solutions. Our common stock is listed on the NASDAQ Global Select Market under the symbol “AVTA.” Our integrated tax-intelligent wealth management services consist of the operations of Avantax Wealth Management and Avantax Planning Partners.
Avantax Wealth Management provides tax-intelligent wealth management solutions for financial professionals, tax professionals, CPA firms, and their clients. Avantax Wealth Management offers its services through its registered broker-dealer, which is a leading U.S. tax-focused independent broker-dealer, registered investment advisor (“RIA”), and insurance agency subsidiaries. Avantax Wealth Management works with a nationwide network of financial professionals that operate as independent contractors. Avantax Wealth Management provides these financial professionals with an integrated platform of technical, practice, compliance, operations, sales, and product support tools that enable them to offer tax-intelligent planning, investing, and wealth management services to their clients.
Avantax Planning Partners is an in-house/employee-based RIA, insurance agency, and wealth management business that partners with CPA firms in order to provide their consumer and small business clients with holistic financial planning and advisory services, as well as retirement plan solutions through Avantax Retirement Plan Services.
Merger Agreement
On September 9, 2023, Avantax entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Aretec Group, Inc., a Delaware corporation that does business as Cetera Holdings (“Parent”), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Sub”) whereby Parent will acquire all of the issued and outstanding equity of Avantax (the “Merger”) in an all-cash transaction valuing Avantax at approximately $1.2 billion, inclusive of Avantax’s net debt. On the terms and subject to the conditions of the Merger Agreement, holders of shares of Avantax common stock (other than Excluded Shares and Dissenting Shares (each, as defined in the Merger Agreement)) will receive $26.00 per share in cash, without interest and less any required tax withholdings. Upon the closing of the transactions contemplated by the Merger Agreement, Avantax will operate as a privately-held company. The closing remains subject to customary closing conditions, including approval by Avantax’s stockholders. Avantax expects the closing to occur by the end of November 2023.
Divestiture of Tax Software Business
On October 31, 2022, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with TaxAct Holdings, Inc. (f/k/a Avantax Holdings, Inc.), a Delaware corporation and a direct subsidiary of Avantax, Franklin Cedar Bidco, LLC, a Delaware limited liability company (the “Buyer”), and, solely for purposes of certain provisions thereof, DS Admiral Bidco, LLC, a Delaware limited liability company, pursuant to which we sold our former tax software business to Buyer for an aggregate purchase price of $720.0 million in cash, subject to customary purchase price adjustments set forth in the Purchase Agreement (the TaxAct Sale). This transaction subsequently closed on December 19, 2022.
In accordance with ASC 205, Presentation of Financial Statements, we determined that the sale of our tax software business represented a strategic shift that will have a major effect on our operations and financial results. As a result of the TaxAct Sale, the historical results of our former tax software business, and any adjustments to amounts previously reported in discontinued operations in a prior period (if applicable) have been reclassified as a
Avantax, Inc. | Q3 2023 Form 10-Q 23


discontinued operation and are excluded from continuing operations for all periods presented within the condensed consolidated financial statements.
Recent Developments
Interest Rate Hedges
During the second quarter of 2023, we entered into two interest rate collar derivative contracts for a total notional value of $1.5 billion. Each contract is indexed to daily simple secured overnight financing rates (“SOFR”) and is a combination of a purchased floor instrument with a strike rate of 2.5% and a sold cap instrument with a strike rate of 5.5%, both of which expire on May 31, 2026. The total cost for these interest rate collars was $15.3 million, which we elected to defer and will settle through monthly straight-line cash payments to the counterparties over the term of the instruments. This hedging strategy enables us to limit the downside risk of significant reductions to interest rates over the term of the instruments in exchange for capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged. We designated these derivative instruments as cash flow hedges and determined that they are highly effective at achieving offsetting changes in cash flows attributable to interest rate fluctuations associated with our cash sweep program. The changes in fair value of these derivative instruments are initially recorded net of tax in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity. These accumulated gains or losses are reclassified into “Revenue” (where the hedged transaction is recorded) on the condensed consolidated statements of comprehensive income (loss) when the hedged transaction affects earnings.
In addition, during the second quarter of 2023, we sold two interest rate cap derivative contracts for a total notional value of $240.0 million. Each contract is indexed to daily simple SOFR, has a strike rate of 5.5%, and expires on May 31, 2026. These interest rate caps were sold for a total premium of $1.2 million, which were deferred and will be settled by the counterparties through monthly straight-line cash payments over the term of the instruments. This hedging strategy enables us to offset a portion of the total cost of our interest rate collar derivatives by capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged. These derivative instruments are not designated for hedge accounting treatment, therefore, realized and unrealized gains or losses on the instruments are immediately recognized within “Interest expense and other, net” on the condensed consolidated statements of comprehensive income (loss).
Avantax, Inc. | Q3 2023 Form 10-Q 24


RESULTS OF OPERATIONS
Summary
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
Revenue$192,343 $165,032 $27,311 16.5 %$557,251 $494,104 $63,147 12.8 %
Operating expenses:
Cost of revenue117,684 105,809 11,875 11.2 %336,783 341,443 (4,660)(1.4)%
Engineering and technology2,352 2,617 (265)(10.1)%7,264 6,733 531 7.9 %
Sales and marketing26,298 23,770 2,528 10.6 %79,902 70,826 9,076 12.8 %
General and administrative33,011 23,792 9,219 38.7 %91,747 69,388 22,359 32.2 %
Acquisition and integration(100)416 (516)(124.0)%(17)(4,710)4,693 99.6 %
Depreciation4,142 3,343 799 23.9 %11,318 8,428 2,890 34.3 %
Amortization of acquired intangible assets6,404 6,342 62 1.0 %18,973 19,435 (462)(2.4)%
Total operating expenses189,791 166,089 23,702 14.3 %545,970 511,543 34,427 6.7 %
Operating income (loss) from continuing operations 2,552 (1,057)3,609 341.4 %11,281 (17,439)28,720 164.7 %
Interest expense and other, net(5,115)(158)(4,957)(3,137.3)%(8,919)(423)(8,496)(2,008.5)%
Income (loss) from continuing operations before income taxes(2,563)(1,215)(1,348)(110.9)%2,362 (17,862)20,224 113.2 %
Income tax benefit (expense)1,068 1,536 (468)(30.5)%(524)22,582 (23,106)(102.3)%
Income (loss) from continuing operations(1,495)321 (1,816)(565.7)%1,838 4,720 (2,882)(61.1)%
Discontinued operations
Income (loss) from discontinued operations before gain on disposal and income taxes— (22,352)22,352 100.0 %— 74,165 (74,165)(100.0)%
Pre-tax gain on disposal— — — N/A2,539 — 2,539 N/A
Income (loss) from discontinued operations before income taxes— (22,352)22,352 100.0 %2,539 74,165 (71,626)(96.6)%
Income tax benefit (expense)— 190 (190)(100.0)%(618)(26,681)26,063 97.7 %
Income (loss) from discontinued operations— (22,162)22,162 100.0 %1,921 47,484 (45,563)(96.0)%
Net income (loss)$(1,495)$(21,841)$20,346 93.2 %$3,759 $52,204 $(48,445)(92.8)%
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, net loss decreased $20.3 million primarily due to the following factors:
Income from continuing operations decreased $1.8 million primarily due to the following factors:
Revenue increased $27.3 million primarily due to incremental advisory revenue from higher asset values coupled with increased cash sweep revenue generated from a higher federal funds rate paired with the program’s structure that increases returns in a higher interest rate environment.
Total operating expenses increased $23.7 million primarily from higher financial professional commissions within cost of revenue caused by increased advisory revenue and an increase in general and administrative expense driven by costs incurred for the Merger and reorganization related costs associated with the TaxAct Sale.
Income tax benefit decreased $0.5 million primarily due to a reduction in our valuation allowance during the prior year associated with the utilization of net operating losses against prior period taxable income.
Income from discontinued operations increased $22.2 million primarily due to the completion of the TaxAct Sale in the prior period.
Avantax, Inc. | Q3 2023 Form 10-Q 25


For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, net income decreased $48.4 million primarily due to the following factors:
Income from continuing operations decreased $2.9 million primarily due to the following factors:
Revenue increased $63.1 million primarily due to incremental cash sweep and advisory revenues consistent with the discussion above, partially offset by lower commission revenue due to reduced transaction activity.
Total operating expenses increased $34.4 million primarily from increased general and administrative and sales and marketing expenses. General and administrative expense increased due to costs associated with the TaxAct Sale, including reorganization and executive transition related costs, and costs incurred for the Merger. These increases were partially offset by decreased acquisition and integration costs due to acquisition-related contingent consideration fair value adjustments that did not reoccur in the current period and decreased financial professional commissions caused by reduced commission revenue.
Income tax benefit decreased $23.1 million primarily due to a reduction in our valuation allowance during the prior year associated with the utilization of net operating losses against prior period taxable income.
Income from discontinued operations decreased $45.6 million primarily due to the completion of the TaxAct Sale in the prior period. During the nine months ended September 30, 2023 we recognized an incremental pre-tax gain on disposal of $2.5 million in connection with the finalization of our closing working capital balance.
Sources of Revenue
Our revenue is derived from multiple sources. We track sources of revenue, primary drivers of each revenue source, and recurring revenue. In addition, we focus on several business and key financial metrics in evaluating the success of our business relationships, our resulting financial position, and operating performance. A summary of our sources of revenue and business and financial metrics is as follows:
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
Sources of RevenuePrimary Drivers20232022$%20232022$%
Financial professional-drivenAdvisory- Advisory asset levels$108,393 $95,070 $13,323 14.0 %$309,234 $306,394 $2,840 0.9 %
Commission- Transactions
- Asset levels
- Product mix
43,351 41,788 1,563 3.7 %126,662 132,278 (5,616)(4.2)%
Other revenueAsset-based- Cash balances
- Interest rates
- Number of accounts
- Client asset levels
33,444 21,147 12,297 58.2 %100,524 33,774 66,750 197.6 %
Transaction and fee- Account activity
- Number of financial
  professionals
- Number of clients
- Number of accounts
7,155 7,027 128 1.8 %20,831 21,658 (827)(3.8)%
Total revenue$192,343 $165,032 $27,311 16.5 %$557,251 $494,104 $63,147 12.8 %
Total recurring revenue$169,183 $144,512 $24,671 17.1 %$493,342 $430,184 $63,158 14.7 %
Recurring revenue rate88.0 %87.6 %88.5 %87.1 %
Recurring revenue consists of advisory fees, trailing commissions, fees from cash sweep programs, and certain transaction and fee revenue, all as described further under the headings “Advisory revenue,” “Commission revenue,” “Asset-based revenue,” and “Transaction and fee revenue,” respectively. Certain recurring revenues are associated with asset balances and fluctuate depending on market values and current interest rates. Accordingly, our recurring revenue can be negatively impacted by adverse external market conditions. However, we believe recurring revenue is meaningful because it is not dependent upon transaction volumes or other activity-based revenues, which are more difficult to predict, particularly in declining or volatile markets.
Avantax, Inc. | Q3 2023 Form 10-Q 26


Business Metrics
($ in thousands)
September 30,Change
20232022$%
Client assets balances:
Total client assets
$82,255,722 $72,592,882 $9,662,840 13.3 %
Brokerage assets
$40,262,060 $37,150,327 $3,111,733 8.4 %
Advisory assets
$41,993,662 $35,442,555 $6,551,107 18.5 %
Advisory assets as a percentage of total client assets51.1 %48.8 %
Number of financial professionals (in ones):
Independent financial professionals (1)
3,073 3,311 (238)(7.2)%
In-house/employee financial professionals (2)
38 36 5.6 %
Total number of financial professionals3,111 3,347 (236)(7.1)%
Advisory and commission revenue per financial professional (3)
$48.8 $40.9 $7.9 19.3 %
___________________________
(1)The number of independent financial professionals includes licensed financial professionals that work with Avantax Wealth Management and operate as independent contractors, as well as 179 licensed referring representatives at CPA firms that partner with Avantax Planning Partners.
(2)The number of in-house/employee financial professionals includes licensed financial planning consultants, all of which are affiliated with Avantax Planning Partners.
(3)Calculation based on advisory and commission revenue for the three months ended September 30, 2023 and 2022, respectively.
Client Assets. Historically we have calculated total client assets to include assets that we hold directly or indirectly on behalf of clients under a safekeeping or custody arrangement or for which we provide administrative services for clients. Beginning in the second quarter of 2022, the calculation of total client assets also includes assets for which financial professionals licensed with Avantax provide administrative services to clients. Because we did not have relationships with financial professionals that had clients for whom we did not provide administrative services prior to the second quarter of 2022, our calculation of total client assets for any prior period would not have changed under our current calculation. To the extent that we or they provide more than one service for a client’s assets, the value of the asset is only counted once in the total amount of total client assets. Total client assets include advisory assets, non-advisory brokerage accounts, annuities, and mutual fund positions held directly with fund companies. These assets are not reported on the Company’s consolidated balance sheets.
Advisory assets include client assets for which we provide investment advisory and management services as a fiduciary under the Investment Advisers Act of 1940. Our compensation for providing such services is typically a fee-based on the value of the advisory assets for each advisory client.
Brokerage assets represent total client assets other than advisory assets.
Total client assets increased $9.7 billion as of September 30, 2023 compared to September 30, 2022, primarily due to $7.2 billion of favorable market changes and $2.5 billion of net client inflows.
Advisory assets increased $6.6 billion as of September 30, 2023 compared to September 30, 2022, and advisory assets as a percentage of total client assets increased to 51.1% as of September 30, 2023, compared to 48.8% as of September 30, 2022. The increase in advisory assets was primarily caused by $3.6 billion of favorable market changes and net new advisory assets of $3.0 billion, both of which contributed to the increase in advisory assets as a percentage of total client assets.
Financial Professionals. The number of our financial professionals decreased 7.1% as of September 30, 2023 compared to September 30, 2022, with the decrease primarily due to attrition related to lower revenue-producing financial professionals. Included within this attrition of lower revenue-producing financial professionals were terminations primarily in the fourth quarter of 2022 associated with certain financial professional’s failure to comply with a policy implemented to ensure regulatory compliance with certain record keeping and supervisory requirements. Advisory and commission revenue per financial professional increased 19.3% for the same period, primarily due to the attrition of lower revenue-producing financial professionals discussed above. The decrease in
Avantax, Inc. | Q3 2023 Form 10-Q 27


the number of financial professionals was partially offset by our continued recruitment and onboarding of independent financial professionals.
Advisory Revenue. Advisory revenue primarily includes fees charged to clients in advisory accounts for which we are the RIA. These fees are based on the value of assets within these advisory accounts. For advisory revenues generated by Avantax Wealth Management, advisory fees are typically billed quarterly, in advance, and the related advisory revenues are deferred and recognized ratably over the period in which our performance obligations have been completed. For advisory revenue generated by Avantax Planning Partners, advisory fees are typically billed quarterly, in arrears, and the related advisory revenues are accrued and recognized ratably over the period in which our performance obligations were completed. Because advisory fees are based on advisory assets on the last day of each quarter, our revenues are impacted, in part, by the timing of market movements relative to when clients are billed.
Advisory asset balances were as follows (in thousands):

September 30,Change
20232022$%
Advisory assets—independent financial professionals
$34,188,023 $29,735,365 $4,452,658 15.0 %
Advisory assets—in-house/employee financial professionals
6,323,639 4,494,178 1,829,461 40.7 %
Retirement advisory assets—in-house/employee financial professionals
1,482,000 1,213,012 268,988 22.2 %
Total advisory assets$41,993,662 $35,442,555 $6,551,107 18.5 %
The activity within our advisory assets was as follows (in thousands):

Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Balance, beginning of the period$42,649,611 $36,746,048 $38,282,333 $42,179,051 
Net new advisory assets706,495 514,293 2,374,116 2,261,923 
Market impact and other(1,362,444)(1,817,786)1,337,213 (8,998,419)
Balance, end of the period$41,993,662 $35,442,555 $41,993,662 $35,442,555 
Advisory revenue$108,393 $95,070 $309,234 $306,394 
Average advisory fee rate (1)
25 bps26 bps76 bps77 bps
_________________________
(1)For the three months ended September 30, 2023 and September 30, 2022, average advisory fee rate equals advisory revenue for the relevant quarterly period divided by the advisory asset balance at the beginning of the relevant quarterly period. For the nine months ended September 30, 2023 and September 30, 2022, average advisory fee rate equals the sum of each quarterly average advisory fee rate within the relevant year-to-date period.
For the three months ended September 30, 2023, advisory assets decreased $0.7 billion primarily due to unfavorable market changes, partially offset by net new advisory assets from organic growth and the recruitment of new assets. For the nine months ended September 30, 2023, advisory assets increased $3.7 billion driven by favorable market changes and net new advisory assets from organic growth and the recruitment of new assets.
For the three and nine months ended September 30, 2023 compared to the three and nine months ended September 30, 2022, advisory revenue increased $13.3 million and $2.8 million, respectively. These increases correspond with the year-over-year increase in advisory assets discussed above, coupled with the timing of market changes relative to when clients are billed. The average advisory fee rates between the two periods remained relatively flat.
Commission Revenue. We generate two types of commissions: (1) transaction-based commissions and (2) trailing commissions. Transaction-based commissions, which occur when clients trade securities or purchase investment products, represent gross commissions generated by our financial professionals. The level of transaction-based commissions can vary from period-to-period based on the overall economic environment, number of trading days in the reporting period, market volatility, interest rate fluctuations, and investment activity of our financial professionals’ clients. We earn trailing commissions (a commission or fee that is paid periodically over time) on certain mutual funds and variable annuities held by clients. Trailing commissions are recurring in nature and are based on the market value of investment holdings in trail-eligible assets.
Avantax, Inc. | Q3 2023 Form 10-Q 28


Our commission revenue, by product category and by type of commission revenue, was as follows (in thousands):
Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
By product category:
Mutual funds$15,936 $16,339 $(403)(2.5)%$47,226 $53,635 $(6,409)(11.9)%
Variable annuities14,437 14,892 (455)(3.1)%44,102 46,961 (2,859)(6.1)%
Insurance6,486 5,048 1,438 28.5 %19,774 13,007 6,767 52.0 %
General securities6,492 5,509 983 17.8 %15,560 18,675 (3,115)(16.7)%
Total commission revenue$43,351 $41,788 $1,563 3.7 %$126,662 $132,278 $(5,616)(4.2)%
By type of commission:
Transaction-based$20,448 $17,868 $2,580 14.4 %$57,333 $56,373 $960 1.7 %
Trailing22,903 23,920 (1,017)(4.3)%69,329 75,905 (6,576)(8.7)%
Total commission revenue$43,351 $41,788 $1,563 3.7 %$126,662 $132,278 $(5,616)(4.2)%
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, commission revenue increased $1.6 million. This increase was primarily due to increased transaction-based commissions for insurance and general securities, partially offset by declines in trailing commissions for variable annuities and mutual funds.
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, commission revenue decreased $5.6 million. This decrease was primarily due to declines in trailing commissions for mutual funds, variable annuities, and general securities, partially offset by increased insurance commissions. Volatility in equity markets and the impact to asset values has negatively impacted mutual funds and variable annuities trail commissions, while the current interest rate environment has led to considerable declines in transaction volume for alternate investment vehicles linked with real estate. We expect the continued growth of assets on our fee-based advisory platform to result in commission revenue headwinds in the future.
Asset-Based Revenue. Asset-based revenue primarily includes fees from financial product manufacturer sponsorship programs, cash sweep programs, asset-based retirement plan service fees, and other asset-based revenues.
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, asset-based revenue increased $12.3 million, primarily due to incremental cash sweep revenue of $12.0 million driven by increases in the federal funds rate, partially offset by declines in client cash sweep balances relative to prior year levels.
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, asset-based revenue increased $66.8 million, primarily due to incremental cash sweep revenue of $67.5 million driven by increases in the federal funds rate, partially offset by declines in client cash sweep balances relative to prior year levels. The increases in cash sweep revenue were partially offset by reduced fees from sponsorship programs.
For the three and nine months ended September 30, 2023, we recognized approximately $1.3 million and $1.7 million of deferred premium charges for our interest rate collar derivatives which are included as a reduction to our cash sweep revenue. Under the terms of our interest rate collar derivative contracts, we expect to recognize approximately $5.1 million of deferred premium charges as a reduction to our cash sweep revenue over the next twelve months. For the remainder of the year, we expect for cash sweep revenue to continue to increase relative to comparable prior year periods driven by rate increases during 2023 and as the full benefits of rate increases during the latter half of 2022 are realized for a full annual period. Currently, the target range for the federal funds rate is below the cap of our interest rate collar derivatives. However, future increases to this range above our cap strike rate will limit our incremental cash sweep revenue on the comparable notional portion of our interest rate collars derivatives.
Transaction and Fee Revenue. Transaction and fee revenue primarily includes support fees charged to financial professionals, fees charged for executing certain transactions in client accounts, and other fees related to
Avantax, Inc. | Q3 2023 Form 10-Q 29


services provided and other account charges as generally outlined in agreements with financial professionals, clients, financial institutions, and retirement plan sponsors.
For the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, transaction and fee revenue remained relatively flat.
OPERATING EXPENSES
Cost of Revenue
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
Cost of revenue$117,684 $105,809 $11,875 11.2 %$336,783 $341,443 $(4,660)(1.4)%
Percentage of revenue61.2 %64.1 %60.4 %69.1 %
Cost of revenue includes commissions and advisory fees paid to independent financial professionals, payments made to CPA firms under fee sharing arrangements, amortization of forgivable loans issued to our financial professionals, and stock-based compensation for awards granted to our financial professionals. Cost of revenue does not include compensation paid to in-house/employee financial professionals. The compensation of our in-house/employee financial professionals is reflected in “Sales and marketing” expense.
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, cost of revenue increased $11.9 million, primarily due to an increase in commissions to financial professionals associated with the increase in advisory and commission revenues discussed above.
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, cost of revenue decreased $4.7 million. Commissions to financial professionals declined $4.1 million primarily due to reductions in commission revenue caused by the volatility in global financial markets discussed above. The remaining change was primarily due to reduced personnel costs, partially offset by incremental financial professional loan amortization.
For the three months ended September 30, 2023, payout ratios to independent financial professionals remained relatively flat. For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, payout ratios to independent financial professionals declined approximately 46 basis points. This decline was primarily caused by the timing of equity market volatility during the trailing twelve-month periods coupled with continued growth in our in-house/employee-based advisory model, which has lower payout rates as compared to our independent model. The decrease in cost of revenue as a percentage of revenue is reflective of the benefits of incremental cash sweep revenue for the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022.
Engineering and Technology
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
Engineering and technology$2,352 $2,617 $(265)(10.1)%$7,264 $6,733 $531 7.9 %
Percentage of revenue1.2 %1.6 %1.3 %1.4 %
Engineering and technology expenses are associated with the research, development, support, and ongoing enhancements of our platforms, which include personnel expenses (including stock-based compensation), the cost of temporary help and contractors, software support and maintenance, and professional services fees. Engineering and technology expenses do not include the costs of computer hardware and software that are capitalized, depreciated over their useful lives, and recognized on the consolidated statements of comprehensive income (loss) as “Depreciation.” For more information, see the “Depreciation and Amortization of Acquired Intangible Assets” sections contained within this discussion of “Operating Expenses.”
For the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, engineering and technology expenses did not materially change.
Avantax, Inc. | Q3 2023 Form 10-Q 30


Sales and Marketing
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
Sales and marketing$26,298 $23,770 $2,528 10.6 %$79,902 $70,826 $9,076 12.8 %
Percentage of revenue13.7 %14.4 %14.3 %14.3 %
Sales and marketing expenses primarily consist of the costs to support our financial professionals and drive growth. This includes personnel costs (including stock-based compensation) for operational and back-office processing support, investment and portfolio strategy support, compliance, and compensation paid to Avantax Planning Partners in-house/employee financial professionals. These costs also include business development costs related to advisor recruitment and retention, costs related to hosting certain advisor conferences that serve as training, sales and marketing events, and other costs that support advisor business growth.
For the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, sales and marketing expenses increased $2.5 million and $9.1 million, respectively, primarily due to incremental personnel costs. The increase in personnel costs is associated with higher employee benefit costs and growth in our Avantax Planning Partners business and investments to enhance our sales and service capabilities that support our financial professionals.
General and Administrative
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
General and administrative$33,011 $23,792 $9,219 38.7 %$91,747 $69,388 $22,359 32.2 %
Percentage of revenue17.2 %14.4 %16.5 %14.0 %
General and administrative (“G&A”) expenses primarily consist of personnel expenses (including stock-based compensation), the cost of temporary help and contractors, professional services fees, general business development and management expenses, occupancy and general office expenses, business taxes, and insurance expenses.
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, G&A expenses increased $9.2 million, primarily due to the following:
Legal, consulting, and other professional costs increased $7.1 million primarily due to costs incurred for the Merger, partially offset by lower TaxAct transaction related costs.
Personnel costs increased $2.2 million primarily due to increased severance costs associated with our reorganization activities.
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, G&A expenses increased $22.4 million, primarily due to the following:
Legal, consulting, and other professional costs increased $11.0 million primarily due to costs incurred for the Merger, TaxAct transaction related costs, and reorganization activities. These increases were partially offset by reduced contested proxy costs.
Personnel costs increased $10.1 million primarily due to executive transition costs for certain executives that departed the company and other reorganization activities.
Network and software related expenses increased approximately $1.8 million due to our obligations under the transition services agreement initiated in connection with the TaxAct Sale, partially offset by lower rent and facilities charges associated with the sublease of a portion of our corporate headquarters.


Avantax, Inc. | Q3 2023 Form 10-Q 31


Acquisition and Integration
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
Professional services and other expenses$(100)$416 $(516)(124.0)%$(17)$610 $(627)(102.8)%
Change in the fair value of acquisition-related contingent consideration— — — N/A— (5,320)5,320 100.0 %
Total$(100)$416 $(516)(124.0)%$(17)$(4,710)$4,693 99.6 %
Percentage of revenue(0.1)%0.3 %— %(1.0)%
Acquisition and integration expenses primarily relate to costs incurred for the acquisitions of Avantax Planning Partners and 1st Global and consist of employee-related expenses, professional services fees, changes in the fair value of contingent consideration, and other expenses.
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, acquisition and integration expenses did not materially change. For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, acquisition and integration expenses decreased $4.7 million, primarily due to prior period acquisition-related contingent consideration fair value adjustments.
Depreciation and Amortization of Acquired Intangible Assets
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
 20232022$%20232022$%
Depreciation$4,142 $3,343 $799 23.9 %$11,318 $8,428 $2,890 34.3 %
Amortization of acquired intangible assets6,404 6,342 62 1.0 %18,973 19,435 (462)(2.4)%
Total$10,546 $9,685 $861 8.9 %$30,291 $27,863 $2,428 8.7 %
Percentage of revenue5.5 %5.9 %5.4 %5.6 %
Depreciation of property, equipment, and software, net includes depreciation of computer equipment and software (including internally developed software), office equipment and furniture, and leasehold improvements. Amortization of acquired intangible assets primarily includes the amortization of financial professional, sponsor, and client relationships, which are amortized over their estimated lives.
For the three and nine months ended September 30, 2023, compared to the three and nine months ended September 30, 2022, depreciation expense increased $0.8 million and $2.9 million, respectively, primarily due to increased capital expenditures for internally developed software. Amortization expense did not materially change.
INTEREST EXPENSE AND OTHER, NET
($ in thousands)Three Months Ended
September 30,
ChangeNine Months Ended
September 30,
Change
20232022$%20232022$%
Interest expense$5,556 $52 $5,504 10,584.6 %$11,748 $133 $11,615 8,733.1 %
Amortization of debt issuance costs363 — 363 N/A737 — 737 N/A
Amortization of debt discount68 — 68 N/A134 — 134 N/A
Total interest expense5,987 52 5,935 11,413.5 %12,619 133 12,486 9,388.0 %
Interest income and other106 106 — — %(918)290 (1,208)(416.6)%
Transition services agreement income(642)— (642)N/A(3,288)— (3,288)N/A
Derivative losses (gains) - interest rate caps(336)— (336)N/A506 — 506 N/A
Interest expense and other, net$5,115 $158 $4,957 3,137.3 %$8,919 $423 $8,496 2,008.5 %
For the three months ended September 30, 2023, compared to the three months ended September 30, 2022, interest expense and other, net, increased $5.0 million. Total interest expense increased $5.9 million, due to borrowings on our Delayed Draw Term Loan Facility, which was partially offset by income received from the transition services agreement initiated in connection with the TaxAct Sale.
Avantax, Inc. | Q3 2023 Form 10-Q 32


For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, interest expense and other, net, increased $8.5 million. Total interest expense increased $12.5 million, due to borrowings on our Delayed Draw Term Loan Facility, which was partially offset by income received from the transition services agreement initiated in connection with the TaxAct Sale, and incremental other income associated with the settlement of escrow funds from a previous acquisition.
INCOME TAXES
Our provision for income taxes in interim periods is based on our estimated annual effective tax rate. We record cumulative adjustments in the quarter in which a change in the estimated annual effective rate is determined. The estimated annual effective tax rate does not include the effects of discrete events that may occur during the year. The effect of these events, if any, is recorded in the quarter in which the event occurs.
We recorded income tax benefit of $1.1 million and income tax expense of $0.5 million for the three and nine months ended September 30, 2023, respectively. Our effective income tax rate for the three and nine months ended September 30, 2023 differed from the 21% statutory rate primarily due to non-deductible compensation and the effect of state taxes.
We recorded an income tax benefit of $1.5 million and $22.6 million for the three and nine months ended September 30, 2022, respectively. Our effective tax rate for the three and nine months ended September 30, 2022 differed from the 21% statutory rate primarily due to the release in our valuation allowance and the effect of state income taxes.
DISCONTINUED OPERATIONS
On October 31, 2022, we entered into the Purchase Agreement with the Buyer to sell our former tax software business for an aggregate purchase price of $720.0 million in cash, subject to customary purchase price adjustments set forth in the Purchase Agreement. The TaxAct Sale subsequently closed on December 19, 2022. This divestiture was considered part of our strategic shift to become a pure-play wealth management company and was determined to meet discontinued operations accounting criteria under ASC 205.
During the nine months ended September 30, 2023, we finalized our previously estimated closing date working capital balance, resulting in an incremental pre-tax gain of $2.5 million which is included within “Pre-tax gain on disposal” in the condensed consolidated statements of comprehensive income (loss).
NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA
We define Adjusted EBITDA as net income (loss), determined in accordance with GAAP, excluding the effects of discontinued operations, stock-based compensation, depreciation and amortization of acquired intangible assets, interest expense and other, net, acquisition and integration costs, contested proxy and other legal and consulting costs, executive transition costs, Merger transaction costs, TaxAct transaction related costs, reorganization costs, hedging program start-up costs, and income tax (benefit) expense. Interest expense and other, net primarily consists of interest expense, net, unrealized mark-to-market (“MTM”) derivative losses (gains) for our interest rate cap derivative instruments, and other non-operating income. It does not include the income associated with the transition services agreement signed in connection with the TaxAct Sale as this income offsets costs included within income from continuing operations, or realized income or loss associated with our interest rate cap derivative instruments. Acquisition and integration costs primarily relate to the acquisitions of Avantax Planning Partners and 1st Global. Hedging program start-up costs include consulting and accounting costs incurred for the implementation of our cash sweep interest rate hedging program. Merger transaction costs include consulting and legal costs incurred for the plan of merger with Aretec Group, Inc., an affiliate of Cetera Financial Group. Inc.
We believe that Adjusted EBITDA provides meaningful supplemental information regarding our performance. We use this non-GAAP financial measure for internal management and compensation purposes, when publicly providing guidance on possible future results, and as a means to evaluate period-to-period comparisons. We believe that Adjusted EBITDA is a common measure used by investors and analysts to evaluate our performance, that it provides a more complete understanding of the results of operations and trends affecting our business when viewed together with GAAP results, and that management and investors benefit from referring to this non-GAAP financial measure. Items excluded from Adjusted EBITDA are significant and necessary components to the operations of our business and, therefore, Adjusted EBITDA should be considered as a supplement to, and not as a
Avantax, Inc. | Q3 2023 Form 10-Q 33


substitute for or superior to, GAAP net income (loss). Other companies may calculate Adjusted EBITDA differently and, therefore, our Adjusted EBITDA may not be comparable to similarly titled measures of other companies.
A reconciliation of GAAP net income (loss), which we believe to be the most comparable GAAP measure, to Adjusted EBITDA, is presented below:
($ in thousands)Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Less: Income (loss) from discontinued operations, net of income taxes— (22,162)1,921 47,484 
Income (loss) from continuing operations, net of income taxes(1,495)321 1,838 4,720 
Stock-based compensation6,585 4,964 17,678 14,782 
Depreciation and amortization of acquired intangible assets
10,546 9,685 30,291 27,863 
Interest expense and other, net5,854 158 12,337 423 
Acquisition and integration—Excluding change in the fair value of acquisition-related contingent consideration(100)416 (17)610 
Acquisition and integration—Change in the fair value of acquisition-related contingent consideration— — — (5,320)
Contested proxy and other legal and consulting costs— (250)694 3,865 
Executive transition costs— — 6,412 — 
Merger transaction costs7,763 — 7,763 — 
TaxAct transaction related costs2,069 3,237 6,228 3,439 
Reorganization costs3,938 — 8,904 — 
Hedging program start-up costs— — 583 — 
Income tax (benefit) expense(1,068)(1,536)524 (22,582)
Adjusted EBITDA$34,092 $16,995 $93,235 $27,800 
Non-GAAP Net Income (Loss) and Non-GAAP Net Income (Loss) Per Share
We define Non-GAAP Net Income (Loss) as net income (loss), determined in accordance with GAAP, excluding the effects of discontinued operations, amortization of acquired intangible assets, acquisition and integration costs, contested proxy and other legal and consulting costs, executive transition costs, Merger transaction costs, TaxAct transaction related costs, reorganization costs, hedging program start-up costs, unrealized MTM derivative losses (gains) for our interest rate cap derivative instruments, and the related tax impact of those adjustments. Unrealized MTM derivative losses (gains) include the unrealized portion of gains and losses that are caused by changes in the fair values of derivatives which do not qualify for hedge accounting treatment under GAAP. It does not include realized income or loss associated with these instruments. The tax impact of these adjustments is determined using the income tax rates in effect for the applicable period, adjusted for any potentially non-deductible amounts.
We believe that Non-GAAP Net Income (Loss) and Non-GAAP Net Income (Loss) per share provide meaningful supplemental information to management, investors, and analysts regarding our performance and the valuation of our business by excluding items in the statement of comprehensive income (loss) that we do not consider part of our ongoing operations or that have not been, or are not expected to be, settled in cash. Additionally, we believe that Non-GAAP Net Income (Loss) and Non-GAAP Net Income (Loss) per share are common measures used by investors and analysts to evaluate our performance and the valuation of our business. Non-GAAP Net Income (Loss) and Non-GAAP Net Income (Loss) per share should be evaluated in light of our financial results prepared in accordance with GAAP and should be considered as a supplement to, and not as a substitute for or superior to, GAAP net income (loss) and GAAP net income (loss) per share. Other companies may calculate Non-GAAP Net Income (Loss) and Non-GAAP Net Income (Loss) per share differently, and, therefore, these measures may not be comparable to similarly titled measures of other companies.
Avantax, Inc. | Q3 2023 Form 10-Q 34


A reconciliation of GAAP net income (loss) and GAAP net income (loss) per share, which we believe to be the most comparable GAAP measures, to Non-GAAP Net Income (Loss) and Non-GAAP Net Income (Loss) per share, respectively, is presented below:
($ in thousands)Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Less: Income (loss) from discontinued operations, net of income taxes— (22,162)1,921 47,484 
Income (loss) from continuing operations, net of income taxes(1,495)321 1,838 4,720 
Amortization of acquired intangible assets
6,404 6,342 18,973 19,435 
Acquisition and integration—Excluding change in the fair value of acquisition-related contingent consideration(100)416 (17)610 
Acquisition and integration—Change in the fair value of acquisition-related contingent consideration— — — (5,320)
Contested proxy and other legal and consulting costs
— (250)694 3,865 
Executive transition costs— — 6,412 — 
Merger transaction costs7,763 — 7,763 — 
TaxAct transaction related costs2,069 3,237 6,228 3,439 
Reorganization costs3,938 — 8,904 — 
Hedging program start-up costs— — 583 — 
Unrealized MTM derivative losses (gains)(239)— 637 — 
Tax impact of adjustments to GAAP net income (loss)
(4,823)(2,315)(11,601)(5,234)
Non-GAAP Net Income$13,517 $7,751 $40,414 $21,515 
Per diluted share:
Net income (loss) (1)
$(0.04)$(0.45)$0.09 $1.06 
Less: Income (loss) from discontinued operations, net of income taxes— (0.46)(0.05)(0.96)
Income (loss) from continuing operations, net of income taxes(0.04)0.01 0.04 0.10 
Amortization of acquired intangible assets
0.18 0.13 0.46 0.40 
Acquisition and integration—Excluding change in the fair value of acquisition-related contingent consideration— 0.01 — 0.01 
Acquisition and integration—Change in the fair value of acquisition-related contingent consideration— — — (0.11)
Contested proxy and other legal and consulting costs
— (0.01)0.02 0.08 
Executive transition costs— — 0.16 — 
Merger transaction costs0.21 — 0.19 — 
TaxAct transaction related costs0.05 0.07 0.15 0.07 
Reorganization costs0.10 — 0.22 — 
Hedging program start-up costs— — 0.01 — 
Unrealized MTM derivative losses (gains)(0.01)— 0.02 — 
Tax impact of adjustments to GAAP net income (loss)
(0.13)(0.05)(0.28)(0.11)
Non-GAAP Net Income per share — Diluted $0.36 $0.16 $0.99 $0.44 
Diluted weighted average shares outstanding
37,791 49,016 40,940 49,153 
____________________________
(1)Any difference in the “per diluted share” amounts between this table and the condensed consolidated statements of comprehensive income (loss) is due to using different diluted weighted average shares outstanding in the event that there is GAAP net loss but Non-GAAP Net Income and vice versa.
LIQUIDITY AND CAPITAL RESOURCES
Cash and Cash Equivalents
Our principal source of liquidity is our cash and cash equivalents. As of September 30, 2023, we had cash and cash equivalents of $106.4 million. We generally invest our excess cash in money market funds that are made up of securities issued by agencies of the U.S. government. From time-to-time, we may invest, in other vehicles, such as debt instruments issued by the U.S. federal government and its agencies, international governments, municipalities,
Avantax, Inc. | Q3 2023 Form 10-Q 35


and publicly held corporations, as well as commercial paper and insured time deposits with commercial banks. Specific holdings can vary from period to period depending upon our cash requirements. Our financial instrument investments held as of September 30, 2023 had minimal default risk and short-term maturities.
Our Avantax Wealth Management broker-dealer subsidiary operates in a highly regulated industry and is subject to various regulatory capital requirements. Failure to meet minimum capital requirements can initiate certain mandatory and possible additional discretionary actions by regulators that, if undertaken, could have substantial monetary and non-monetary impacts on Avantax Wealth Management’s operations. As of September 30, 2023, Avantax Wealth Management met all capital adequacy requirements to which it was subject.
Historically, we have financed our operations primarily from cash provided by operating activities and access to credit markets. Our historical uses of cash have been funding our operations, servicing our debt obligations, capital expenditures, acquisitions that enhance our strategic position, financial professional loans, contingent consideration associated with our acquisitions, and stock repurchases. Execution of our growth strategies through strategic asset acquisitions is expected to remain a capital allocation priority during the next twelve months. For at least the next twelve months, we plan to finance these cash needs, and our regulatory capital requirements at our broker-dealer subsidiary largely through our cash and cash equivalents on hand and cash provided by operating activities, and access to capital under our Revolving Credit Facility (as defined below), subject to customary terms and conditions. Our future investments in our business through capital expenditures or acquisitions, prepayment of debt to achieve desired leverage ratios, or our return of capital to stockholders through stock repurchases, will be determined after considering the best interests of our stockholders.
Indebtedness
On January 24, 2023 (the “Closing Date”), we entered into a restatement agreement (the Amended and Restated Credit Agreement”), which amended and restated in its entirety our previous Credit Agreement. The Amended and Restated Credit Agreement provides for a new delayed draw term loan facility up to a maximum principal amount of $270.0 million (the “Delayed Draw Term Loan Facility”) and a revolving credit facility with a commitment amount of $50.0 million (the “Revolving Credit Facility”). We may borrow term loans under the Delayed Draw Term Loan Facility (the “Term Loans”) until January 24, 2024. The stated maturity date of the Delayed Draw Term Loan Facility and the Revolving Credit Facility is January 24, 2028 (the “Maturity Date”). The proceeds of any Term Loans may be used to fund shareholder distributions and for general corporate purposes. The proceeds of any loans under the Revolving Credit Facility may be used to finance working capital needs and for general corporate purposes. On February 24, 2023, we borrowed $170.0 million under the Delayed Draw Term Loan Facility. During the second quarter of 2023, we borrowed the remaining $100.0 million available under the Delayed Draw Term Loan Facility.
As of September 30, 2023, we had $266.6 million in principal amount outstanding under the Delayed Draw Term Loan Facility and no amounts outstanding under the Revolving Credit Facility. As of September 30, 2023, $50.0 million was available for future borrowings under the Revolving Credit Facility, subject to customary terms and conditions. The obligations of the Company under the Amended and Restated Credit Agreement are secured by a first-priority security interest in substantially all of the existing and future personal property of the Company and certain of its subsidiaries.
We are required to make quarterly principal amortization payments on the Delayed Draw Term Loan Facility on the last business day of each fiscal quarter, beginning with the last business day of June 2023. These payments will amortize in equal quarterly installments based on the following aggregate annual amounts (expressed as a percentage of the principal amount of Term Loans borrowed): 2.5% during the first year ended December 31, 2023, 5% during years two and three, 7.5% during year four, and 10% during year five. Any remaining Term Loans outstanding are due on the Maturity Date.
Commencing with the first year ending December 31, 2023, we may be required to make annual prepayments on the Term Loans in an amount equal to a percentage of Excess Cash Flow (as defined in the Amended and Restated Credit Agreement). The percentage of Excess Cash Flow ranges from 0% to 50% depending on our Consolidated First Lien Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement). We may voluntarily prepay the Term Loans in whole or in part without premium or penalty.
Subject to customary reference rate availability provisions, the borrowings under the Amended and Restated Credit Agreement will bear interest at a rate per annum equal to (i) the Term SOFR Rate (as defined in the Amended and Restated Credit Agreement, and which includes a 0.10% credit spread adjustment) plus a margin ranging from 2.25% to 2.75% (which margin would be 2.75% as of the Closing Date), or (ii) a base rate based on
Avantax, Inc. | Q3 2023 Form 10-Q 36


the highest of the Wall Street Journal prime rate, the federal funds rate plus 0.50% and the Term SOFR (as defined in the Amended and Restated Credit Agreement, and which includes a 0.10% credit spread adjustment) rate plus 1.00%, in each case plus a margin ranging from 1.25% to 1.75% (which margin would be 1.75% as of the Closing Date). The margin is determined based on the Company’s Consolidated First Lien Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement). We are required to pay a quarterly commitment fee on the daily amount of the undrawn portion of the revolving commitments under the Revolving Credit Facility ranging from 0.35% to 0.45%. Interest is payable at the end of each interest period, typically quarterly.
Pursuant to the Amended and Restated Credit Agreement, we shall not permit (i) the Consolidated Total Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement) to exceed 4.00 to 1.00 between March 31, 2023 and June 30, 2024, or 3.75 to 1.00 between July 1, 2024 and the Maturity Date, (ii) the Consolidated Fixed Charge Coverage Ratio (as defined in the Amended and Restated Credit Agreement) to be less than 1.25 to 1.00 or (iii) Liquidity (as defined in the Amended and Restated Credit Agreement) on the last day of any fiscal quarter to be less than $50 million. The Company was in compliance with the debt covenants of the Amended and Restated Credit Agreement as of September 30, 2023.
Capital Return Program
On January 27, 2023, we commenced a modified “Dutch Auction” tender offer (the “Tender Offer”) to purchase shares of our common stock for an aggregate purchase price of up to $250.0 million at a price per share not less than $27.00 and not greater than $31.00. The Tender Offer was in addition to, and separate from, the $200.0 million stock repurchase authorization discussed below. Upon the conclusion of the Tender Offer, we repurchased and subsequently retired approximately 8.3 million shares of our common stock at the purchase price of $30.00 per share, for aggregate cash consideration of $250.0 million. We incurred approximately $4.5 million for fees and expenses associated with the Tender Offer, including approximately $2.4 million for estimated excise taxes owed under the Inflation Reduction Act of 2022, which were recorded within stockholders’ equity.
Repurchased common stock that is subsequently retired is deducted from common stock for par value and from additional paid-in capital for the excess over par value. Direct costs incurred to repurchase common stock are included in the total cost of the shares.
Stock Repurchase Authorization
On December 19, 2022, we announced that our board of directors authorized the Company to repurchase up to $200.0 million of our common stock. Our repurchase authorization does not obligate us to repurchase any specific number of shares, may be suspended or discontinued at any time, and does not have a specified expiration date. Any repurchases of our stock pursuant to the stock repurchase authorization may materially reduce the amount of cash we have available and may not materially enhance the long-term value of our business or our stock.
For the three months ended September 30, 2023, we repurchased approximately 0.4 million shares of our common stock under the stock repurchase authorization for aggregate purchase consideration of approximately $9.1 million. For the nine months ended September 30, 2023, we repurchased approximately 3.5 million shares of our common stock under the stock repurchase authorization for aggregate purchase consideration of approximately $85.0 million. The remaining authorized amount under the stock repurchase authorization as of September 30, 2023, was approximately $115.0 million.
For the three months ended September 30, 2022, we did not repurchase any shares of our common stock under our previous stock repurchase plan. For the nine months ended September 30, 2022, we repurchased approximately 1.9 million shares of our common stock under our previous stock repurchase plan for aggregate purchase consideration of approximately $35.0 million.
Contractual Obligations and Commitments
Asset Acquisitions
We have entered into several asset purchase agreements that are accounted for as asset acquisitions. These acquisitions may include up-front cash consideration, fixed deferred cash consideration, and contingent consideration arrangements. Future fixed payments are recognized as client relationship intangible assets on the date of acquisition. Contingent consideration arrangements encompass obligations to make future payments to the previous sellers contingent upon the achievement of future financial targets. These contingent payments are not recognized until all contingencies are resolved and the consideration is payable. As of September 30, 2023, the
Avantax, Inc. | Q3 2023 Form 10-Q 37


maximum future fixed and contingent payments associated with these asset acquisitions was $25.6 million, with specified payment dates from 2023 through 2027.
Interest Rate Hedges
During the second quarter of 2023, we entered into two interest rate collar derivative contracts for a total notional value of $1.5 billion. Each contract is indexed to daily simple SOFR and is a combination of a purchased floor instrument with a strike rate of 2.5% and a sold cap instrument with a strike rate of 5.5%, both of which expire on May 31, 2026. The total cost for these interest rate collars was $15.3 million, which we elected to defer and will settle through monthly straight-line cash payments to the counterparties over the term of the instruments. This hedging strategy enables us to limit the downside risk of significant reductions to interest rates over the term of the instruments in exchange for capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
In addition, during the second quarter of 2023, we sold two interest rate cap derivative contracts for a total notional value of $240.0 million. Each contract is indexed to daily simple SOFR, has a strike rate of 5.5%, and expires on May 31, 2026. These interest rate caps were sold for a total premium of $1.2 million, which were deferred and will be settled by the counterparties through monthly straight-line cash payments over the term of the instruments. This hedging strategy enables us to offset a portion of the total cost of our interest rate collar derivatives by capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
None of our derivative financial instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.
Cash Flows
Our cash flows were comprised of the following (in thousands):
Nine Months Ended September 30,
 20232022$ Change
Net cash provided (used) by operating activities from continuing operations$(63,561)$9,909 $(73,470)
Net cash used by investing activities from continuing operations(16,274)(16,344)70 
Net cash used by financing activities from continuing operations(79,870)(84,739)4,869 
Net cash provided by discontinued operations2,212 64,956 (62,744)
Net decrease in cash and cash equivalents$(157,493)$(26,218)$(131,275)
Net Cash from Operating Activities from Continuing Operations
Net cash provided by operating activities from continuing operations consists of income from continuing operations, offset by certain non-cash adjustments, and changes in operating assets and liabilities, which were as follows (in thousands):
Nine Months Ended September 30,
 20232022$ Change
Net income$3,759 $52,204 $(48,445)
Less: Income from discontinued operations, net of income taxes1,921 47,484 (45,563)
Income from continuing operations1,838 4,720 (2,882)
Non-cash adjustments to net income55,047 43,569 11,478 
Operating cash flows before changes in operating assets and liabilities56,885 48,289 8,596 
Changes in operating assets and liabilities, net of acquisitions and disposals(120,446)(38,380)(82,066)
Net cash provided (used) by operating activities from continuing operations$(63,561)$9,909 $(73,470)
Net cash provided by operating activities from continuing operations for the nine months ended September 30, 2023, included $56.9 million of operating cash flows before changes in operating assets and liabilities and $120.4 million of changes in operating assets and liabilities. Non-cash adjustments to net income for the nine months ended September 30, 2023 primarily related to depreciation and amortization costs of $30.3 million, stock-based compensation of $17.7 million, and $4.5 million of amortization related to payments made to financial professionals in support of ongoing growth programs. Changes in operating assets and liabilities were primarily impacted by $100.0 million of federal and state income tax payments for prior year accrued taxes and current year estimated quarterly payments and $11.1 million in payments made to financial professionals in support of ongoing growth
Avantax, Inc. | Q3 2023 Form 10-Q 38


programs. The remaining changes in operating assets and liabilities were for normal activity within our working capital accounts.
Net Cash from Investing Activities from Continuing Operations
Net cash used by investing activities from continuing operations consists of acquisitions, purchases of property, equipment, and software, net, and were as follows (in thousands):
Nine Months Ended September 30,
 20232022$ Change
Purchases of property, equipment, and software$(8,257)$(12,601)$4,344 
Asset acquisitions(8,017)(3,743)(4,274)
Net cash used by investing activities from continuing operations$(16,274)$(16,344)$70 
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, net cash used by investing activities from continuing operations did not materially change as reduced capital expenditures were offset by increased outflows for asset acquisitions.
Net Cash from Financing Activities from Continuing Operations
Net cash used by financing activities from continuing operations primarily consists of debt issuance and repayments, common stock and stock-based awards transactions, and acquisition-related contingent consideration payments. Financing cash flows from continuing operations were as follows (in thousands):
Nine Months Ended September 30,
 20232022$ Change
Proceeds from credit facilities, net of debt discount and issuance costs$261,543 $— $261,543 
Payments on credit facilities(3,375)(35,906)32,531 
Acquisition-related fixed and contingent consideration payments(287)(14,548)14,261 
Stock repurchases(337,192)(35,000)(302,192)
Proceeds from issuance of stock through employee stock purchase plan1,584 2,324 (740)
Proceeds from stock option exercises2,203 481 1,722 
Tax payments from shares withheld for equity awards(4,346)(2,090)(2,256)
Net cash used by financing activities from continuing operations$(79,870)$(84,739)$4,869 
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, we used $4.9 million less cash for financing activities. Our primary use of cash for financing activities during the nine months ended September 30, 2023 was for incremental stock repurchases associated with our Tender Offer and stock repurchase authorization, which were funded in part by net borrowings under our Amended and Restated Credit Agreement. These net cash outflows, coupled with incremental outflows associated with our stock incentive and employee stock purchase plans, were more than offset by reduced payments on credit facilities during the current period due to the voluntary prepayment of a portion our previous term loan facility in the prior period and a reduction in acquisition-related fixed and contingent consideration payments.
Net Cash Flows from Discontinued Operations
Net cash flows provided by discontinued operations were comprised of the following (in thousands):
Nine Months Ended September 30,
 20232022$ Change
Net cash provided by operating activities from discontinued operations$— $69,508 $(69,508)
Net cash provided (used) by investing activities from discontinued operations2,212 (4,552)6,764 
Net cash provided by financing activities from discontinued operations— — — 
Net cash provided by discontinued operations$2,212 $64,956 $(62,744)
For the nine months ended September 30, 2023, compared to the nine months ended September 30, 2022, net cash provided by discontinued operations decreased $62.7 million. During the nine months ended September 30, 2023, we finalized our previously estimated closing date working capital balance for the TaxAct Sale, resulting in incremental purchase consideration of $2.2 million and an incremental pre-tax gain on disposal of $2.5 million. Net cash provided by discontinued operations declined compared to the prior period due to the completion of the TaxAct Sale in the prior period.
Avantax, Inc. | Q3 2023 Form 10-Q 39


Critical Accounting Estimates
This Management’s Discussion and Analysis of Financial Condition and Results of Operations and the disclosures included elsewhere in this Quarterly Report on Form 10-Q are based upon our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and disclosure of contingencies. In some cases, we could have reasonably used different accounting policies and estimates.
We have identified certain accounting estimates which involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on our financial condition or results of operations. On an ongoing basis, we evaluate the estimates used. We base our estimates on historical experience, current conditions, and on various other assumptions that we believe to be reasonable under the circumstances and, based on information available to us at that time, we make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources, as well as identify and assess our accounting treatment with respect to commitments and contingencies. Actual results may differ significantly from these estimates under different assumptions, judgments, or conditions. The critical accounting estimates which we believe to be the most critical in the preparation of our condensed consolidated financial statements involve business combinations, goodwill impairment, and income taxes. We continually update and assess the facts, circumstances, and assumptions used in making both our critical accounting estimates and judgments related to our other significant accounting matters.
There have been no material changes in our critical accounting policies as disclosed under “Critical Accounting Estimates” in Part II, Item 7 and in Note 2 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Other than for our Amended and Restated Credit Agreement discussed in “Item 1. Financial Statements—Note 6”, and our interest rate derivative contracts discussed in “Item 1. Financial Statements—Note 11” and further below, there have been no material changes to the financial instruments for which we are exposed to market risk, as disclosed within our Annual Report on Form 10-K for the year ended December 31, 2022, during the nine months ended September 30, 2023.
As of September 30, 2023, we had $266.6 million in principal amount of debt outstanding under the Delayed Draw Term Loan Facility, which carries a degree of interest rate risk. For further information on our outstanding debt, see “Item 1. Financial Statements—Note 6” and the section “Liquidity and Capital Resources” of “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations” under the subheading “Indebtedness.” A hypothetical 100 basis point increase in the interest rates under the Delayed Draw Term Loan Facility on September 30, 2023 would result in a $10.4 million increase in our interest expense until the scheduled maturity date in 2028. For additional information, see Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2022.
During the second quarter of 2023, we entered into two interest rate collar derivative contracts for a total notional value of $1.5 billion. Each contract is indexed to daily simple secured overnight financing rates (“SOFR”) and is a combination of a purchased floor instrument with a strike rate of 2.5% and a sold cap instrument with a strike rate of 5.5%, both of which expire on May 31, 2026. The total cost for these interest rate collars was $15.3 million, which we elected to defer and will settle through monthly straight-line cash payments to the counterparties over the term of the instruments. This hedging strategy enables us to limit the downside risk of significant reductions to interest rates over the term of the instruments in exchange for capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
In addition, during the second quarter of 2023, we sold two interest rate cap derivative contracts for a total notional value of $240.0 million. Each contract is indexed to daily simple SOFR, has a strike rate of 5.5%, and expires on May 31, 2026. These interest rate caps were sold for a total premium of $1.2 million, which were deferred and will be settled by the counterparties through monthly straight-line cash payments over the term of the instruments. This hedging strategy enables us to offset a portion of the total cost of our interest rate collar derivatives by capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
Avantax, Inc. | Q3 2023 Form 10-Q 40


We are exposed to credit risk in the event of nonperformance of counterparties for our derivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and actively monitoring counterparty credit ratings. We also employ master netting arrangements which allow us to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative financial instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated (pursuant to Rule 13a-15(b) of the Securities Exchange Act of 1934) the effectiveness of our disclosure controls and procedures as of September 30, 2023. Based on that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rule 13a-15(e)) were effective as of September 30, 2023.
Changes in Internal Control over Financial Reporting
There were no changes to our internal control over financial reporting during the nine months ended September 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION
Item 1. Legal Proceedings
See “Item 1. Financial Statements—Note 9” for information regarding legal proceedings.
Item 1A. Risk Factors
Our business and future results may be affected by a number of risks and uncertainties that should be considered carefully. In addition, this Form 10-Q also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including the risks described in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2022.
Except as follows, we believe that there have been no material changes in our risk factors as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.
The proposed acquisition of the Company by Cetera may disrupt or could adversely affect our business, prospects, financial condition and results of operations.
On September 9, 2023, Avantax entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Aretec Group, Inc., a Delaware corporation that does business as Cetera Holdings (“Parent”), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Sub”) whereby Parent will acquire all of the issued and outstanding equity of Avantax (the “Merger”) in an all-cash transaction valuing Avantax at approximately $1.2 billion, inclusive of Avantax’s net debt. On the terms and subject to the conditions of the Merger Agreement, holders of shares of Avantax common stock (other than Excluded Shares and Dissenting Shares (each, as defined in the Merger Agreement)) will receive $26.00 per share in cash, without interest and less any required tax withholdings. Upon the closing of the transactions contemplated by the Merger Agreement, Avantax will operate as a privately-held company. The closing remains subject to customary closing conditions, including approval by Avantax’s stockholders.
The announcement and pendency of the Merger could cause disruptions in and create uncertainty surrounding our business, which could have an adverse effect on our business, prospects, financial condition and results of operations, regardless of whether the Merger is completed. The Merger Agreement generally requires us to use our reasonable best efforts to operate our business in the ordinary course of business pending consummation of the Merger and restricts us, without Parent’s consent, from taking certain specified actions until the Merger is
Avantax, Inc. | Q3 2023 Form 10-Q 41


completed. These restrictions may affect our ability to execute our business strategies, respond effectively to competitive pressures and industry developments and attain our financial and other goals, and these restrictions may impact our financial condition, results of operations and cash flows.
Employee retention and recruitment may be challenging before the completion of the Merger, as employees and prospective employees may experience uncertainty about their future roles at the Company. If, despite our retention and recruiting efforts, key employees depart or prospective key employees fail to accept employment with the Company because of issues relating to the uncertainty and difficulty of integration or a desire not to remain with the combined company, our business, financial condition and results of operations could be adversely affected.
The announcement and pendency of the Merger could also cause disruptions to our business or business relationships, which could have an adverse impact on our business, financial condition and results of operations. Parties with which we have business relationships, including clients, channel partners, suppliers and other business partners, may experience uncertainty as to the future of such relationships and may delay or defer certain business decisions, seek alternative relationships with third parties or seek to alter their present business relationships with us. Parties with whom we otherwise may have sought to establish business relationships may seek alternative relationships with third parties. The pursuit of the Merger and the preparation for the integration may place a significant burden on management and internal resources. The diversion of management’s attention away from day-to-day business concerns could adversely affect our business, financial condition and results of operations.
We could also be subject to litigation related to the Merger, which could prevent or delay the consummation of the Merger or result in significant costs and expenses. Stockholders have filed, and may continue to file, lawsuits challenging the Merger or the other transactions contemplated by the Merger Agreement, which may name us or our board of directors as defendants. We cannot assure you as to the outcome of such lawsuits, including the amount of costs associated with defending these claims or any other liabilities that may be incurred in connection with the litigation of these claims. If plaintiffs are successful in obtaining an injunction prohibiting the parties from completing the Merger on the agreed-upon terms, such an injunction may delay the consummation of the Merger in the expected timeframe, or may prevent the Merger from being consummated altogether. Whether or not any plaintiff’s claim is successful, this type of litigation may result in significant costs and divert management’s attention and resources, which could adversely affect our business, financial condition and results of operations.
We have incurred and will continue to incur substantial transaction fees and costs in connection with the Merger.
We have incurred and expect to continue to incur significant costs, expenses and fees for professional services, such as legal, financial and accounting fees, and other transaction costs in connection with the Merger. A material portion of these expenses are payable by us whether or not the Merger is completed and may relate to activities that we would not have undertaken other than to complete the Merger. If the Merger is not completed, we will have received little or no benefit from such expenses. Further, although we have assumed that a certain amount of transaction expenses will be incurred, factors beyond our control could affect the total amount or the timing of these expenses. Many of the expenses that will be incurred, by their nature, are difficult to estimate accurately. These costs could adversely affect our business, financial condition and results of operations.
The Merger may not be completed within the expected timeframe, or at all, and significant delay or the failure to complete the Merger could adversely affect our business and the market price of our common stock.
The consummation of the Merger is subject to customary closing conditions, including, without limitation, the adoption of the Merger Agreement by the affirmative vote of not less than 51% of the outstanding shares of the Company’s common stock entitled to vote thereon at the meeting of the Company’s stockholders held for the purpose of voting upon the adoption of the Merger Agreement, the expiration or termination of the required waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or the grant of early termination thereof, customary regulatory approvals and the absence of any law or order enacted, issued, promulgated, enforced or entered by any governmental authority restraining, enjoining, rendering illegal or otherwise prohibiting the Merger. Parent’s obligation to consummate the Merger is also subject to the absence of a Company Material Adverse Effect (as defined in the Merger Agreement) occurring after the date of the Merger Agreement that is continuing.
Many of the conditions to consummation of the Merger are not within our control or the control of Parent or Acquisition Sub, and we cannot predict when or if these conditions will be satisfied. There can be no assurance that our business, our relationships or our financial condition will not be adversely affected, as compared to the condition
Avantax, Inc. | Q3 2023 Form 10-Q 42


prior to the announcement of the Merger, if the Merger is not consummated within the expected timeframe, or at all. Failure to complete the Merger within the expected timeframe, or at all, could adversely affect our business and the market price of our common stock in a number of ways, including the following:
if the Merger is not completed within the expected timeframe, or at all, the share price of our common stock will change to the extent that the current market price of our stock reflects assumptions regarding the completion of the Merger;
we have incurred, and will continue to incur, significant costs, expenses and fees for professional services and other costs in connection with the Merger, for which we may receive little or no benefit if the Merger is not completed. Many of these fees and costs will be payable by us even if the Merger is not completed and may relate to activities that we would not have undertaken other than to complete the Merger;
failure to complete the Merger within the expected timeframe, or at all, may result in negative publicity and a negative impression of us in the investment community and may lead to subsequent offers to acquire the Company at a lower price or otherwise on less favorable terms to us and our stockholders than contemplated by the Merger;
the impairment of our ability to attract, retain and motivate personnel, including our senior management;
difficulties maintaining relationships with customers, distributors, suppliers and other business partners; and
upon termination of the Merger Agreement by us or Parent under specified circumstances, we would be required to pay a termination fee of $32.3 million.
The Merger Agreement contains provisions that could discourage a potential competing acquirer of the Company or could result in a competing proposal being at a lower price than it might otherwise be.
We are subject to certain restrictions on our ability to solicit alternative acquisition proposals from third parties, to provide information to third parties and to enter into or continue discussions or negotiations with third parties regarding alternative acquisition proposals, subject to customary exceptions. In addition, we may be required to pay Parent a termination fee of $32.3 million in specified circumstances, including if the Merger Agreement is terminated in specified circumstances following our receipt of a Competing Proposal (as defined in the Merger Agreement). These provisions could discourage a potential competing acquirer that might have an interest in acquiring all or a significant part of the Company from considering or proposing such an acquisition, including, if the Merger Agreement is terminated prior to the consummation of the Merger, after such termination of the Merger Agreement, even if it were prepared to pay a price per share higher than the price per share proposed to be paid in the Merger, or might result in a potential competing acquirer proposing to pay a lower price than it might otherwise have proposed to pay because of the added expense of the termination fee that may become payable in specified circumstances under the Merger Agreement, including, in certain circumstances, after a valid termination of the Merger Agreement in accordance with the terms thereof.
If the Merger Agreement is terminated and we decide to seek another similar transaction, we may not be able to negotiate or consummate a transaction with another party on terms comparable to, or better than, the terms of the Merger Agreement.
We are exposed to credit risk in the event of nonperformance of counterparties for our derivative financial instruments.
The Company recently implemented a hedging policy to mitigate and manage risks caused by yield curve, duration and interest rate fluctuations, and other macroeconomic factors upon our business and financing arrangements. The hedging policy will be managed by our Chief Financial Officer in consultation with our Chief Executive Officer and subject to oversight by our Chief Legal Officer, Chief Compliance Officer, Chief Accounting Officer, and Accounting Director as well as our board of directors. However, we cannot assure you of the financial stability or viability of our counterparties and by engaging in derivative transactions, we are exposed to counterparty credit risk. If the counterparty fails to perform, credit risk exists to the extent of the fair value gain in the derivative. The existence of credit risk associated with our hedging policy over time could adversely affect our profitability and, therefore, could have a materially adverse effect on our business, results of operations, and financial condition.

Avantax, Inc. | Q3 2023 Form 10-Q 43


Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table details our repurchases of common stock for the nine months ended September 30, 2023 (in thousands, except the average price paid per share data):
PeriodTotal Number of Shares PurchasedAverage Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Approximate Dollar Value of Shares that May Yet be Purchased under the Plans or Programs
January 1-31, 2023 (1)
460 $27.20 460 $187,483 
February 1-28, 2023 (2)
8,333 $30.00 — $187,483 
March 1-31, 2023 (1)
498 $24.66 498 $175,212 
April 1-30, 2023 (1)
484 $26.39 484 $162,446 
May 1-31, 2023 (1)
882 $22.15 882 $142,914 
June 1-30, 2023 (1)
840 $22.45 840 $124,046 
July 1-31, 2023 (1)
378 $24.00 378 $114,972 
August 1-31, 2023 (1)
— $— — $114,972 
September 1-30, 2023 (1)
— $— — $114,972 
Total (3)
11,875 $24.01 3,542 
___________________________
(1)Represents shares repurchased through the Company’s $200.0 million stock repurchase authorization, which was originally announced on December 19, 2022. This repurchase authorization does not obligate us to repurchase any specific number of shares, may be suspended or discontinued at any time, and does not have a specified expiration date. See “Item 1. Financial Statements—Note 12” for further information.
(2)Represents shares repurchased through the Tender Offer, which was fully subscribed. See “Item 1. Financial Statements—Note 12” for further information.
(3)“Average Price Paid per Share” represents the average price paid per share through the Company’s stock repurchase authorization from January 1, 2023 through September 30, 2023, but does not include the price paid per share pursuant to the Tender Offer discussed in note (2) above.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
During the three months ended September 30, 2023, none of our officers or directors adopted or terminated any contract, instruction, or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.”
Avantax, Inc. | Q3 2023 Form 10-Q 44


Item 6. Exhibits
Exhibit
Number
Exhibit DescriptionFormDate of
First Filing
Exhibit NumberFiled
Herewith
Stock Purchase Agreement, dated as of October 31, 2022, by and among Avantax, Inc. (f/k/a Blucora, Inc.), TaxAct Holdings, Inc., Franklin Cedar Bidco, LLC and DS Admiral Bidco, LLC8-KNovember 1, 20222.1
Merger Agreement, dated as of September 9, 2023, by and among Avantax, Inc., Aretec Group, Inc., and C2023 Sub Corp8-KSeptember 11, 20232.1
Restated Certificate of Incorporation, as filed with the Secretary of the State of Delaware on August 10, 20128-KAugust 13, 20123.1
Certificate of Amendment to the Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 1, 20178-KJune 5, 20173.1
Certificate of Amendment No. 2 to the Restated Certificate of Incorporation filed with the Secretary of State of Delaware on June 8, 20188-KJune 8, 20183.1
Certificate of Amendment No. 3 to the Restated Certificate of Incorporation, effective January 26, 20238-KJanuary 26, 20233.1
Certificate of Amendment No. 4 to the Restated Certificate of Incorporation of Avantax, Inc., effective May 4, 20238-KMay 5, 20233.1
Amended and Restated Bylaws of Avantax, Inc. dated as of January 26, 20238-KJanuary 26, 20233.2
Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Exchange Act rules 13a-14(a) and 15d-14(a))
X
Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Exchange Act rules 13a-14(a) and 15d-14(a))
X
Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. section 1350)
X
Certification of Principal Financial Officer pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. section 1350)
X
101
The following financial statements from the Company's Form 10-Q for the fiscal quarter ended September 30, 2023, formatted in Inline XBRL: (i) Unaudited Condensed Consolidated Balance Sheets, (ii) Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss), (iii) Unaudited Condensed Consolidated Statements of Stockholders' Equity; (iv) Unaudited Condensed Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Condensed Consolidated Financial Statements
X
104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)X
____________________________
*The certifications attached as Exhibits 32.1 and 32.2 are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Avantax, Inc. under the Securities Act of 1933, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
**Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company hereby undertakes to furnish supplemental copies of any of the omitted schedules or exhibits upon request by the SEC; provided that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended, for any schedules or exhibits so furnished.
Avantax, Inc. | Q3 2023 Form 10-Q 45


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
AVANTAX, INC.
By:/s/ Marc Mehlman
 Marc Mehlman
Chief Financial Officer and Treasurer
(On behalf of the registrant and as
Principal Financial Officer)
Date:
November 6, 2023

Avantax, Inc. | Q3 2023 Form 10-Q 46

Exhibit 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
(EXCHANGE ACT RULES 13a-14(a) and 15d-14(a))
I, Christopher W. Walters, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Avantax, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 6, 2023
/s/ Christopher W. Walters
Christopher W. Walters
Chief Executive Officer and President
(Principal Executive Officer)



Exhibit 31.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
(EXCHANGE ACT RULES 13a-14(a) and 15d-14(a))
I, Marc Mehlman, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Avantax, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.    The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): 
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated: November 6, 2023
/s/ Marc Mehlman
Marc Mehlman
Chief Financial Officer and Treasurer
(Principal Financial Officer)



Exhibit 32.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
I, Christopher W. Walters, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Avantax, Inc. for the quarter ended September 30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Avantax, Inc.
Dated: November 6, 2023
By:/s/ Christopher W. Walters
Name:Christopher W. Walters
Title:Chief Executive Officer and President
(Principal Executive Officer)



Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(18 U.S.C. SECTION 1350)
I, Marc Mehlman, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report on Form 10-Q of Avantax, Inc. for the quarter ended September 30, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Avantax, Inc.
Dated: November 6, 2023
By:/s/ Marc Mehlman
Name:Marc Mehlman
Title:Chief Financial Officer and Treasurer
(Principal Financial Officer)


v3.23.3
Cover Page - shares
9 Months Ended
Sep. 30, 2023
Oct. 30, 2023
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 000-25131  
Entity Registrant Name Avantax, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 91-1718107  
Entity Address, Address Line One 3200 Olympus Blvd, Suite 100  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75019  
City Area Code 972  
Local Phone Number 870-6400  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol AVTA  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   36,811,784
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Central Index Key 0001068875  
v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 106,435 $ 263,928
Accounts receivable, net 24,680 24,117
Commissions and advisory fees receivable 22,177 20,679
Prepaid expenses and other current assets 32,944 15,027
Total current assets 186,236 323,751
Long-term assets:    
Property, equipment, and software, net 49,932 53,041
Right-of-use assets, net 18,126 19,361
Goodwill, net 266,279 266,279
Acquired intangible assets, net 256,867 266,002
Other long-term assets 48,239 35,081
Total long-term assets 639,443 639,764
Total assets 825,679 963,515
Current liabilities:    
Accounts payable 3,771 7,531
Commissions and advisory fees payable 15,033 13,829
Accrued expenses and other current liabilities 49,798 111,212
Current deferred revenue 4,241 4,583
Current lease liabilities 5,107 5,139
Current portion of long-term debt 11,813 0
Total current liabilities 89,763 142,294
Long-term liabilities:    
Long-term debt, net 248,388 0
Long-term lease liabilities 27,797 30,332
Deferred tax liabilities, net 15,584 20,819
Long-term deferred revenue 3,701 4,396
Other long-term liabilities 36,759 22,476
Total long-term liabilities 332,229 78,023
Total liabilities 421,992 220,317
Commitments and contingencies (Note 9)
Stockholders’ equity:    
Common stock, par value $0.0001 per share—900,000 shares authorized; 43,530 shares issued and 36,807 shares outstanding as of September 30, 2023; 51,260 shares issued and 48,079 shares outstanding as of December 31, 2022 4 5
Additional paid-in capital 1,391,702 1,636,134
Accumulated deficit (825,783) (829,542)
Accumulated other comprehensive loss (13,043) 0
Treasury stock, at cost—6,723 shares as of September 30, 2023 and 3,181 shares as of December 31, 2022 (149,193) (63,399)
Total stockholders’ equity 403,687 743,198
Total liabilities and stockholders’ equity $ 825,679 $ 963,515
v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, par value (in USD per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 900,000,000 900,000,000
Common stock, shares issued (in shares) 43,530,000 51,260,000
Common stock, shares outstanding (in shares) 36,807,000 48,079,000
Treasury stock (in shares) 6,723,000 3,181,000
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Revenue $ 192,343 $ 165,032 $ 557,251 $ 494,104
Operating expenses:        
Cost of revenue 117,684 105,809 336,783 341,443
Engineering and technology 2,352 2,617 7,264 6,733
Sales and marketing 26,298 23,770 79,902 70,826
General and administrative 33,011 23,792 91,747 69,388
Acquisition and integration (100) 416 (17) (4,710)
Depreciation 4,142 3,343 11,318 8,428
Amortization of acquired intangible assets 6,404 6,342 18,973 19,435
Total operating expenses 189,791 166,089 545,970 511,543
Operating income (loss) from continuing operations 2,552 (1,057) 11,281 (17,439)
Interest expense and other, net (5,115) (158) (8,919) (423)
Income (loss) from continuing operations before income taxes (2,563) (1,215) 2,362 (17,862)
Income tax benefit (expense) 1,068 1,536 (524) 22,582
Income (loss) from continuing operations (1,495) 321 1,838 4,720
Discontinued operations (Note 3)        
Income (loss) from discontinued operations before gain on disposal and income taxes 0 (22,352) 0 74,165
Pre-tax gain on disposal 0 0 2,539 0
Income (loss) from discontinued operations before income taxes 0 (22,352) 2,539 74,165
Income tax benefit (expense) 0 190 (618) (26,681)
Income (loss) from discontinued operations 0 (22,162) 1,921 47,484
Net income (loss) $ (1,495) $ (21,841) $ 3,759 $ 52,204
Basic net income (loss) per share:        
Continuing operations (in dollars per share) $ (0.04) $ 0.01 $ 0.05 $ 0.10
Discontinued operations (in dollars per share) 0 (0.47) 0.04 0.99
Basic net income (loss) per share: (in dollars per share) (0.04) (0.46) 0.09 1.09
Diluted net income (loss) per share:        
Continuing operations (in dollars per share) (0.04) 0.01 0.04 0.10
Discontinued operations (in dollars per share) 0 (0.46) 0.05 0.96
Diluted net income (loss) per share: (in dollars per share) $ (0.04) $ (0.45) $ 0.09 $ 1.06
Weighted average shares outstanding:        
Basic (in shares) 36,921 47,847 39,971 47,981
Diluted (in shares) 36,921 49,016 40,940 49,153
Comprehensive income (loss):        
Net income (loss) $ (1,495) $ (21,841) $ 3,759 $ 52,204
Other comprehensive loss, net of tax (982) 0 (13,043) 0
Comprehensive income (loss) $ (2,477) $ (21,841) $ (9,284) $ 52,204
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Treasury stock
Beginning balance (in shares) at Dec. 31, 2021   50,137        
Beginning balance at Dec. 31, 2021 $ 341,622 $ 5 $ 1,619,805 $ (1,249,789) $ 0 $ (28,399)
Beginning balance (in shares) at Dec. 31, 2021           1,306
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued pursuant to stock incentive and employee stock purchase plans (in shares)   247        
Common stock issued pursuant to stock incentive and employee stock purchase plans 96   96      
Stock repurchases (in shares)           1,645
Stock repurchases (30,537)         $ (30,537)
Stock-based compensation 4,641   4,641      
Tax payments from shares withheld for equity awards (1,569)   (1,569)      
Net income (loss) 34,620     34,620    
Ending balance (in shares) at Mar. 31, 2022   50,384        
Ending balance at Mar. 31, 2022 348,873 $ 5 1,622,973 (1,215,169) 0 $ (58,936)
Ending balance (in shares) at Mar. 31, 2022           2,951
Beginning balance (in shares) at Dec. 31, 2021   50,137        
Beginning balance at Dec. 31, 2021 341,622 $ 5 1,619,805 (1,249,789) 0 $ (28,399)
Beginning balance (in shares) at Dec. 31, 2021           1,306
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss, net of tax 0          
Net income (loss) 52,204          
Ending balance (in shares) at Sep. 30, 2022   50,955        
Ending balance at Sep. 30, 2022 371,590 $ 5 1,632,569 (1,197,585) 0 $ (63,399)
Ending balance (in shares) at Sep. 30, 2022           3,181
Beginning balance (in shares) at Mar. 31, 2022   50,384        
Beginning balance at Mar. 31, 2022 348,873 $ 5 1,622,973 (1,215,169) 0 $ (58,936)
Beginning balance (in shares) at Mar. 31, 2022           2,951
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued pursuant to stock incentive and employee stock purchase plans (in shares)   537        
Common stock issued pursuant to stock incentive and employee stock purchase plans 2,402   2,402      
Stock repurchases (in shares)           230
Stock repurchases (4,463)         $ (4,463)
Stock-based compensation 3,683   3,683      
Tax payments from shares withheld for equity awards (467)   (467)      
Net income (loss) 39,425     39,425    
Ending balance (in shares) at Jun. 30, 2022   50,921        
Ending balance at Jun. 30, 2022 389,453 $ 5 1,628,591 (1,175,744) 0 $ (63,399)
Ending balance (in shares) at Jun. 30, 2022           3,181
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued pursuant to stock incentive and employee stock purchase plans (in shares)   34        
Common stock issued pursuant to stock incentive and employee stock purchase plans 307   307      
Stock-based compensation 3,725   3,725      
Tax payments from shares withheld for equity awards (54)   (54)      
Other comprehensive loss, net of tax 0          
Net income (loss) (21,841)     (21,841)    
Ending balance (in shares) at Sep. 30, 2022   50,955        
Ending balance at Sep. 30, 2022 $ 371,590 $ 5 1,632,569 (1,197,585) 0 $ (63,399)
Ending balance (in shares) at Sep. 30, 2022           3,181
Beginning balance (in shares) at Dec. 31, 2022 51,260 51,260        
Beginning balance at Dec. 31, 2022 $ 743,198 $ 5 1,636,134 (829,542) 0 $ (63,399)
Beginning balance (in shares) at Dec. 31, 2022 3,181         3,181
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued pursuant to stock incentive and employee stock purchase plans (in shares)   307        
Common stock issued pursuant to stock incentive and employee stock purchase plans $ 1,135   1,135      
Stock repurchases (in shares)           9,291
Stock repurchases (279,562)         $ (279,562)
Retirement of common stock (in shares)   (8,333)       (8,333)
Retirement of common stock 0 $ (1) (254,538)     $ 254,539
Stock-based compensation 4,714   4,714      
Tax payments from shares withheld for equity awards (3,114)   (3,114)      
Net income (loss) 1,673     1,673    
Ending balance (in shares) at Mar. 31, 2023   43,234        
Ending balance at Mar. 31, 2023 $ 468,044 $ 4 1,384,331 (827,869) 0 $ (88,422)
Ending balance (in shares) at Mar. 31, 2023           4,139
Beginning balance (in shares) at Dec. 31, 2022 51,260 51,260        
Beginning balance at Dec. 31, 2022 $ 743,198 $ 5 1,636,134 (829,542) 0 $ (63,399)
Beginning balance (in shares) at Dec. 31, 2022 3,181         3,181
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Other comprehensive loss, net of tax $ (13,043)          
Net income (loss) $ 3,759          
Ending balance (in shares) at Sep. 30, 2023 43,530 43,530        
Ending balance at Sep. 30, 2023 $ 403,687 $ 4 1,391,702 (825,783) (13,043) $ (149,193)
Ending balance (in shares) at Sep. 30, 2023 6,723         6,723
Beginning balance (in shares) at Mar. 31, 2023   43,234        
Beginning balance at Mar. 31, 2023 $ 468,044 $ 4 1,384,331 (827,869) 0 $ (88,422)
Beginning balance (in shares) at Mar. 31, 2023           4,139
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued pursuant to stock incentive and employee stock purchase plans (in shares)   229        
Common stock issued pursuant to stock incentive and employee stock purchase plans 1,506   1,506      
Stock repurchases (in shares)           2,206
Stock repurchases (51,624)         $ (51,624)
Stock-based compensation 2,910   2,910      
Tax payments from shares withheld for equity awards (1,156)   (1,156)      
Other comprehensive loss, net of tax (12,061)       (12,061)  
Net income (loss) 3,581     3,581    
Ending balance (in shares) at Jun. 30, 2023   43,463        
Ending balance at Jun. 30, 2023 411,200 $ 4 1,387,591 (824,288) (12,061) $ (140,046)
Ending balance (in shares) at Jun. 30, 2023           6,345
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued pursuant to stock incentive and employee stock purchase plans (in shares)   67        
Common stock issued pursuant to stock incentive and employee stock purchase plans 1,146   1,146      
Stock repurchases (in shares)           378
Stock repurchases (9,147)         $ (9,147)
Stock-based compensation 3,041   3,041      
Tax payments from shares withheld for equity awards (76)   (76)      
Other comprehensive loss, net of tax (982)       (982)  
Net income (loss) $ (1,495)     (1,495)    
Ending balance (in shares) at Sep. 30, 2023 43,530 43,530        
Ending balance at Sep. 30, 2023 $ 403,687 $ 4 $ 1,391,702 $ (825,783) $ (13,043) $ (149,193)
Ending balance (in shares) at Sep. 30, 2023 6,723         6,723
v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net income (loss) $ 3,759 $ 52,204
Less: Income from discontinued operations, net of income taxes 1,921 47,484
Income from continuing operations 1,838 4,720
Adjustments to reconcile income from continuing operations to net cash from operating activities:    
Depreciation and amortization of acquired intangible assets 30,291 27,863
Stock-based compensation 17,678 14,782
Change in the fair value of acquisition-related contingent consideration 0 (5,320)
Reduction of right-of-use lease assets 1,235 1,103
Deferred income taxes (1,043) (599)
Amortization of debt discount and issuance costs 871 0
Accretion of lease liabilities 1,405 1,522
Other non-cash items 4,610 4,218
Changes in operating assets and liabilities, net of acquisitions and disposals:    
Accounts receivable, net (551) (2,505)
Commissions and advisory fees receivable (1,498) 4,587
Prepaid expenses and other current assets (16,533) (3,755)
Other long-term assets (17,276) (14,829)
Accounts payable (3,760) (5,047)
Commissions and advisory fees payable 1,204 (4,137)
Lease liabilities (3,972) (3,788)
Deferred revenue (1,037) (1,447)
Accrued expenses and other current and long-term liabilities (77,023) (7,459)
Net cash provided (used) by operating activities from continuing operations (63,561) 9,909
Investing activities:    
Purchases of property, equipment, and software (8,257) (12,601)
Asset acquisitions (8,017) (3,743)
Net cash used by investing activities from continuing operations (16,274) (16,344)
Financing activities:    
Proceeds from credit facilities, net of debt discount and issuance costs 261,543 0
Payments on credit facilities (3,375) (35,906)
Acquisition-related fixed and contingent consideration payments (287) (14,548)
Stock repurchases (337,192) (35,000)
Proceeds from issuance of stock through employee stock purchase plan 1,584 2,324
Proceeds from stock option exercises 2,203 481
Tax payments from shares withheld for equity awards (4,346) (2,090)
Net cash used by financing activities from continuing operations (79,870) (84,739)
Net cash used by continuing operations (159,705) (91,174)
Net cash provided by operating activities from discontinued operations 0 69,508
Net cash provided (used) by investing activities from discontinued operations 2,212 (4,552)
Net cash provided by financing activities from discontinued operations 0 0
Net cash provided by discontinued operations 2,212 64,956
Net decrease in cash and cash equivalents (157,493) (26,218)
Cash and cash equivalents, beginning of period 263,928 100,629
Cash and cash equivalents, end of period 106,435 74,411
Supplemental cash flow information:    
Cash paid for income taxes 99,966 2,408
Cash paid for interest $ 11,422 $ 23,005
v3.23.3
Description of the Business
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of the Business
Note 1: Description of the Business
Avantax, Inc. (the Company,” “Avantax, we, our, or us) is a leading provider of integrated tax-intelligent wealth management services and software, assisting consumers, small business owners, tax professionals, financial professionals, and certified public accounting (“CPA”) firms. Our integrated tax-intelligent wealth management services consist of the operations of Avantax Wealth Management and Avantax Planning Partners.
Avantax Wealth Management provides tax-intelligent wealth management solutions for financial professionals, tax professionals, CPA firms, and their clients. Avantax Wealth Management offers its services through its registered broker-dealer, which is a leading U.S. tax-focused independent broker-dealer, registered investment advisor (“RIA”), and insurance agency subsidiaries. Avantax Wealth Management works with a nationwide network of financial professionals that operate as independent contractors. Avantax Wealth Management provides these financial professionals with an integrated platform of technical, practice, compliance, operations, sales, and product support tools that enable them to offer tax-intelligent planning, investing, and wealth management services to their clients.
Avantax Planning Partners is an in-house/employee-based RIA, insurance agency, and wealth management business that partners with CPA firms in order to provide their consumer and small business clients with holistic financial planning and advisory services, as well as retirement plan solutions through Avantax Retirement Plan Services.
Merger Agreement
On September 9, 2023, Avantax entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Aretec Group, Inc., a Delaware corporation that does business as Cetera Holdings (“Parent”), and C2023 Sub Corp., a Delaware corporation and a wholly-owned subsidiary of Parent (“Acquisition Sub”) whereby Parent will acquire all of the issued and outstanding equity of Avantax in an all-cash transaction valuing Avantax at approximately $1.2 billion, inclusive of Avantax’s net debt. On the terms and subject to the conditions of the Merger Agreement, holders of shares of Avantax common stock (other than Excluded Shares and Dissenting Shares (each, as defined in the Merger Agreement)) will receive $26.00 per share in cash, without interest and less any required tax withholdings. Upon the closing of the transactions contemplated by the Merger Agreement, Avantax will operate as a privately-held company. The closing remains subject to customary closing conditions, including approval by Avantax’s stockholders. Avantax expects the closing to occur by the end of November 2023.
Divestiture of Tax Software Business
On October 31, 2022, we entered into a Stock Purchase Agreement (the “Purchase Agreement”) with TaxAct Holdings, Inc. (f/k/a Avantax Holdings, Inc.), a Delaware corporation and a direct subsidiary of Avantax, Franklin Cedar Bidco, LLC, a Delaware limited liability company (the “Buyer”), and, solely for purposes of certain provisions thereof, DS Admiral Bidco, LLC, a Delaware limited liability company, pursuant to which we sold our former tax software business to Buyer for an aggregate purchase price of $720.0 million in cash, subject to customary purchase price adjustments set forth in the Purchase Agreement (the TaxAct Sale). This transaction subsequently closed on December 19, 2022.
In accordance with ASC 205 (“ASC 205”), Presentation of Financial Statements, we determined that the sale of our tax software business represented a strategic shift that will have a major effect on our operations and financial results. As a result of the TaxAct Sale, the historical results of our former tax software business, and any adjustments to amounts previously reported in discontinued operations in a prior period (if applicable) have been reclassified as a discontinued operation and are excluded from continuing operations for all periods presented within the condensed consolidated financial statements.
Segments
Our Chief Executive Officer is our chief operating decision maker and assesses performance and allocates resources on a consolidated basis. Given the similarities in economic characteristics between our operations and the common nature of the products, services, we currently operate in one reportable segment.
v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies
Note 2: Summary of Significant Accounting Policies
Interim Financial Information
The accompanying unaudited condensed consolidated financial statements have been prepared by us under the rules and regulations of the SEC for interim financial reporting. These condensed consolidated financial statements are unaudited and, in management’s opinion, include all adjustments, consisting of normal recurring adjustments and accruals, necessary for a fair presentation of the condensed consolidated financial position, results of operations, and cash flows for the periods presented. Certain information and footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States (GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2022. Interim results are not necessarily indicative of results for a full year.
A summary of our significant accounting policies is included in Note 2 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022. Other than below, there have been no significant changes in our significant accounting policies since December 31, 2022.
Derivative Financial Instruments
We primarily enter into derivative financial instruments as part of our strategy to manage our exposure to changes in interest rates. Derivative instruments represent contracts between parties that result in one party delivering cash to the other party based on a notional amount and an underlying term (such as an interest rate or index) as specified in the contract. The amount of cash delivered from one party to the other is determined based on the interaction of the notional amount of the contract with the underlying term. We do not enter into derivative instruments for any purpose other than hedging interest rate risk, and none of our derivative instruments are used for trading purposes.
We recognize derivatives as assets or liabilities on our consolidated balance sheets at their fair value in accordance with ASC 815, Derivatives and Hedging. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, and further, on the type of hedging relationship. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Currently, we have only designated derivative instruments as cash flow hedges. We may also enter into derivative contracts that are intended to economically hedge interest rate risk, even though hedge accounting does not apply, or we elect not to apply hedge accounting.
To qualify for hedge accounting, concurrent with the execution of a derivative contract, we formally document our risk management objective and strategy for undertaking the hedging transaction, how the hedging instrument is expected to hedge the designated risk related to the hedged item, and the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.
For derivatives designated as cash flow hedging instruments, changes in fair value are initially recorded net of tax in accumulated other comprehensive income (loss) and subsequently reclassified into earnings when the hedged transaction affects earnings. Additionally, changes in the fair value of amounts excluded from the assessment of effectiveness are recorded net of tax in accumulated other comprehensive income (loss) and recognized in earnings using a straight-line amortization method over the term of instrument. Changes in fair value for derivative contracts that do not qualify for hedge accounting (or for those that we elect to not apply hedge accounting), are immediately recognized within earnings. Realized and unrealized gains and losses for derivatives are presented in the statements of comprehensive income (loss) based on the nature and use of the instrument.
We prospectively discontinue hedge accounting if it is determined that the derivative is no longer effective in offsetting the designated risk of the hedged item, the derivative is terminated prior to maturity, or the occurrence of the forecasted transaction (for a cash flow hedge) is no longer probable. When hedge accounting for a cash flow hedge is discontinued, any subsequent changes in fair value of the derivative are recognized immediately in earnings. The cumulative unrealized gain or loss related to the discontinued hedge continues to be reported in accumulated other comprehensive income (loss) and is subsequently reclassified into earnings in the same manner
discussed above, unless it is probable that the forecasted transaction will not occur by the end of the originally specified time period, in which case the cumulative unrealized gain or loss is reclassified into earnings immediately.
v3.23.3
Discontinued Operations
9 Months Ended
Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued Operations
Note 3: Discontinued Operations
On October 31, 2022, we entered into the Purchase Agreement with the Buyer to sell our former tax software business for an aggregate purchase price of $720.0 million in cash, subject to customary purchase price adjustments set forth in the Purchase Agreement. The TaxAct Sale subsequently closed on December 19, 2022. This divestiture was considered part of our strategic shift to become a pure-play wealth management company and was determined to meet discontinued operations accounting criteria under ASC 205.
During the nine months ended September 30, 2023, we finalized our previously estimated closing date working capital balance, resulting in an incremental pre-tax gain of $2.5 million which is included within “Pre-tax gain on disposal” in the condensed consolidated statements of comprehensive income (loss).
The following table presents summarized information regarding certain components of income (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Revenues$— $6,664 $— $242,028 
Operating expenses— 19,425 — 142,579 
Interest expense and other, net— (9,591)— (25,284)
Income (loss) from discontinued operations before gain on disposal and income taxes— (22,352)— 74,165 
Pre-tax gain on disposal— — 2,539 — 
Income (loss) from discontinued operations before income taxes— (22,352)2,539 74,165 
Income tax benefit (expense)— 190 (618)(26,681)
Income (loss) from discontinued operations$— $(22,162)$1,921 $47,484 
v3.23.3
Revenue Recognition
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Revenue Recognition
Note 4: Revenue Recognition
Revenue primarily consists of advisory revenue, commission revenue, asset-based revenue, and transaction and fee revenue.
Revenues by major category and the timing of revenue recognition was as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Recognized upon transaction:
Commission$20,448 $17,868 $57,333 $56,373 
Transaction and fee1,054 1,307 3,066 3,813 
Total revenue recognized upon transaction$21,502 $19,175 $60,399 $60,186 
Recognized over time:
Advisory$108,393 $95,070 $309,234 $306,394 
Commission22,903 23,920 69,329 75,905 
Asset-based33,444 21,147 100,524 33,774 
Transaction and fee6,101 5,720 17,765 17,845 
Total revenue recognized over time$170,841 $145,857 $496,852 $433,918 
Total revenue:
Advisory$108,393 $95,070 $309,234 $306,394 
Commission43,351 41,788 126,662 132,278 
Asset-based33,444 21,147 100,524 33,774 
Transaction and fee7,155 7,027 20,831 21,658 
Total revenue$192,343 $165,032 $557,251 $494,104 
v3.23.3
Asset Acquisitions
9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Asset Acquisitions
Note 5: Asset Acquisitions
During the nine months ended September 30, 2023, we completed acquisitions that met the criteria to be accounted for as asset acquisitions. Total initial purchase consideration, including acquisition costs and fixed deferred payments, was $5.2 million. This purchase consideration was allocated to client relationship intangibles. Client relationship intangibles are amortized on a straight-line basis over an amortization period of 15 years.
We are subject to variable contingent consideration payments related to our asset acquisitions that are not recognized as a liability on our condensed consolidated balance sheets until all contingencies related to the achievement of future financial targets are resolved and the consideration is payable. As of September 30, 2023, the maximum future fixed and contingent payments associated with all prior asset acquisitions were $25.6 million, with specified payment dates from 2023 through 2027.
v3.23.3
Debt
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Debt
Note 6: Debt
Our debt consisted of the following as of the periods indicated in the table below (in thousands):
September 30, 2023December 31, 2022
Delayed Draw Term Loan Facility
Principal outstanding$266,625 $— 
Unamortized debt issuance costs(5,208)— 
Unamortized debt discount(1,216)— 
Net carrying value$260,201 $— 
In May 2017, we entered into a credit agreement (as the same has been amended, the “Credit Agreement”) with a syndicate of lenders, which provided for a term loan facility and a revolving line of credit (including a letter of credit sub-facility) for working capital, capital expenditures, and general business purposes. Subject to the terms of the Credit Agreement, we repaid the remaining principal amount outstanding under the Credit Agreement in connection with the TaxAct Sale in the fourth quarter of 2022.
On January 24, 2023 (the “Closing Date”), we entered into a restatement agreement (the Amended and Restated Credit Agreement”), which amended and restated in its entirety our previous Credit Agreement. The Amended and Restated Credit Agreement provides for a new delayed draw term loan facility up to a maximum principal amount of $270.0 million (the “Delayed Draw Term Loan Facility”) and a revolving credit facility with a commitment amount of $50.0 million (the “Revolving Credit Facility”). We may borrow term loans under the Delayed Draw Term Loan Facility (the “Term Loans”) until January 24, 2024. The stated maturity date of the Delayed Draw Term Loan Facility and the Revolving Credit Facility is January 24, 2028 (the “Maturity Date”). The proceeds of any Term Loans may be used to fund shareholder distributions and for general corporate purposes. The proceeds of any loans under the Revolving Credit Facility may be used to finance working capital needs and for general corporate purposes. On February 24, 2023, we borrowed $170.0 million under the Delayed Draw Term Loan Facility. During the second quarter of 2023, we borrowed the remaining $100.0 million available under the Delayed Draw Term Loan Facility.
We capitalized approximately $8.5 million of debt discount and issuance costs in connection with the Amended and Restated Credit Agreement. A portion of these costs were allocated to the Revolving Credit Facility and are included in other long-term assets on the Company’s condensed consolidated balance sheets.
As of September 30, 2023, we had $266.6 million in principal amount outstanding under the Delayed Draw Term Loan Facility and no amounts outstanding under the Revolving Credit Facility. As of September 30, 2023, $50.0 million was available for future borrowings under the Revolving Credit Facility, subject to customary terms and conditions. Subject to certain conditions set forth in the Amended and Restated Credit Agreement, we may borrow, prepay, and reborrow under the Revolving Credit Facility and terminate or reduce the Lenders’ commitments at any time prior to the Maturity Date.
We are required to make quarterly principal amortization payments on the Delayed Draw Term Loan Facility on the last business day of each fiscal quarter, beginning with the last business day of June 2023. These payments will amortize in equal quarterly installments based on the following aggregate annual amounts (expressed as a percentage of the principal amount of Term Loans borrowed): 2.5% during the first year ended December 31, 2023, 5% during years two and three, 7.5% during year four, and 10% during year five. Any remaining Term Loans outstanding are due on the Maturity Date.
Commencing with the first year ending December 31, 2023, we may be required to make annual prepayments on the Term Loans in an amount equal to a percentage of Excess Cash Flow (as defined in the Amended and Restated Credit Agreement). The percentage of Excess Cash Flow ranges from 0% to 50% depending on our Consolidated First Lien Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement). We may voluntarily prepay the Term Loans in whole or in part without premium or penalty.
Subject to customary reference rate availability provisions, the borrowings under the Amended and Restated Credit Agreement will bear interest at a rate per annum equal to (i) the Term SOFR Rate (as defined in the Amended and Restated Credit Agreement, and which includes a 0.10% credit spread adjustment) plus a margin ranging from 2.25% to 2.75% (which margin would be 2.75% as of the Closing Date), or (ii) a base rate based on the highest of the Wall Street Journal prime rate, the federal funds rate plus 0.50% and the Term SOFR (as defined in the Amended and Restated Credit Agreement, and which includes a 0.10% credit spread adjustment) rate plus 1.00%, in each case plus a margin ranging from 1.25% to 1.75% (which margin would be 1.75% as of the Closing Date). The margin is determined based on the Company’s Consolidated First Lien Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement). We are required to pay a quarterly commitment fee on the daily amount of the undrawn portion of the revolving commitments under the Revolving Credit Facility ranging from 0.35% to 0.45%. Interest is payable at the end of each interest period, typically quarterly.
The obligations of the Company under the Amended and Restated Credit Agreement are secured by a first-priority security interest in substantially all of the existing and future personal property of the Company and certain of its subsidiaries.
Pursuant to the Amended and Restated Credit Agreement, we shall not permit (i) the Consolidated Total Net Leverage Ratio (as defined in the Amended and Restated Credit Agreement) to exceed 4.00 to 1.00 between March 31, 2023 and June 30, 2024, or 3.75 to 1.00 between July 1, 2024 and the Maturity Date, (ii) the Consolidated Fixed Charge Coverage Ratio (as defined in the Amended and Restated Credit Agreement) to be less than 1.25 to 1.00 or (iii) Liquidity (as defined in the Amended and Restated Credit Agreement) on the last day of any fiscal quarter to be less than $50 million. The Company was in compliance with the debt covenants of the Amended and Restated Credit Agreement as of September 30, 2023.
v3.23.3
Leases
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Leases
Note 7: Leases
Our leases are primarily related to office space and are classified as operating leases. Operating lease cost, net of sublease income, is recognized in “General and administrative” expense for those net costs related to leases used in our operations and within “Acquisition and integration” expense for those net costs related to an unoccupied lease assumed in a previous acquisition on the condensed consolidated statements of comprehensive income (loss).
During the nine months ended September 30, 2023, we began subleasing portions of our corporate headquarters in Dallas, Texas. These subleases were classified as operating leases at inception, with sublease income recognized on a straight-line basis over the five-year and ten-year respective sublease terms.
Operating lease cost, net of sublease income, and cash paid on operating lease liabilities for the three and nine months ended September 30, 2023 and 2022 were as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Fixed lease cost$972 $965 $2,908 $2,885 
Variable lease cost415 258 1,163 1,023 
Operating lease cost, before sublease income1,387 1,223 4,071 3,908 
Sublease income(684)(235)(1,642)(703)
Total operating lease cost, net of sublease income$703 $988 $2,429 $3,205 
Additional lease information:
Cash paid on operating lease liabilities$1,336 $1,297 $3,955 $3,788 
Lease liabilities obtained from new right-of-use assets$— $262 $— $390 
Right-of-use assets and operating lease liabilities were recorded on the condensed consolidated balance sheets as follows (in thousands):
September 30, 2023December 31, 2022
Right-of-use assets, net$18,126 $19,361 
Current lease liabilities$5,107 $5,139 
Long-term lease liabilities27,797 30,332 
Total operating lease liabilities$32,904 $35,471 
Weighted-average remaining lease term (in years)8.99.4
Weighted-average discount rate5.5 %5.5 %
The maturities of our operating lease liabilities as of September 30, 2023 were as follows (in thousands):
Undiscounted cash flows:
Remainder of 2023$1,329 
20245,174 
20255,086 
20264,256 
20273,858 
Thereafter22,315 
Total undiscounted cash flows42,018 
Imputed interest(9,114)
Present value of cash flows$32,904 
Leases
Note 7: Leases
Our leases are primarily related to office space and are classified as operating leases. Operating lease cost, net of sublease income, is recognized in “General and administrative” expense for those net costs related to leases used in our operations and within “Acquisition and integration” expense for those net costs related to an unoccupied lease assumed in a previous acquisition on the condensed consolidated statements of comprehensive income (loss).
During the nine months ended September 30, 2023, we began subleasing portions of our corporate headquarters in Dallas, Texas. These subleases were classified as operating leases at inception, with sublease income recognized on a straight-line basis over the five-year and ten-year respective sublease terms.
Operating lease cost, net of sublease income, and cash paid on operating lease liabilities for the three and nine months ended September 30, 2023 and 2022 were as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Fixed lease cost$972 $965 $2,908 $2,885 
Variable lease cost415 258 1,163 1,023 
Operating lease cost, before sublease income1,387 1,223 4,071 3,908 
Sublease income(684)(235)(1,642)(703)
Total operating lease cost, net of sublease income$703 $988 $2,429 $3,205 
Additional lease information:
Cash paid on operating lease liabilities$1,336 $1,297 $3,955 $3,788 
Lease liabilities obtained from new right-of-use assets$— $262 $— $390 
Right-of-use assets and operating lease liabilities were recorded on the condensed consolidated balance sheets as follows (in thousands):
September 30, 2023December 31, 2022
Right-of-use assets, net$18,126 $19,361 
Current lease liabilities$5,107 $5,139 
Long-term lease liabilities27,797 30,332 
Total operating lease liabilities$32,904 $35,471 
Weighted-average remaining lease term (in years)8.99.4
Weighted-average discount rate5.5 %5.5 %
The maturities of our operating lease liabilities as of September 30, 2023 were as follows (in thousands):
Undiscounted cash flows:
Remainder of 2023$1,329 
20245,174 
20255,086 
20264,256 
20273,858 
Thereafter22,315 
Total undiscounted cash flows42,018 
Imputed interest(9,114)
Present value of cash flows$32,904 
v3.23.3
Balance Sheet Components
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components
Note 8: Balance Sheet Components
Prepaid expenses and other current assets consisted of the following (in thousands):
September 30, 2023December 31, 2022
Prepaid expenses$9,679 $7,857 
Prepaid income taxes14,062 — 
Forgivable loans6,910 5,951 
Other current assets2,293 1,219 
Total prepaid expenses and other current assets$32,944 $15,027 
Accrued expenses and other current liabilities consisted of the following (in thousands):
September 30, 2023December 31, 2022
Salaries and related benefit expenses$15,734 $17,481 
Accrued legal costs5,539 1,102 
Accrued vendor and advertising costs1,650 2,726 
Accrued taxes5,444 85,965 
Accrued fixed and variable acquisition consideration3,386 897 
Accrued cash-settled stock-based compensation8,629 2,121 
Interest rate derivatives7,581 — 
Other1,835 920 
Total accrued expenses and other current liabilities$49,798 $111,212 
Other long-term liabilities consisted of the following (in thousands):
September 30, 2023December 31, 2022
Deferred compensation$13,555 $7,974 
Accrued cash-settled stock-based compensation5,594 7,556 
Accrued tax positions4,248 3,616 
Interest rate derivatives10,291 — 
Other3,071 3,330 
Other long-term liabilities$36,759 $22,476 
v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Note 9: Commitments and Contingencies
TaxAct Indemnification Obligations
In connection with the TaxAct Sale, we have certain indemnification obligations to the Buyer, TaxAct Holdings, Inc. and their respective affiliates and representatives with respect to certain losses actually incurred or suffered as a result of any claim, action, suit, or proceeding against such indemnitees arising out of or relating to the use by us or any of our affiliates in the tax software business of website tracking and analytics technologies prior to the closing of the TaxAct Sale. Such indemnification obligations terminate on December 19, 2027 and may not exceed $5.4 million ($1.0 million of which is allocable to the deductible under our insurance policies). We believe that applicable insurance policies will cover all or a substantial portion of any claims made by the Buyer under such indemnification obligations. The current carrying amount of the liability for these indemnification obligations is approximately $0.9 million as of September 30, 2023 and is included within “Other long-term liabilities” on the condensed consolidated balance sheets.
Litigation
From time to time, we are subject to various legal proceedings, regulatory matters or fines, or claims that arise in the ordinary course of business. We accrue a liability when management believes that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. Although we believe that resolving such claims, individually or in aggregate, will not have a material adverse impact on our financial statements, these matters are subject to inherent uncertainties.
We are not currently a party to any such matters for which we have recognized a material liability on our condensed consolidated balance sheet as of September 30, 2023.
We have entered into indemnification agreements in the ordinary course of business with our officers and directors. Pursuant to these agreements, we may be obligated to advance payment of legal fees and costs incurred by the defendants pursuant to our obligations under these indemnification agreements and applicable Delaware law.
v3.23.3
Fair Value Measurements
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 10: Fair Value Measurements
Certain of our assets and liabilities are carried at fair value and are valued using inputs that are classified in one of the following three categories:
Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs, other than Level 1, or unobservable inputs that are corroborated by market data.
Level 3: Unobservable inputs that are not corroborated by market data and reflect our own assumptions.
Assets and Liabilities Measured on a Recurring Basis
The fair value hierarchy of our financial assets and liabilities carried at estimated fair value and measured on a recurring basis were as follows (in thousands):
  Fair value measurements at the reporting date using
 September 30, 2023Quoted prices in
active markets
using identical 
assets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Cash equivalents: money market and other funds
$219 $219 $— $— 
Deferred compensation assets14,012 14,012 — — 
Total assets at fair value$14,231 $14,231 $— $— 
Deferred compensation liabilities$14,012 $14,012 $— $— 
Interest rate derivatives 17,872 — 17,872 — 
Total liabilities at fair value$31,884 $14,012 $17,872 $— 
  Fair value measurements at the reporting date using
 December 31, 2022Quoted prices in
active markets
using identical 
assets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Cash equivalents: money market and other funds
$4,369 $4,369 $— $— 
Deferred compensation assets7,974 7,974 — — 
Total assets at fair value$12,343 $12,343 $— $— 
Deferred compensation liabilities$7,974 $7,974 $— $— 
Total liabilities at fair value$7,974 $7,974 $— $— 
Cash equivalents are classified within Level 1 of the fair value hierarchy because we value them utilizing quoted prices in active markets.
We offer non-qualified deferred compensation plans to our executive officers, board of directors, and certain independent financial professionals. Participants in these plans direct the investment of their accounts among the available investment options, which are generally the same as those available under our 401(k) plan. We have elected to fund these obligations through a rabbi trust which mirrors the investment elections made by participants. The assets in the rabbi trust are held for the purpose of satisfying our obligations to participants, however, remain subject to the claims of our creditors in the event we become insolvent. Our obligations and corresponding investments held under these non-qualified deferred compensation plans primarily consist of money market and mutual funds and are classified within Level 1 of the fair value hierarchy because we value them utilizing quoted prices in active markets. These investments, and the corresponding deferred compensation liabilities, are primarily included within “Other long-term assets” and “Other long-term liabilities,” respectively, on the condensed consolidated balance sheets.
We utilize a third-party pricing service to estimate the fair value of our derivative financial instruments. Fair value is estimated using industry standard valuation models that primarily rely on observable market inputs, including daily simple secured overnight financing rates (“SOFR”) overnight index swap rate curves, SOFR swap rate curves, and volatility. Credit valuation adjustments are incorporated in the fair values to reflect nonperformance risk for both the Company and our counterparties. Although we have determined that the majority of the inputs used to value these derivative instruments fall within Level 2 of the fair value hierarchy, the credit valuation adjustments utilize Level 3 inputs, such as estimates of current credit spreads. We have determined that the impact of the credit valuation adjustments is not significant to the overall valuation of these derivatives. As a result, we have classified our derivative financial instruments in Level 2 of the fair value hierarchy.
Fair Value of Financial Instruments
We consider the carrying values of accounts receivable, commissions receivable, other receivables, prepaid expenses, other current assets, financial professional loans, accounts payable, commissions and advisory fees
payable, accrued expenses, and other current liabilities to approximate fair values primarily due to their short-term natures.As of September 30, 2023, the principal amount outstanding for our Delayed Draw Term Loan Facility was $266.6 million. The principal amount outstanding approximated its fair value as it is a variable rate instrument, and its applicable margin is consistent with current market conditions.
v3.23.3
Derivative Financial Instruments
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments
Note 11: Derivative Financial Instruments
We primarily enter into derivative financial instruments as part of our strategy to manage our exposure to changes in interest rates. Our objective in using interest rate derivatives is to reduce variability in the future cash flows we earn from our cash sweep program by limiting our exposure to changes in our contractually specified rate, which is primarily tied to the federal funds rate. To accomplish this objective, we currently utilize interest rate collar and interest rate cap derivative instruments. Our interest rate collar derivatives involve the payment of variable-rate amounts if interest rates rise above the cap strike rate on the contracts and receipts of fixed-rate amounts if interest rates fall below the floor strike rate on the contracts. Our interest rate cap derivatives involve the payment of variable-rate amounts if interest rates rise above the cap strike rate on the contracts. Our interest rate collar derivatives are designated and qualify as cash flow hedges, as defined in ASC 815. Our interest rate cap derivatives do not qualify for cash flow hedge accounting and are considered economic hedges. As of September 30, 2023, the total notional value of our interest rate derivatives represented approximately 65% of the ending client cash balances in our cash sweep program.
We are exposed to credit risk in the event of nonperformance of counterparties for our derivative financial instruments. We manage concentration of counterparty credit risk by limiting acceptable counterparties to major financial institutions with investment grade credit ratings, limiting the amount of credit exposure to individual counterparties and actively monitoring counterparty credit ratings. We also employ master netting arrangements which allow us to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty. Although not completely eliminated, we do not consider the risk of counterparty default to be significant as a result of these protections. Further, none of our derivative financial instruments are subject to collateral or other security arrangements, nor do they contain provisions that are dependent on our credit ratings from any credit rating agency.
We recognize derivative financial instruments in the condensed consolidated financial statements at fair value regardless of the purpose or intent for holding the instruments. The following table presents the gross fair value of our derivative financial instruments as of September 30, 2023 and December 31, 2022 (in thousands):
 Derivative AssetsDerivative Liabilities
September 30, 2023December 31, 2022September 30, 2023December 31, 2022
Derivatives designated as hedging instruments under ASC 815:
Interest rate collars (1)
$— $— $17,235 $— 
Total derivatives designated as hedging instruments under ASC 815— — 17,235 — 
Derivatives not designated as hedging instruments under ASC 815:
Interest rate caps (1)
— — 637 — 
Total derivatives not designated as hedging instruments under ASC 815— — 637 — 
Total derivatives$— $— $17,872 $— 
______________________
(1)As of September 30, 2023, approximately $7.6 million of the fair value of these derivative financial instruments was recorded within “Accrued expenses and other current liabilities,” with the remaining balance recorded within “Other long-term liabilities” on the condensed consolidated balance sheets.
Cash Flow Hedges of Interest Rate Risk
During the second quarter of 2023, we entered into two interest rate collar derivative contracts for a total notional value of $1.5 billion. Each contract is indexed to daily simple SOFR and is a combination of a purchased floor instrument with a strike rate of 2.5% and a sold cap instrument with a strike rate of 5.5%, both of which expire
on May 31, 2026. The total cost for these interest rate collars was $15.3 million, which we elected to defer and will settle through monthly straight-line cash payments to the counterparties over the term of the instruments. This hedging strategy enables us to limit the downside risk of significant reductions to interest rates over the term of the instruments in exchange for capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
We designated these derivative instruments as cash flow hedges and determined that they are highly effective at achieving offsetting changes in cash flows attributable to interest rate fluctuations associated with our cash sweep program. The changes in fair value of the effective portion of these derivative instruments are initially recorded net of tax in accumulated other comprehensive income (loss) as a separate component of stockholders’ equity. These accumulated gains or losses are reclassified into “Revenue” (where the hedged transaction is recorded) on the condensed consolidated statements of comprehensive income (loss) when the hedged transaction affects earnings. We have elected to exclude the change in fair value of these derivative instruments attributable to the passage of time from the assessment of hedge effectiveness. Changes in the fair value of amounts excluded from the assessment of effectiveness are recorded net of tax in accumulated other comprehensive income (loss) and recognized as a reduction to “Revenue” on the condensed consolidated statements of comprehensive income (loss) using a straight-line amortization method over the term of the instruments.
The table below presents the amount of gains and losses related to these derivative financial instruments and their location in the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 (in thousands):
 Gain (Loss)
Recognized in OCI
Gain (Loss)
Recognized in Income
Three Months EndedSeptember 30, 2023September 30, 2022Location of Gain (Loss) Recognized in IncomeSeptember 30, 2023September 30, 2022
Interest rate collars, net of tax$(1,957)$— Revenue$(975)$— 
Nine Months Ended
Interest rate collars, net of tax$(14,350)$— Revenue$(1,307)$— 
As of September 30, 2023, we estimate that $4.9 million of the deferred amounts recorded in accumulated other comprehensive income (loss) for our cash flow hedges will be reclassified into earnings within the next twelve months.
Gains and losses on our cash flow hedges are net of income tax benefit of $0.3 million and $4.2 million for the three and nine months ended September 30, 2023, respectively. Cash flows from these derivative instruments are included within operating activities in the condensed consolidated statements of cash flows, as our accounting policy is to present cash flows from hedging instruments in the same category as the item being hedged.
Economic Hedges of Interest Rate Risk
We also utilize interest rate cap derivatives to manage our economic exposure to interest rate movements which do not meet the hedge accounting requirements of ASC 815. During the second quarter of 2023, we sold two interest rate cap derivative contracts for a total notional value of $240.0 million. Each contract is indexed to daily simple SOFR, has a strike rate of 5.5%, and expires on May 31, 2026. These interest rate caps were sold for a total premium of $1.2 million, which were deferred and will be settled by the counterparties through monthly straight-line cash payments over the term of the instruments. This hedging strategy enables us to offset a portion of the total cost of our interest rate collar derivatives by capping the amount of our future cash flows that may be received from our cash sweep program for the comparable notional amount hedged.
These derivative instruments are not designated for hedge accounting treatment, therefore, realized and unrealized gains or losses on the instruments are immediately recognized within “Interest expense and other, net” on the condensed consolidated statements of comprehensive income (loss). Cash flows from these derivative instruments are included within operating activities in the condensed consolidated statements of cash flows.
The table below presents the amount of gains and losses related to these derivative financial instruments and their location in the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 (in thousands):
 Gain (Loss)
Recognized in Income
Three Months EndedLocation of Gain (Loss)
Recognized in Income
September 30, 2023September 30, 2022
Interest rate capsInterest expense and other, net$336 $— 
Nine Months Ended
Interest rate capsInterest expense and other, net$(506)$— 
Accumulated Other Comprehensive Income (Loss)
The table below presents a roll forward of the amounts included in accumulated other comprehensive income (loss), net of taxes, for the three and nine months ended September 30, 2023 (in thousands):
Interest Rate CollarsDeferred TaxesAccumulated Other Comprehensive Income (Loss)
Balance as of December 31, 2022$— $— $— 
Balance as of March 31, 2023— — — 
Changes in fair value(16,377)3,984 (12,393)
Reclassification to earnings439 (107)332 
Balance as of June 30, 2023(15,938)3,877 (12,061)
Changes in fair value(2,585)628 (1,957)
Reclassification to earnings1,288 (313)975 
Balance as of September 30, 2023$(17,235)$4,192 $(13,043)
There was no derivative activity to report for the three and nine months ended September 30, 2022.
v3.23.3
Stockholders' Equity
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stockholders' Equity
Note 12: Stockholders' Equity
Capital Return Program
On January 27, 2023, we commenced a modified “Dutch Auction” tender offer (the “Tender Offer”) to purchase shares of our common stock for an aggregate purchase price of up to $250.0 million at a price per share not less than $27.00 and not greater than $31.00. The Tender Offer was in addition to, and separate from, the $200.0 million stock repurchase authorization discussed below. Upon the conclusion of the Tender Offer, we repurchased and subsequently retired approximately 8.3 million shares of our common stock at the purchase price of $30.00 per share, for aggregate cash consideration of $250.0 million. We incurred approximately $4.5 million for fees and expenses associated with the Tender Offer, including approximately $2.4 million for estimated excise taxes owed under the Inflation Reduction Act of 2022, which were recorded within stockholders’ equity.
Repurchased common stock that is subsequently retired is deducted from common stock for par value and from additional paid-in capital for the excess over par value. Direct costs incurred to repurchase common stock are included in the total cost of the shares.
Stock Repurchase Authorization
On December 19, 2022, we announced that our board of directors authorized the Company to repurchase up to $200.0 million of our common stock. This repurchase authorization does not obligate us to repurchase any specific number of shares, may be suspended or discontinued at any time, and does not have a specified expiration date.
For the three months ended September 30, 2023, we repurchased approximately 0.4 million shares of our common stock under the stock repurchase authorization for aggregate purchase consideration of approximately $9.1 million. For the nine months ended September 30, 2023, we repurchased approximately 3.5 million shares of
our common stock under the stock repurchase authorization for aggregate purchase consideration of approximately $85.0 million. The remaining authorized amount under the stock repurchase authorization as of September 30, 2023, was approximately $115.0 million.
For the three months ended September 30, 2022, we did not repurchase any shares of our common stock under our previous stock repurchase plan. For the nine months ended September 30, 2022, we repurchased approximately 1.9 million shares of our common stock under our previous stock repurchase plan for aggregate purchase consideration of approximately $35.0 million.
v3.23.3
Interest Expense and Other, Net
9 Months Ended
Sep. 30, 2023
Other Income and Expenses [Abstract]  
Interest Expense and Other, Net
Note 13: Interest Expense and Other, Net
“Interest expense and other, net” on the condensed consolidated statements of comprehensive income (loss) consisted of the following (in thousands):            
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Interest expense$5,556 $52 $11,748 $133 
Amortization of debt issuance costs363 — 737 — 
Amortization of debt discount68 — 134 — 
Total interest expense5,987 52 12,619 133 
Interest income and other106 106 (918)290 
Transition services agreement income(642)— (3,288)— 
Derivative losses (gains) - interest rate caps(336)— 506 — 
Interest expense and other, net$5,115 $158 $8,919 $423 
In connection with the TaxAct Sale, we entered into a transition services agreement with the Buyer pursuant to which we will provide the Buyer with certain transition services for an initial period ending on June 19, 2023. Under the terms of the original transition services agreement, this agreement was extended to and completed on September 19, 2023. The income from this agreement is included in the table above and largely offsets the costs incurred to provide these transition services, which are included within our operating expenses.
v3.23.3
Income Taxes
9 Months Ended
Sep. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes
Note 14: Income Taxes
Our provision for income taxes in interim periods is based on our estimated annual effective tax rate. We record cumulative adjustments in the quarter in which a change in the estimated annual effective rate is determined. The estimated annual effective tax rate does not include the effects of discrete events that may occur during the year. The effect of these events, if any, is recorded in the quarter in which the event occurs.
We recorded income tax benefit of $1.1 million and income tax expense of $0.5 million for the three and nine months ended September 30, 2023, respectively. Our effective income tax rate for the three and nine months ended September 30, 2023 differed from the 21% statutory rate primarily due to non-deductible compensation and the effect of state taxes.
We recorded an income tax benefit of $1.5 million and $22.6 million for the three and nine months ended September 30, 2022, respectively. Our effective tax rate for the three and nine months ended September 30, 2022 differed from the 21% statutory rate primarily due to the release in our valuation allowance and the effect of state income taxes.
v3.23.3
Net Income Per Share
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Net Income Per Share
Note 15: Net Income Per Share
“Basic net income (loss) per share” is calculated using the weighted average number of common shares outstanding during the applicable period. “Diluted net income (loss) per share” is calculated using the weighted average number of common shares outstanding plus the number of dilutive potential common shares outstanding during the applicable period. Dilutive potential common shares consist of the incremental common shares issuable upon the exercise of outstanding stock options and the vesting of outstanding RSUs using the treasury stock method. Cash-settled restricted stock units are not settled in common shares and are therefore excluded from dilutive potential common shares. Dilutive potential common shares are excluded from the calculation of diluted net income (loss) per share if their effect is antidilutive, including when we report a loss from continuing operations. Performance-based RSUs are considered contingently issuable shares and are excluded from the diluted weighted
average common shares outstanding computation if the related performance-based criteria are not expected to be achieved as of the end of the reporting period.
The calculation of basic and diluted net income (loss) per share is as follows (in thousands, except per share amounts):
Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Numerator:
Income (loss) from continuing operations$(1,495)$321 $1,838 $4,720 
Income (loss) from discontinued operations— (22,162)1,921 47,484 
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Denominator:
Basic weighted average common shares outstanding36,921 47,847 39,971 47,981 
Dilutive potential common shares (1)
— 1,169 969 1,172 
Diluted weighted average common shares outstanding36,921 49,016 40,940 49,153 
Basic net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.05 $0.10 
Discontinued operations— (0.47)0.04 0.99
Basic net income (loss) per share$(0.04)$(0.46)$0.09 $1.09 
Diluted net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.04 $0.10 
Discontinued operations— (0.46)0.05 0.96
Diluted net income (loss) per share$(0.04)$(0.45)$0.09 $1.06 
Shares excluded (1)
2,647 893 387 921 
________________________
(1)Potential common shares were excluded from the calculation of diluted net income per share for these periods because their effect would have been anti-dilutive. For the three months ended September 30, 2023, all potential common shares were excluded from the calculation of diluted net loss per share as their effect would have been anti-dilutive due to the net loss recognized for the period.
v3.23.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Pay vs Performance Disclosure                
Net income (loss) $ (1,495) $ 3,581 $ 1,673 $ (21,841) $ 39,425 $ 34,620 $ 3,759 $ 52,204
v3.23.3
Insider Trading Arrangements
3 Months Ended
Sep. 30, 2023
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.23.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Segments Given the similarities in economic characteristics between our operations and the common nature of the products, services, we currently operate in one reportable segment
Interim Financial Information
The accompanying unaudited condensed consolidated financial statements have been prepared by us under the rules and regulations of the SEC for interim financial reporting. These condensed consolidated financial statements are unaudited and, in management’s opinion, include all adjustments, consisting of normal recurring adjustments and accruals, necessary for a fair presentation of the condensed consolidated financial position, results of operations, and cash flows for the periods presented. Certain information and footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States (GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes in Part II, Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2022. Interim results are not necessarily indicative of results for a full year.
A summary of our significant accounting policies is included in Note 2 to the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022. Other than below, there have been no significant changes in our significant accounting policies since December 31, 2022.
Derivative Financial Instruments
We primarily enter into derivative financial instruments as part of our strategy to manage our exposure to changes in interest rates. Derivative instruments represent contracts between parties that result in one party delivering cash to the other party based on a notional amount and an underlying term (such as an interest rate or index) as specified in the contract. The amount of cash delivered from one party to the other is determined based on the interaction of the notional amount of the contract with the underlying term. We do not enter into derivative instruments for any purpose other than hedging interest rate risk, and none of our derivative instruments are used for trading purposes.
We recognize derivatives as assets or liabilities on our consolidated balance sheets at their fair value in accordance with ASC 815, Derivatives and Hedging. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship, and further, on the type of hedging relationship. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Currently, we have only designated derivative instruments as cash flow hedges. We may also enter into derivative contracts that are intended to economically hedge interest rate risk, even though hedge accounting does not apply, or we elect not to apply hedge accounting.
To qualify for hedge accounting, concurrent with the execution of a derivative contract, we formally document our risk management objective and strategy for undertaking the hedging transaction, how the hedging instrument is expected to hedge the designated risk related to the hedged item, and the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness is formally assessed at inception and at least quarterly throughout the life of the designated hedging relationship.
For derivatives designated as cash flow hedging instruments, changes in fair value are initially recorded net of tax in accumulated other comprehensive income (loss) and subsequently reclassified into earnings when the hedged transaction affects earnings. Additionally, changes in the fair value of amounts excluded from the assessment of effectiveness are recorded net of tax in accumulated other comprehensive income (loss) and recognized in earnings using a straight-line amortization method over the term of instrument. Changes in fair value for derivative contracts that do not qualify for hedge accounting (or for those that we elect to not apply hedge accounting), are immediately recognized within earnings. Realized and unrealized gains and losses for derivatives are presented in the statements of comprehensive income (loss) based on the nature and use of the instrument.
We prospectively discontinue hedge accounting if it is determined that the derivative is no longer effective in offsetting the designated risk of the hedged item, the derivative is terminated prior to maturity, or the occurrence of the forecasted transaction (for a cash flow hedge) is no longer probable. When hedge accounting for a cash flow hedge is discontinued, any subsequent changes in fair value of the derivative are recognized immediately in earnings. The cumulative unrealized gain or loss related to the discontinued hedge continues to be reported in accumulated other comprehensive income (loss) and is subsequently reclassified into earnings in the same manner
discussed above, unless it is probable that the forecasted transaction will not occur by the end of the originally specified time period, in which case the cumulative unrealized gain or loss is reclassified into earnings immediately.
v3.23.3
Discontinued Operations (Tables)
9 Months Ended
Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
Schedule of Financial Information
The following table presents summarized information regarding certain components of income (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Revenues$— $6,664 $— $242,028 
Operating expenses— 19,425 — 142,579 
Interest expense and other, net— (9,591)— (25,284)
Income (loss) from discontinued operations before gain on disposal and income taxes— (22,352)— 74,165 
Pre-tax gain on disposal— — 2,539 — 
Income (loss) from discontinued operations before income taxes— (22,352)2,539 74,165 
Income tax benefit (expense)— 190 (618)(26,681)
Income (loss) from discontinued operations$— $(22,162)$1,921 $47,484 
v3.23.3
Revenue Recognition (Tables)
9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue by Major Customers by Reporting Segments Revenues by major category and the timing of revenue recognition was as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Recognized upon transaction:
Commission$20,448 $17,868 $57,333 $56,373 
Transaction and fee1,054 1,307 3,066 3,813 
Total revenue recognized upon transaction$21,502 $19,175 $60,399 $60,186 
Recognized over time:
Advisory$108,393 $95,070 $309,234 $306,394 
Commission22,903 23,920 69,329 75,905 
Asset-based33,444 21,147 100,524 33,774 
Transaction and fee6,101 5,720 17,765 17,845 
Total revenue recognized over time$170,841 $145,857 $496,852 $433,918 
Total revenue:
Advisory$108,393 $95,070 $309,234 $306,394 
Commission43,351 41,788 126,662 132,278 
Asset-based33,444 21,147 100,524 33,774 
Transaction and fee7,155 7,027 20,831 21,658 
Total revenue$192,343 $165,032 $557,251 $494,104 
v3.23.3
Debt (Tables)
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Schedule of Company's Debt Our debt consisted of the following as of the periods indicated in the table below (in thousands):
September 30, 2023December 31, 2022
Delayed Draw Term Loan Facility
Principal outstanding$266,625 $— 
Unamortized debt issuance costs(5,208)— 
Unamortized debt discount(1,216)— 
Net carrying value$260,201 $— 
v3.23.3
Leases (Tables)
9 Months Ended
Sep. 30, 2023
Leases [Abstract]  
Schedule of Operating Lease Expense Operating lease cost, net of sublease income, and cash paid on operating lease liabilities for the three and nine months ended September 30, 2023 and 2022 were as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Fixed lease cost$972 $965 $2,908 $2,885 
Variable lease cost415 258 1,163 1,023 
Operating lease cost, before sublease income1,387 1,223 4,071 3,908 
Sublease income(684)(235)(1,642)(703)
Total operating lease cost, net of sublease income$703 $988 $2,429 $3,205 
Additional lease information:
Cash paid on operating lease liabilities$1,336 $1,297 $3,955 $3,788 
Lease liabilities obtained from new right-of-use assets$— $262 $— $390 
Schedule of Supplemental Balance Sheet Information Related to Leases Right-of-use assets and operating lease liabilities were recorded on the condensed consolidated balance sheets as follows (in thousands):
September 30, 2023December 31, 2022
Right-of-use assets, net$18,126 $19,361 
Current lease liabilities$5,107 $5,139 
Long-term lease liabilities27,797 30,332 
Total operating lease liabilities$32,904 $35,471 
Weighted-average remaining lease term (in years)8.99.4
Weighted-average discount rate5.5 %5.5 %
Schedule of Maturities of Operating Lease Liabilities The maturities of our operating lease liabilities as of September 30, 2023 were as follows (in thousands):
Undiscounted cash flows:
Remainder of 2023$1,329 
20245,174 
20255,086 
20264,256 
20273,858 
Thereafter22,315 
Total undiscounted cash flows42,018 
Imputed interest(9,114)
Present value of cash flows$32,904 
v3.23.3
Balance Sheet Components (Tables)
9 Months Ended
Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands):
September 30, 2023December 31, 2022
Prepaid expenses$9,679 $7,857 
Prepaid income taxes14,062 — 
Forgivable loans6,910 5,951 
Other current assets2,293 1,219 
Total prepaid expenses and other current assets$32,944 $15,027 
Schedule of Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands):
September 30, 2023December 31, 2022
Salaries and related benefit expenses$15,734 $17,481 
Accrued legal costs5,539 1,102 
Accrued vendor and advertising costs1,650 2,726 
Accrued taxes5,444 85,965 
Accrued fixed and variable acquisition consideration3,386 897 
Accrued cash-settled stock-based compensation8,629 2,121 
Interest rate derivatives7,581 — 
Other1,835 920 
Total accrued expenses and other current liabilities$49,798 $111,212 
Schedule of Other Liabilities Other long-term liabilities consisted of the following (in thousands):
September 30, 2023December 31, 2022
Deferred compensation$13,555 $7,974 
Accrued cash-settled stock-based compensation5,594 7,556 
Accrued tax positions4,248 3,616 
Interest rate derivatives10,291 — 
Other3,071 3,330 
Other long-term liabilities$36,759 $22,476 
v3.23.3
Fair Value Measurements (Tables)
9 Months Ended
Sep. 30, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Hierarchy of Financial Assets Carried at Fair Value and Measured on Recurring Basis The fair value hierarchy of our financial assets and liabilities carried at estimated fair value and measured on a recurring basis were as follows (in thousands):
  Fair value measurements at the reporting date using
 September 30, 2023Quoted prices in
active markets
using identical 
assets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Cash equivalents: money market and other funds
$219 $219 $— $— 
Deferred compensation assets14,012 14,012 — — 
Total assets at fair value$14,231 $14,231 $— $— 
Deferred compensation liabilities$14,012 $14,012 $— $— 
Interest rate derivatives 17,872 — 17,872 — 
Total liabilities at fair value$31,884 $14,012 $17,872 $— 
  Fair value measurements at the reporting date using
 December 31, 2022Quoted prices in
active markets
using identical 
assets
(Level 1)
Significant other
observable
inputs
(Level 2)
Significant
unobservable
inputs
(Level 3)
Cash equivalents: money market and other funds
$4,369 $4,369 $— $— 
Deferred compensation assets7,974 7,974 — — 
Total assets at fair value$12,343 $12,343 $— $— 
Deferred compensation liabilities$7,974 $7,974 $— $— 
Total liabilities at fair value$7,974 $7,974 $— $— 
v3.23.3
Derivative Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Gross Fair Value of Our Derivative Financial Instruments The following table presents the gross fair value of our derivative financial instruments as of September 30, 2023 and December 31, 2022 (in thousands):
 Derivative AssetsDerivative Liabilities
September 30, 2023December 31, 2022September 30, 2023December 31, 2022
Derivatives designated as hedging instruments under ASC 815:
Interest rate collars (1)
$— $— $17,235 $— 
Total derivatives designated as hedging instruments under ASC 815— — 17,235 — 
Derivatives not designated as hedging instruments under ASC 815:
Interest rate caps (1)
— — 637 — 
Total derivatives not designated as hedging instruments under ASC 815— — 637 — 
Total derivatives$— $— $17,872 $— 
______________________ (1)As of September 30, 2023, approximately $7.6 million of the fair value of these derivative financial instruments was recorded within “Accrued expenses and other current liabilities,” with the remaining balance recorded within “Other long-term liabilities” on the condensed consolidated balance sheets.
Schedule of Gains and Losses Related to Derivative Financial Instruments and their Location The table below presents the amount of gains and losses related to these derivative financial instruments and their location in the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 (in thousands):
 Gain (Loss)
Recognized in OCI
Gain (Loss)
Recognized in Income
Three Months EndedSeptember 30, 2023September 30, 2022Location of Gain (Loss) Recognized in IncomeSeptember 30, 2023September 30, 2022
Interest rate collars, net of tax$(1,957)$— Revenue$(975)$— 
Nine Months Ended
Interest rate collars, net of tax$(14,350)$— Revenue$(1,307)$— 
The table below presents the amount of gains and losses related to these derivative financial instruments and their location in the condensed consolidated statements of comprehensive income (loss) for the three and nine months ended September 30, 2023 and 2022 (in thousands):
 Gain (Loss)
Recognized in Income
Three Months EndedLocation of Gain (Loss)
Recognized in Income
September 30, 2023September 30, 2022
Interest rate capsInterest expense and other, net$336 $— 
Nine Months Ended
Interest rate capsInterest expense and other, net$(506)$— 
Schedule of Accumulated Other Comprehensive Income (Loss)
The table below presents a roll forward of the amounts included in accumulated other comprehensive income (loss), net of taxes, for the three and nine months ended September 30, 2023 (in thousands):
Interest Rate CollarsDeferred TaxesAccumulated Other Comprehensive Income (Loss)
Balance as of December 31, 2022$— $— $— 
Balance as of March 31, 2023— — — 
Changes in fair value(16,377)3,984 (12,393)
Reclassification to earnings439 (107)332 
Balance as of June 30, 2023(15,938)3,877 (12,061)
Changes in fair value(2,585)628 (1,957)
Reclassification to earnings1,288 (313)975 
Balance as of September 30, 2023$(17,235)$4,192 $(13,043)
v3.23.3
Interest Expense and Other, Net (Tables)
9 Months Ended
Sep. 30, 2023
Other Income and Expenses [Abstract]  
Schedule of Other Loss, Net “Interest expense and other, net” on the condensed consolidated statements of comprehensive income (loss) consisted of the following (in thousands):            
Three Months Ended
September 30,
Nine Months Ended
September 30,
2023202220232022
Interest expense$5,556 $52 $11,748 $133 
Amortization of debt issuance costs363 — 737 — 
Amortization of debt discount68 — 134 — 
Total interest expense5,987 52 12,619 133 
Interest income and other106 106 (918)290 
Transition services agreement income(642)— (3,288)— 
Derivative losses (gains) - interest rate caps(336)— 506 — 
Interest expense and other, net$5,115 $158 $8,919 $423 
v3.23.3
Net Income Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Dilutive Effect for Awards with Exercise Price Less Than Average Stock Price
The calculation of basic and diluted net income (loss) per share is as follows (in thousands, except per share amounts):
Three Months Ended
September 30,
Nine Months Ended
September 30,
 2023202220232022
Numerator:
Income (loss) from continuing operations$(1,495)$321 $1,838 $4,720 
Income (loss) from discontinued operations— (22,162)1,921 47,484 
Net income (loss)$(1,495)$(21,841)$3,759 $52,204 
Denominator:
Basic weighted average common shares outstanding36,921 47,847 39,971 47,981 
Dilutive potential common shares (1)
— 1,169 969 1,172 
Diluted weighted average common shares outstanding36,921 49,016 40,940 49,153 
Basic net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.05 $0.10 
Discontinued operations— (0.47)0.04 0.99
Basic net income (loss) per share$(0.04)$(0.46)$0.09 $1.09 
Diluted net income (loss) per share:
Continuing operations$(0.04)$0.01 $0.04 $0.10 
Discontinued operations— (0.46)0.05 0.96
Diluted net income (loss) per share$(0.04)$(0.45)$0.09 $1.06 
Shares excluded (1)
2,647 893 387 921 
________________________
(1)Potential common shares were excluded from the calculation of diluted net income per share for these periods because their effect would have been anti-dilutive. For the three months ended September 30, 2023, all potential common shares were excluded from the calculation of diluted net loss per share as their effect would have been anti-dilutive due to the net loss recognized for the period.
v3.23.3
Description of the Business (Details)
$ / shares in Units, $ in Millions
1 Months Ended 9 Months Ended
Oct. 31, 2022
USD ($)
Nov. 30, 2023
USD ($)
$ / shares
Sep. 30, 2023
segment
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Number of reportable segments | segment     1
Discontinued Operations, Disposed of by Sale | Former Tax Software Business      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Cash received from sale of business $ 720.0    
Avantax, Inc | Cetera Holdings | Forecast      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Consideration transferred   $ 1,200.0  
Share price (in USD per share) | $ / shares   $ 26.00  
v3.23.3
Discontinued Operations - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Oct. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Pre-tax gain on disposal   $ 0 $ 0 $ 2,539 $ 0
Discontinued Operations, Disposed of by Sale | Former Tax Software Business          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Cash received from sale of business $ 720,000        
Pre-tax gain on disposal   $ 0 $ 0 $ 2,539 $ 0
v3.23.3
Discontinued Operations- Income Statement (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Pre-tax gain on disposal $ 0 $ 0 $ 2,539 $ 0
Income (loss) from discontinued operations before income taxes 0 (22,352) 2,539 74,165
Income tax benefit (expense) 0 190 (618) (26,681)
Income (loss) from discontinued operations 0 (22,162) 1,921 47,484
Discontinued Operations, Disposed of by Sale | Former Tax Software Business        
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]        
Revenues 0 6,664 0 242,028
Operating expenses 0 19,425 0 142,579
Interest expense and other, net 0 (9,591) 0 (25,284)
Income (loss) from discontinued operations before gain on disposal and income taxes 0 (22,352) 0 74,165
Pre-tax gain on disposal 0 0 2,539 0
Income (loss) from discontinued operations before income taxes 0 (22,352) 2,539 74,165
Income tax benefit (expense) 0 190 (618) (26,681)
Income (loss) from discontinued operations $ 0 $ (22,162) $ 1,921 $ 47,484
v3.23.3
Revenue Recognition (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Disaggregation of Revenue [Line Items]        
Total revenue $ 192,343 $ 165,032 $ 557,251 $ 494,104
Recognized upon transaction:        
Disaggregation of Revenue [Line Items]        
Total revenue 21,502 19,175 60,399 60,186
Recognized over time:        
Disaggregation of Revenue [Line Items]        
Total revenue 170,841 145,857 496,852 433,918
Commission        
Disaggregation of Revenue [Line Items]        
Total revenue 43,351 41,788 126,662 132,278
Commission | Recognized upon transaction:        
Disaggregation of Revenue [Line Items]        
Total revenue 20,448 17,868 57,333 56,373
Commission | Recognized over time:        
Disaggregation of Revenue [Line Items]        
Total revenue 22,903 23,920 69,329 75,905
Transaction and fee        
Disaggregation of Revenue [Line Items]        
Total revenue 7,155 7,027 20,831 21,658
Transaction and fee | Recognized upon transaction:        
Disaggregation of Revenue [Line Items]        
Total revenue 1,054 1,307 3,066 3,813
Transaction and fee | Recognized over time:        
Disaggregation of Revenue [Line Items]        
Total revenue 6,101 5,720 17,765 17,845
Advisory        
Disaggregation of Revenue [Line Items]        
Total revenue 108,393 95,070 309,234 306,394
Advisory | Recognized over time:        
Disaggregation of Revenue [Line Items]        
Total revenue 108,393 95,070 309,234 306,394
Asset-based        
Disaggregation of Revenue [Line Items]        
Total revenue 33,444 21,147 100,524 33,774
Asset-based | Recognized over time:        
Disaggregation of Revenue [Line Items]        
Total revenue $ 33,444 $ 21,147 $ 100,524 $ 33,774
v3.23.3
Asset Acquisitions (Details)
$ in Millions
9 Months Ended
Sep. 30, 2023
USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]  
Asset acquisition, consideration transferred $ 5.2
Maximum  
Acquired Finite-Lived Intangible Assets [Line Items]  
Maximum future contingent payments $ 25.6
Customer Relationships  
Acquired Finite-Lived Intangible Assets [Line Items]  
Useful life 15 years
v3.23.3
Debt - Schedule of Company's Debt (Details) - Delayed Draw Term Loan Facility - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Principal outstanding $ 266,625 $ 0
Unamortized debt issuance costs (5,208) 0
Unamortized debt discount (1,216) 0
Net carrying value $ 260,201 $ 0
v3.23.3
Debt - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Feb. 24, 2023
Jan. 24, 2023
Jun. 30, 2023
Sep. 30, 2023
Term Loan        
Debt Instrument [Line Items]        
Debt outstanding       $ 266,600,000
Revolving Credit Facility        
Debt Instrument [Line Items]        
Debt outstanding       0
Amended and Restate Credit Facility        
Debt Instrument [Line Items]        
Payments of debt issuance costs   $ 8,500,000    
Amount available for future borrowings       $ 50,000,000
Credit spread adjustment (as a percent)   0.10%    
Liquidity requirement   $ 50,000,000    
Amended and Restate Credit Facility | April 1, 2021 Through December 31, 2021        
Debt Instrument [Line Items]        
Line of credit facility, leverage ratio   4.00    
Amended and Restate Credit Facility | January 1, 2022 Through September 30, 2022        
Debt Instrument [Line Items]        
Line of credit facility, leverage ratio   3.75    
Amended and Restate Credit Facility | October 1, 2022 Through December 31, 2022        
Debt Instrument [Line Items]        
Line of credit facility, leverage ratio   1.25    
Amended and Restate Credit Facility | Minimum        
Debt Instrument [Line Items]        
Line of credit facility, commitment fee percentage   0.35%    
Amended and Restate Credit Facility | Maximum        
Debt Instrument [Line Items]        
Line of credit facility, commitment fee percentage   0.45%    
Amended and Restate Credit Facility | SOFR        
Debt Instrument [Line Items]        
Variable interest rate   2.75%    
Amended and Restate Credit Facility | SOFR | Minimum        
Debt Instrument [Line Items]        
Variable interest rate   2.25%    
Amended and Restate Credit Facility | SOFR | Maximum        
Debt Instrument [Line Items]        
Variable interest rate   2.75%    
Amended and Restate Credit Facility | Federal Funds Rate        
Debt Instrument [Line Items]        
Variable interest rate   0.50%    
Amended and Restate Credit Facility | Base Rate        
Debt Instrument [Line Items]        
Credit spread adjustment (as a percent)   0.10%    
Variable interest rate   1.00%    
Amended and Restate Credit Facility | Base Rate | Minimum        
Debt Instrument [Line Items]        
Variable interest rate   1.25%    
Amended and Restate Credit Facility | Base Rate | Maximum        
Debt Instrument [Line Items]        
Variable interest rate   1.75%    
Amended and Restate Credit Facility | Term Loan        
Debt Instrument [Line Items]        
Credit facility   $ 270,000,000    
Proceeds from credit facilities, net of debt discount and issuance costs $ 170,000,000   $ 100,000,000  
Quarterly amortization, year one (as a percent)       2.50%
Quarterly amortization, years two and three (as a percent)       5.00%
Quarterly amortization, year four (as a percent)       7.50%
Quarterly amortization, year five (as a percent)       10.00%
Amended and Restate Credit Facility | Term Loan | Minimum        
Debt Instrument [Line Items]        
Percentage of excess cash flow       0.00%
Amended and Restate Credit Facility | Term Loan | Maximum        
Debt Instrument [Line Items]        
Percentage of excess cash flow       50.00%
Amended and Restate Credit Facility | Revolving Credit Facility        
Debt Instrument [Line Items]        
Credit facility   $ 50,000,000    
v3.23.3
Leases - Narrative (Details)
9 Months Ended
Sep. 30, 2023
Corporate Headquarters 5 Year Sublease  
Lessee, Lease, Description [Line Items]  
Sublease term 5 years
Corporate Headquarters 10 Year Sublease  
Lessee, Lease, Description [Line Items]  
Sublease term 10 years
v3.23.3
Leases - Operating Lease Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Leases [Abstract]        
Fixed lease cost $ 972 $ 965 $ 2,908 $ 2,885
Variable lease cost 415 258 1,163 1,023
Operating lease cost, before sublease income 1,387 1,223 4,071 3,908
Sublease income (684) (235) (1,642) (703)
Total operating lease cost, net of sublease income 703 988 2,429 3,205
Additional lease information:        
Cash paid on operating lease liabilities 1,336 1,297 3,955 3,788
Lease liabilities obtained from new right-of-use assets $ 0 $ 262 $ 0 $ 390
v3.23.3
Leases - Supplement Balance Sheet Information Related to Leases (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
Right-of-use assets, net $ 18,126 $ 19,361
Current lease liabilities 5,107 5,139
Long-term lease liabilities 27,797 30,332
Total operating lease liabilities $ 32,904 $ 35,471
Weighted-average remaining lease term (in years) 8 years 10 months 24 days 9 years 4 months 24 days
Weighted-average discount rate 5.50% 5.50%
v3.23.3
Leases - Maturities of Operating Lease Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Leases [Abstract]    
Remainder of 2023 $ 1,329  
2024 5,174  
2025 5,086  
2026 4,256  
2027 3,858  
Thereafter 22,315  
Total undiscounted cash flows 42,018  
Imputed interest (9,114)  
Present value of cash flows $ 32,904 $ 35,471
v3.23.3
Balance Sheet Components - Prepaid Expenses and Other Current Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Prepaid expenses $ 9,679 $ 7,857
Prepaid income taxes 14,062 0
Forgivable loans 6,910 5,951
Other current assets 2,293 1,219
Total prepaid expenses and other current assets $ 32,944 $ 15,027
v3.23.3
Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Salaries and related benefit expenses $ 15,734 $ 17,481
Accrued legal costs 5,539 1,102
Accrued vendor and advertising costs 1,650 2,726
Accrued taxes 5,444 85,965
Accrued fixed and variable acquisition consideration 3,386 897
Accrued cash-settled stock-based compensation 8,629 2,121
Interest rate derivatives 7,581 0
Other 1,835 920
Total accrued expenses and other current liabilities $ 49,798 $ 111,212
v3.23.3
Balance Sheet Components - Accrued Other Long Term Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Deferred compensation $ 13,555 $ 7,974
Accrued cash-settled stock-based compensation 5,594 7,556
Accrued tax positions 4,248 3,616
Interest rate derivatives 10,291 0
Other 3,071 3,330
Other long-term liabilities $ 36,759 $ 22,476
v3.23.3
Commitments and Contingencies (Details) - Indemnification Agreement
$ in Millions
Sep. 30, 2023
USD ($)
Business Acquisition [Line Items]  
Maximum obligation $ 5.4
Deductible amount 1.0
Loss contingency accrual $ 0.9
v3.23.3
Fair Value Measurements - Schedule of Fair Value Hierarchy of Financial Assets Carried at Fair Value and Measured on Recurring Basis (Details) - Fair Value Measurements, Recurring - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
ASSETS    
Deferred compensation assets $ 14,012 $ 7,974
Total assets at fair value 14,231 12,343
Liabilities    
Deferred compensation liabilities 14,012 7,974
Interest rate derivatives 17,872  
Total liabilities at fair value 31,884 7,974
Money market and other funds    
ASSETS    
Cash equivalents: money market and other funds 219 4,369
Quoted prices in active markets using identical  assets (Level 1)    
ASSETS    
Deferred compensation assets 14,012 7,974
Total assets at fair value 14,231 12,343
Liabilities    
Deferred compensation liabilities 14,012 7,974
Interest rate derivatives 0  
Total liabilities at fair value 14,012 7,974
Quoted prices in active markets using identical  assets (Level 1) | Money market and other funds    
ASSETS    
Cash equivalents: money market and other funds 219 4,369
Significant other observable inputs (Level 2)    
ASSETS    
Deferred compensation assets 0 0
Total assets at fair value 0 0
Liabilities    
Deferred compensation liabilities 0 0
Interest rate derivatives 17,872  
Total liabilities at fair value 17,872 0
Significant other observable inputs (Level 2) | Money market and other funds    
ASSETS    
Cash equivalents: money market and other funds 0 0
Significant unobservable inputs (Level 3)    
ASSETS    
Deferred compensation assets 0 0
Total assets at fair value 0 0
Liabilities    
Deferred compensation liabilities 0 0
Interest rate derivatives 0  
Total liabilities at fair value 0 0
Significant unobservable inputs (Level 3) | Money market and other funds    
ASSETS    
Cash equivalents: money market and other funds $ 0 $ 0
v3.23.3
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Delayed Draw Term Loan Facility    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Principal outstanding $ 266,625 $ 0
v3.23.3
Derivative Financial Instruments - Narrative (Details)
$ in Millions
3 Months Ended 9 Months Ended 38 Months Ended
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
derivativeContract
derivativeContractSold
Sep. 30, 2023
USD ($)
May 31, 2026
USD ($)
Derivative [Line Items]        
Notional value representing cash balance percentage 65.00%   65.00%  
Cash flow hedges reclassified into earnings within next twelve months $ 4.9   $ 4.9  
Income tax benefit $ 0.3   $ 4.2  
Interest Rate Collars | Cash Flow Hedges of Interest Rate Risk        
Derivative [Line Items]        
Number of derivative contracts | derivativeContract   2    
Notional value   $ 1,500.0    
Floor instrument strike rate 2.50%   2.50%  
Interest Rate Collars | Cash Flow Hedges of Interest Rate Risk | Forecast        
Derivative [Line Items]        
Total interest rate cost       $ 15.3
Interest rate caps | Economic Hedges of Interest Rate Risk        
Derivative [Line Items]        
Notional value   $ 240.0    
Number of derivative contracts sold | derivativeContractSold   2    
Derivative strike rate 5.50%   5.50%  
Interest rate caps sold     $ 1.2  
Interest rate caps | Cash Flow Hedges of Interest Rate Risk        
Derivative [Line Items]        
Cap instrument strike rate 5.50%   5.50%  
v3.23.3
Derivative Financial Instruments - Schedule of Gross Fair Value of Our Derivative Financial Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Derivatives, Fair Value [Line Items]    
Derivative Assets $ 0 $ 0
Derivative Liabilities 17,872 0
Accrued Expenses and Other Current Liabilities    
Derivatives, Fair Value [Line Items]    
Derivative Liabilities 7,600  
Derivatives designated as hedging instruments under ASC 815    
Derivatives, Fair Value [Line Items]    
Derivative Assets 0 0
Derivative Liabilities 17,235 0
Derivatives not designated as hedging instruments under ASC 815    
Derivatives, Fair Value [Line Items]    
Derivative Assets 0 0
Derivative Liabilities 637 0
Interest Rate Collars | Derivatives designated as hedging instruments under ASC 815    
Derivatives, Fair Value [Line Items]    
Derivative Assets 0 0
Derivative Liabilities 17,235 0
Interest rate caps | Derivatives not designated as hedging instruments under ASC 815    
Derivatives, Fair Value [Line Items]    
Derivative Assets 0 0
Derivative Liabilities $ 637 $ 0
v3.23.3
Derivative Financial Instruments - Schedule of Gains and Losses Related to Derivative Financial Instruments and their Location (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Interest Rate Collars        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Gain (Loss) Recognized in OCI $ (1,957) $ 0 $ (14,350) $ 0
Interest Rate Collars | Revenue        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Gain (Loss) Recognized in Income (975) 0 (1,307) 0
Interest rate caps | Interest expense and other, net        
Derivative Instruments and Hedging Activities Disclosures [Line Items]        
Gain (Loss) Recognized in Income $ 336 $ 0 $ (506) $ 0
v3.23.3
Derivative Financial Instruments - Schedule of Rollforward of the Amounts Included in Accumulated Other Comprehensive Loss, Net of Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosures [Line Items]              
Equity attributable to parent $ 403,687 $ 411,200 $ 743,198 $ 371,590 $ 389,453 $ 348,873 $ 341,622
AOCI Attributable to Parent, Net of Tax [Roll Forward]              
Beginning balance 411,200 468,044          
Changes in fair value (1,957) (12,393)          
Reclassification to earnings 975 332          
Ending balance 403,687 411,200          
Accumulated Other Comprehensive Income (Loss)              
Derivative Instruments and Hedging Activities Disclosures [Line Items]              
Equity attributable to parent (13,043) (12,061) 0 $ 0 $ 0 $ 0 $ 0
AOCI Attributable to Parent, Net of Tax [Roll Forward]              
Beginning balance (12,061) 0          
Ending balance (13,043) (12,061)          
Interest Rate Collars              
Derivative Instruments and Hedging Activities Disclosures [Line Items]              
Equity attributable to parent (17,235) (15,938) 0        
AOCI Attributable to Parent, Net of Tax [Roll Forward]              
Beginning balance (15,938) 0          
Changes in fair value (2,585) (16,377)          
Reclassification to earnings 1,288 439          
Ending balance (17,235) (15,938)          
Deferred Taxes              
Derivative Instruments and Hedging Activities Disclosures [Line Items]              
Equity attributable to parent 4,192 3,877 $ 0        
AOCI Attributable to Parent, Net of Tax [Roll Forward]              
Beginning balance 3,877 0          
Changes in fair value 628 3,984          
Reclassification to earnings (313) (107)          
Ending balance $ 4,192 $ 3,877          
v3.23.3
Stockholders' Equity (Details) - USD ($)
3 Months Ended 9 Months Ended
Jan. 27, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 19, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Treasury stock $ 250,000,000 $ 9,147,000 $ 51,624,000 $ 279,562,000   $ 4,463,000 $ 30,537,000      
Stock repurchased and retired during period (in shares) 8,300,000                  
Common stock purchase price (in dollars per share) $ 30.00                  
Stock repurchased fees and expenses $ 4,500,000                  
Stock repurchased excise taxes $ 2,400,000                  
Stock Repurchase Authorization Program                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Treasury stock   $ 9,100,000           $ 85,000,000 $ 35,000,000  
Stock repurchase authorization                   $ 200,000,000
Stock repurchases (in shares)   400,000     0     3,500,000 1,900,000  
Stock repurchase program, remaining authorized repurchase amount   $ 115,000,000           $ 115,000,000    
Minimum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share price (USD per share) $ 27.00                  
Maximum                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                    
Share price (USD per share) $ 31.00                  
v3.23.3
Interest Expense and Other, Net (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Other Income and Expenses [Abstract]        
Interest expense $ 5,556 $ 52 $ 11,748 $ 133
Amortization of debt issuance costs 363 0 737 0
Amortization of debt discount 68 0 134 0
Total interest expense 5,987 52 12,619 133
Interest income and other 106 106 (918) 290
Transition services agreement income (642) 0 (3,288) 0
Derivative losses (gains) - interest rate caps (336)      
Derivative losses (gains) - interest rate caps   0 506 0
Interest expense and other, net $ 5,115 $ 158 $ 8,919 $ 423
v3.23.3
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Tax Disclosure [Abstract]        
Income tax expense (benefit) $ (1,068) $ (1,536) $ 524 $ (22,582)
v3.23.3
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Numerator:                
Income (loss) from continuing operations $ (1,495)     $ 321     $ 1,838 $ 4,720
Income (loss) from discontinued operations 0     (22,162)     1,921 47,484
Net income (loss) $ (1,495) $ 3,581 $ 1,673 $ (21,841) $ 39,425 $ 34,620 $ 3,759 $ 52,204
Denominator:                
Basic weighted average common shares outstanding (in shares) 36,921     47,847     39,971 47,981
Dilutive potential common shares (in shares) 0     1,169     969 1,172
Diluted weighted average common shares outstanding (in shares) 36,921     49,016     40,940 49,153
Basic net income (loss) per share:                
Continuing operations (in dollars per share) $ (0.04)     $ 0.01     $ 0.05 $ 0.10
Discontinued operations (in dollars per share) 0     (0.47)     0.04 0.99
Basic net income (loss) per share (in dollars per share) (0.04)     (0.46)     0.09 1.09
Diluted net income (loss) per share:                
Continuing operations (in dollars per share) (0.04)     0.01     0.04 0.10
Discontinued operations (in dollars per share) 0     (0.46)     0.05 0.96
Diluted net income (loss) per share (in dollars per share) $ (0.04)     $ (0.45)     $ 0.09 $ 1.06
Shares excluded (in shares) 2,647     893     387 921

Avantax (NASDAQ:AVTA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Avantax Charts.
Avantax (NASDAQ:AVTA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Avantax Charts.